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Synopsis: Chelation of ‘ferrotoxic’ iron within the colon 
Iron is central to the aetiology of gastrointestinal disease.  Specifically, the toxic effects of 
excess, unabsorbed ‘luminal’ iron ingested from the diet has been shown to be important in 
the development of inflammatory bowel disease and intestinal cancer.  A platform for 
therapeutic intervention is likely to involve chelation of this luminal pool of iron.  As such, a 
range of dietary iron chelators have been tested for their iron binding capacity.   
Natural biopolymers extracted from seaweed (alginates) and a variety of natural polyphenolic 
compounds were stratified in terms of their iron binding potential.  With respect to alginate, it 
was demonstrated that chemical composition had profound effects on iron chelation potential 
and competition from other metal cations.  It was also identified that alginates bind iron and 
subsequently format the chelated iron into a nanoparticle; such activity is likely to modulate 
cellular iron concentrations.  One alginate, Manucol LD, was unique in its iron binding, and 
decreased iron absorption in vitro and in vivo with results demonstrating the chelation of 
luminal iron.   
  The chemical composition that endows Manucol LD with this unique iron 
binding potential was probed and it was concluded that the specific monomeric composition 
of the alginate, alongside its polymer chain length are implicit in forming a ‘protein-like’ iron 
binding pocket.  Disruption of the chemical nature of Manucol LD removed its iron binding 
ability.  With respect to the polyphenols, only one of the tested compounds (quercetin) 
displayed iron chelation activity in vitro and was able to suppress cellular concentrations of 
reactive oxygen species acting as an antioxidant. 
As such, it has been demonstrated that a unique alginate, Manucol LD, is an excellent 
candidate for sequestering luminal iron present in the gastrointestinal tract and in vivo shows 
promising anti-neoplastic activity.  These results underpin the rationale in utilising these types 
of natural and safe bio-polymers for the prevention and treatment of gastrointestinal disease. 
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Iron, Cancer and Chelation. 
 
1.1  Iron  
Iron is central to health and wellbeing, whereas iron excess and accumulation is associated 
with detrimental effects.  For this reason complex homeostatic mechanisms have evolved to 
keep iron concentrations within physiological ranges.  Iron is classified as a micronutrient, 
despite playing a crucial role in the regulation of many cellular functions and as such the total 
amount of body iron is between 3 – 4 g.[1, 2]   When iron is used in biology, for instance 
within the active site of an enzyme, its presence and exposure within that protein structure is 
carefully regulated to ensure it is unable to partake in any toxic related processes. The 
apparent importance of iron becomes evident upon consideration of the numerous proteins 
reliant upon iron such as haemoglobin, myoglobin, cytochrome enzymes, ribonucleotide 
reductase and NADH dehydrogenase.[3, 4]   
 
1.1.1 Cellular iron absorption 
Dietary iron exists in two major forms; haem (or ‘organic’) iron and inorganic iron.  Both 
forms of iron are absorbed by distinct mechanisms.[5]  It is known that only 10-20 % of the 
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daily ingested intake of iron (around 10 – 15 mg) is absorbed, with haem iron being absorbed 
more efficiently than inorganic iron, yet inorganic iron is the most prevalent dietary form 
accounting for around 80 – 90 % of total daily intake.[5-7]  Recommended daily allowances 
of iron are 10 and 15 mg day-1 for men and women respectively.  Table 1.1 illustrates the iron 
content of some foods and the prevalent form of iron within. 
 
Table 1.1: Iron concentrations and type from a variety of food sources.[8] 
Dietary iron form Food source Iron amount per serving (mg) 
Inorganic Oatmeal (90 g) 11.0 
Inorganic Lentils (200 g) 6.6 
Inorganic Spinach (225 g) 3.2 
Inorganic White bread (1 slice) 0.9 
Haem Turkey (85 g) 2.0 
Haem Beef (85 g) 2.2 
Haem Tuna (85 g) 1.3 
Haem  Pork (85 g) 0.7 
 
Inorganic iron absorption takes places within the duodenum; the enterocytes of the proximal 
small intestine express many proteins involved in cellular iron transport; the more distal along 
the small intestine the more reduced the capacity for iron absorption becomes.[9]  Inorganic 
iron from the diet can exist in two forms (ferric or ferrous iron).  Many factors dictate the 
bioavailability of both forms.  Ferric iron with its high charge readily forms salt complexes 
with anionic species present within the diet resulting in diminished absorption.[5]  Another 
confounding factor on ferric-iron bioavailability is its solubility in less-acidic environments, 
specifically above pH 3.  In contrast, ferrous iron does not complex as readily and is soluble at 
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higher pH levels.[5]  As such, gastric acid promotes the reduction and solubilisation of dietary 
ferric iron.[5]   The chronic use of proton pump inhibitors, Helicobacter pylori infection and 
inflammatory conditions decrease non-haem iron absorption.[10]  Not only can the pH 
environment have an impact on iron bioavailability but chemicals within the diet can also 
have considerable influences.  Two notable examples include ascorbic acid and tannins found 
in fruit juices and tea respectively; these can be classed as dietary iron chelators.[11, 12]  
Ascorbic acid can bind to iron increasing its solubility which in turn enhances its 
bioavailability whereas tannins bind iron to form insoluble complexes which decreases irons 
absorbability.[13]  Phytic acid, which forms a considerable component of rice and grains also 
binds iron to limit its absorption likelihood and the effect is so prominent that it has been 
hypothesised that in countries where consumption of phytic-acid containing food is high, the 
increased prevalence of iron deficiency anaemia is due to this diet.[14-17] 
The first phase of inorganic iron absorption, at the apical membrane of the enterocyte, a ferric 
reductase, namely Duodenal cytochrome B (Dcytb), reduces ferric iron to ferrous iron, before 
it is transported into the cell through divalent metal transporter-1 (DMT1).[18]  DMT1 co-
transports Fe(II) and hydrogen ions into the cell.  Interestingly, although ascorbic acid binds 
to iron to increase its bioavailability it has been reported that Dcytb facilitates the reduction of 
ferric iron by electron transfer with intracellular ascorbate, and thus this maybe the 
mechanism by which vitamin C enhances iron absorption.[19]  DMT1 protein in the proximal 
duodenum is expressed exclusively to the villi and is absent within the crypts.[20]  Once 
inside the enterocyte, iron is either stored in an inert form for later use in ferritin (an iron 
storage protein) or it can be utilised immediately for the various cellular processes stated.  
Recently an iron-chaperone has been identified, poly-r(V)-binding protein 1 (PCBP1), which 
transports iron to ferritin and other iron proteins within the cell.[21]  If homeostatic iron 
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demand is high, then the iron will be transported out of the enterocyte into systemic 
circulation.  Exit from the enterocyte is orchestrated by ferroportin (FPN) and the ferroxidase 
hephaestin (HEPH) at the basolateral membrane.[22]  Iron exits via FPN as ferrous iron, 
where it is oxidised to ferric iron before complexation to transferrin (Tf); it is within this 
transferrin carrier protein that iron is safely transported around the body in the serum (figure 
1.1).[23, 24]   
 




Organic iron is also absorbed at the brush border of the enterocyte but occurs via a different 
mechanism which to date is still not clearly defined.  Haem iron is imported into the cell 
through haem carrier protein (HCP1), however this candidate for haem-transport is still 
debated as recent evidence suggests HCP1 is likely to be a folate transporter.[26] Once inside 
the enterocyte, haem is broken down into biliverdin releasing its coordinated iron by haem 
oxygenase-1 (HO-1).[27, 28]    The free ferrous iron is subsequently processed in an identical 
manner to inorganic iron absorption.  More recently it has been described that absorption of 
iron may occur via an endocytic mechanism within the small bowel,[29, 30]  since it is 
unlikely that iron will reach the small bowel in its ‘free’ form due to the chemical conditions 
throughout gastro-intestinal transit.  The more likely form is a precipitated mineralised form 
of iron oxo-hydroxo species, that have been found to be in the form of nanoparticles.[31, 32]  
 
1.1.2 Regulation of cellular and systemic iron metabolism 
Unlike most essential nutrients, no active mechanisms exist for iron excretion in humans, 
although small amounts are lost through skin cell exfoliation and the sloughing of gastro-
intestinal cells.[33]  At a cellular level, the usage and storage of iron is coordinated by iron-
regulatory proteins 1 and 2 (IRP1 and IRP2).  These proteins are directly sensitive to 
intracellular iron concentrations and are able to bind to the 5’ or 3’ iron responsive elements 
(IREs) on the untranslated regions of iron transport protein mRNA to either stabilise or 
destabilise the transcript.[34]  During low intracellular iron concentrations, IRPs bind to the 
3’ IREs of iron uptake proteins and the 5’ of iron storage protein mRNA to stabilise and 
inhibit its translation respectively.  Conversely, in augmented cellular iron concentrations, 




Figure 1.2: Iron-regulatory protein interaction in response to high and low intracellular iron 
levels. 
 
Control of systemic iron levels is solely maintained by modulation of iron absorption.  It has 
been found that Dyctb is upregulated in the duodenum when body iron stores are low.[36] 
Iron absorption is precisely orchestrated by circulating hepcidin (HEPC) which acts on the 
duodenum and also influences the release of iron from hepatocytes and macrophages that are 
involved in the recycling of iron from senescent erythrocytes.[37]  HEPC binds to FPN1 
which initiates its internalisation and lysosomal degradation.  This process results in the 
inhibition of iron release to decrease serum iron levels.[38] 
Hepcidin is a key hormone that is involved in the control of iron homeostasis in the body. 
Physiologically, hepcidin is controlled by iron stores, inflammation, hypoxia, and 
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erythropoiesis and its regulation and release from hepatocytes is coordinated by complex 
processes.[39]  As well as the historical mediation of HEPC by hemojuvelin, TfR2 and HFE, 
other more recently identified pathways exist to regulate HEPC expression (i.e. bone 
morphogenetic protein and JAK2/STAT3 signalling).[40, 41]  The pathophysiology of 
hereditary hemochromatosis as an iron metabolism disorder arises from mutations in the HFE 
protein such that the function of HEPC is lost.[40]  The evolutionary use of HEPC is thought 
to be one of mediating host defence against siderophilic infections, since it has a potent ability 
to limit the accessibility of iron to infectious bacteria.[42] 
 
1.1.3 Disorders of iron metabolism 
Dysregulation of iron metabolism can lead to diseases of iron deficiency or diseases of iron 
overload.  Iron deficiency anaemia arises when the dietary intake of iron does not meet the 
body’s homeostatic demands.[2]  This may be due to inadequate absorption (from poor 
bioavailability, high gastric pH environments, bowel resection or disease) or due to blood loss 
(for example due to gastritis, tumours and ulcers).[2]  Another disease implicated in the 
dysregulation of metabolism is anaemia of chronic inflammation, whereby elevated basal 
levels of interleukin 6 (IL-6) stimulate HEPC expression which in turn ‘locks up’ iron within 
the macrophages and hinders iron export from the enterocytes.[43]  Conversely, iron overload 
can be caused by Hereditary Haemochromatosis (HH) and by frequent blood transfusions.[2]  
Patients with HH absorb two to three times more dietary iron than a normal person, and as 
such once transferrin becomes saturated and is unable to sequester any more absorbed iron 
from enterocytes and as a consequence so called ‘non-transferrin bound iron’ (NTBI) is 
produced.[44]  Excess iron is deposited in parenchymal cells of the liver, heart, pancreas, 
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pituitary gland and the parathyroid gland in these clinical cases.[2]  Interestingly, HH patients 
carry a 20 to 200 fold increase in the risk of developing hepatocellular carcinoma and, as such 
transferrin saturation is a biochemical marker that can be correlated to cancer incidence.[45-
47]  The toxic nature of NTBI is the cause of disease in iron overload, since the usual 
mechanisms that regulate the toxic nature of ‘free iron’ are disrupted.[48]  
 
1.1.4 Redox cycling of iron 
The body prevents the possible toxic chemical activity of iron by storing and transporting it 
around the body in ferritin and transferrin alike.  Ferritin is a complex protein, with a 
molecular weight of 450 kDa and being composed of 24 individual sub-unit proteins, which 
together form the protein coat that surrounds the core of iron.  In total, ferritin can hold up to 
4,500 atoms of iron in the form of hydrous ferric oxides (such as ferrihydrite).[49]  Such 
arrangement minimises the production of potentially harmful redox products from ‘free’ iron.  
Similarly, transferrin binds iron but is a much smaller protein and has the capacity for only 
two iron atoms, yet the affinity of iron binding is strong.[50]  Despite its smaller size, the four 
subunits of Tf interact to form a deep hydrophilic metal binding site, removing iron from 
exposure to the surrounding environment where it can have damaging effects.[51]    
Iron thus represents a paradox for living organisms, by being essential for life with its labile, 
reactive nature but also having the potential to be toxic.  Iron can be toxic through its ability 
to redox cycle, in such a way that it is able to catalyse the formation of reactive oxygen 
species (ROS).  Physiological ROS include superoxide (O2-), hydroxyl radicals (OH∙), alkoxy 
radicals (RO∙) and hydroperoxyl radicals (HO2∙).[52]  Iron being a transition metal has many 
accessible atomic orbitals allowing it to accept and donate electrons of any spin state.  As 
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such, in a reaction with molecular oxygen (that in its ground electronic state has two single 
electrons in two different orbitals) iron can interact in Fenton-type chemistry (figure 1.3). 
 
Fe2+ + H2O2      Fe3+ + OH- +OH∙ 
Fe3+ + O2∙-       Fe2+ + O2 
O2∙- + H2O2        OH- +OH∙ 
Figure 1.3: Fenton chemistry. (I) Fenton-type reaction of ferrous iron with hydrogen peroxide 
to form the hydroxyl radical.  (II) Reduction of ferric iron by the superoxide anion.  (III) Sum 
of reactions (I) and (II) to give the Haber-Weiss reaction, which is iron-catalysed formation of 
the hydroxyl radical.[53] 
 
In order to prevent iron from participating in such a catalytic cycle, its redox potential needs 
to be controlled by iron chelation which alters the electronic configuration of iron and 
sterically hinders access to other compounds (such as H2O2) as only when a free and 
exchangeable coordination site on iron is accessible can such reactions take place.[53, 54] 
Free radicals target DNA, RNA, proteins and lipids to elicit mutations or cause damage 
ultimately resulting in the impairment of cellular function which can lead to cell death.[55]  
The earliest study to document the action of free radicals in DNA damage was the observation 
that chromosomes become fragmented in the presence of hydrogen peroxide and a 
peroxidation activator, such as iron.[56]  Such damaging effects of ROS can promote many 










1.2 Colorectal cancer incidence and prevalence 
Over 40,000 people are diagnosed with colorectal cancer in the UK each year, making it the 
4th most common cancer, behind breast, lung and prostate.  It is the 2nd leading cause of cancer 
related death, with over 16, 000 deaths yearly.[58]  More than 85 % of bowel cancers occur in 
cohort ages 60 and over; this reflects the life-span of the disease and its slow, progressive 
nature.  Approximately 30 % of colorectal cancers arise from the rectum, 25 % in the caecum 
and ascending colon respectively and 20 % in the sigmoid colon.   
 
1.2.1 Structure and function of the colon 
Unlike the small intestine, which utilises endogenous enzymes to break down food into 
absorbable nutrients, the large intestine relies on billions of bacteria, namely the gut flora, to 
process the food in ways that enzymes secreted more proximally are unable to perform.[9]  
The large intestine consists of the caecum, appendix, colon and rectum with its main function 
in desiccation of remnant digesta, storage of faeces and as mentioned, breakdown of complex 
nutrients (for example carbohydrates). 
At a histological level, the intestine is composed of an epithelial layer which contains rapidly 
proliferating cells that reside within the crypts of Lieberkühn, this proliferation is under 
orchestration of the Wnt signalling pathway. [59]  The crypts harbour stem cells, which in 
time differentiate to transit-amplifying cells. Transit-amplifying cells spend approximately 
two days in the crypt, in which they divide 4–5 times before they terminally differentiate into 
the specialised intestinal epithelial cell types.[60-62]   With respect to nutrient absorption, the 
mucosal surfaces of the large intestine consists of three layers; the first containing a single 
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layer of epithelial cells (the epithelium), the second which is the lamina propria which 
consists of subepithelial connective tissue and lymph nodes to the third layer which is the 
muscularis mucosae.[63] The mucosa of the large intestine folds to form crypts that 
invaginate deep into the submucosa (figure 1.4).[64] 
 
Figure 1.4: formation of crypt. Stem cells reside at the crypt bottom and progenitors are 
amplified by constant division along the bottom two thirds of the crypts. Cell cycle arrest and 
differentiation occur along the villus-crypt axis.[64] 
 
Four differentiated cell types mediate the functions of the intestinal epithelium, yet the 
colonocyte which is responsible for absorption within the large intestine is the most abundant.   
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1.2.2 Colorectal cancer symptoms, diagnosis and treatment 
Typically, colorectal cancer patients present with abdominal bloating, pain, blood present in 
the faeces, weight loss or iron deficiency (and as such tiredness) or in emergency situations 
with bowel obstruction.[65]  The faecal occult blood screening test is now established within 
the UK to screen for patients who are asymptomatic but have possible colorectal cancer.  In 
England alone, men and women aged between 60 and 74 are invited to partake, of which, 2 % 
of the cohort will be identified as abnormal.  Of this 2 % cancer will be incident and  38 % 
will have confirmed polyps.[66] 
Colorectal cancer is diagnosed through histological examination of a suspected tissue biopsy 
and following confirmation, the cancer is then staged using computed tomography (CT).  The 
Tumour, Node and Metastasis (TNM) staging system is referenced to rank the progression of 
the identified cancer.  A ‘T’ stage describes the size of the primary tumour, with T1 indicating 
localisation to the inner layer of the bowel, through to T4 whereby the tumour is invaded into 
adjacent organs.  The ‘N’ stage describes presence of cancer within the lymph nodes, with N0 
indicated no lymph node metastasis through to N2 where positive identification in several 
lymph nodes is found.  The ‘M’ stages describe the presence of  distant metastasis, with M0 
and M1 signifying no metastasis and found metastasis respectively.[67]  Unsurprisingly, a 
stage I cancer with TNM rating T1 N0 has a 91 % 5-year survival rate whereas a stage III 
T4N2 has a 27 % 5-year survival rate.[68] 
The tumour stage dictates the extent of treatment required.  Low staged, localised tumours are 
commonly removed, without the need for chemotherapy or sectional removal of the colon.  
Partial colectomy is the standard treatment, with the need for adjuvant chemotherapy if there 
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is an associated high risk of reoccurrence.[69]  It is hoped that screening programmes will 
identify pre-cancerous lesions (benign polyps) within the colon before malignancy is evident. 
 
1.2.3 Colorectal cancer development; a genetic basis 
It is well understood how colorectal cancer results from genetic alterations, tumour-
suppressor inactivation and alterations in cellular molecular pathways.[70]  Changes in the 
Wnt signalling pathway are regarded as the initiating event in colorectal cancer, which is 
unsurprising since Wnt controls cellular proliferation within the intestinal crypts.[71, 72]  
Other molecular pathways which are abrogated in colorectal cancer include p53 and TGF-
β.[73, 74]  These are typical pathological changes that occur in many sporadic colorectal 
carcinomas, with over 85 % showing loss of APC function (figure 1.5).[75, 76] 
  
 




Homozygous deletion of APC, the initial driver in colorectal cancer formation, leads to polyp 
growth through activation of the Wnt signalling pathway.  Normal functioning APC serves to 
dampen Wnt signalling through its formation of a destruction complex, coupled with 
glycogen synthase 3β (GSK3β) and axin which phosphorylates β-catenin, targeting it for 
ubiquitination and subsequent degradation.[71]   As such, colon cancer cells with loss of APC 
contain high levels of β-catenin, which is able to translocate to the nucleus where it can bind 
to transcription factors activing oncogenes such as c-myc and cyclin D1 (figure 1.6).[78] 
 
 
Figure 1.6: Cellular functions of APC in Wnt signalling.[78] 
 
FUNCTIONING APC MUTANT APC 
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The importance of Wnt is further exemplified by the inherited condition of familial 
adenomatous polyposis (FAP), which is one of many risk factors for the development of 
colorectal cancer.   
 
1.2.4 Risk factors associated with colorectal cancer 
Most cases of colorectal cancer arise sporadically.[79]  Despite this, two hereditary genetic 
conditions, namely, familial adenomatous polyposis (FAP) and hereditary non polyposis 
colorectal (HNPCC or Lynch syndrome) account for around 5 % of bowel cancers.[80, 81]   
FAP originates with germ line mutations in APC and with subsequent loss of a second copy of 
APC within intestinal cells leads to many small, polyps or adenomas to develop within the 
large bowel.[76]   Most bowel cancers stem from adenomas and it has been estimated that a   
1 cm2 polyp has a 1 in 6 chance of becoming neoplastic within 5 years of initial growth.[80]  
Risk of colorectal cancer development is almost certain if mutations in other tumour 
suppressors and oncogenes arises.[82] 
Inflammatory bowel disease; Ulcerative Colitis (UC) and Crohn’s disease both augment the 
risk of colorectal cancer development.[83-86]  The majority of gastro-intestinal disease 
originates from an inflammatory state, and the toxic effects of iron are able to aggravate this 
inflammatory phenotype.[87]  As such, iron has been implicated in Crohn’s disease, 
inflammatory bowel disease and ulcerative colitis.[88-91]  It has been suggested that iron 
present within the lumen on the colon is able to augment the inflammatory environment 
through its ROS generating potential.[92, 93]  Paradoxically, sufferers of gastrointestinal 
disease are commonly supplemented with iron to combat anaemia which is likely to be a 
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consequence of blood loss or anaemia of chronic disease.  Other likely risk factors for 
colorectal cancer include smoking, alcohol consumption, physical inactivity and obesity.[58] 
Diet and lifestyle are without doubt the main contributing factor in risk to developing 
colorectal cancer, with between 30-40 % of cancer cases worldwide being preventable by a 
change in diet.[94, 95]  High amounts of fat, protein and low fibre diets have been correlated 
with an increased risk of developing colorectal cancer, alongside diets that contain high 
proportions of red and processed meat.[96]    Iron is highly concentrated in red meat, and 
although there are other possible mechanisms in which red meat can cause colorectal cancer, 
high consumption of iron has been implicated.[93] 
 
1.2.4.1 Iron and cancer association; human studies 
It has been observed that the incidence of colorectal cancer is greater in those continents 
where high amounts of red and processed meats are consumed, compared to continents whose 






Figure 1.7: Map of global incidence (per 100,000) distribution of colorectal cancer. 
 
Increased prevalence of colorectal cancer is evident in western continents where red and 
processed meat consumption is high, as such, considered that since these foods contain high 
amounts of iron that dietary iron intake has been may be a risk factor in colorectal cancer 
development.[46, 98, 99]  A meta-analysis of 33 epidemiological studies showed that 75 % of 
studies supported an association between excess iron and colorectal cancer incidence, 
however clarification between the difference of iron ‘exposure’ and body iron levels needs to 
be better defined.[100]    In a more recent meta-analysis of red-meat and processed meat 
consumption correlation with colorectal cancer incidence, the same relationship was found 
and results suggest that the risk of colorectal cancer development increases linearly up to 
approximately 140 g/day of intake.[101] With respect to body iron stores, and transferrin 
saturation, Mainous et al. demonstrated that daily intake of dietary iron exceeding more than 
18 mg is associated with an increased risk of cancer.[46] 
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Likewise, Hereditary Haemochromatosis (HH), a highly prevalent genetic disease in western 
populations, is a condition characterised by iron overload and high cellular loading of iron 
within the liver, heart and endocrine organs due to mutations in the haemochromatosis (HFE) 
gene.[102, 103]  As such, this condition presents itself as an excellent case for an association 
study, and indeed, it has been found that there is a positive correlation between heterozygosity 
of HFE and the risk of colorectal cancer.[102, 104]   
 
1.2.4.2 Iron and cancer association; cell studies 
The crucial role of iron in cellular proliferation, growth and cell cycle progression makes it 
somewhat unsurprising that iron has been implicated in the development of cancer.[105, 106]  
Neoplastic cells therefore have a higher demand for iron.[107]  It has been observed that 
cancer cells do indeed have increased intracellular iron concentrations and increased 
expression of iron acquisition proteins, namely TfR1 and DMT1 have been reported.[108, 
109]. Increased iron acquisition, along the adenoma-carcinoma progression pathway has also 
been established.[110]    As such, iron can not only drive cancer growth, but also, as 
discussed, its redox ability maybe such that it can also act as a mutagenic initiator.[111]  The 
ability for ‘free’ iron to redox cycle and catalyse ROS formation has been demonstrated as a 
potential carcinogenic initiator in cancer development. [112]   
 
Loss of functioning APC is implicated in the neoplastic advancement from adenoma to 
carcinoma.[64]  It has been found that iron can amplify the effects of APC loss in enterocytes, 
exacerbating the cancer phenotype.[113]  Likewise, the target gene of Wnt is the proto-
oncogene c-myc, which is able to regulate TfR1, enabling the cancer cell to acquire more 
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systemically circulating iron.[114]  It has been demonstrated that iron chelation can serve as 
an effective mechanism to inhibit Wnt signalling, which may present a possible 
chemotherapeutic mechanism in colorectal cancer treatment.[115]  Evidence suggesting irons 
ability to suppress expression of the cell adhesion protein E-cadherin further suggests that a 
dysregulation of iron metabolism is intimately linked to tumorigenesis.[113]  
 
1.2.4.3 Animal evidence; a role for luminal iron 
The earliest study performed to demonstrate the carcinogenic potential of iron in vivo 
demonstrated that 70 % of rats injected subcutaneously with iron (dextran) formed tumorous 
lesions at the site of administration.[116]  Many in vivo studies have followed with paralleled 
findings that there is a synergy between iron and carcinogenic initiators (chemical or genetic) 
driving tumorigenesis.[117-122]     
It has recently been demonstrated that it is specifically an excess of iron residing within the 
colonic lumen that is driving colorectal cancer.[120]  This is best exemplified by a study 
conducted using APC min/+ mice, a model of human intestinal cancer.  In this study, when 
APCmin/+ mice were fed an iron deficient diet tumour burden was dramatically reduced 
compared to their control cohort who received a standard iron-containing diet.  However, the 
reduced tumour burden could be due to i) systemic iron deficiency or ii) the loss of so-called 
‘luminal iron’ (excess iron present within the large bowel).  To delineate which pool of iron 
was associated with the decrease in tumour burden the same group of mice that were fed an 
iron deficient diet were maintained systemically iron replete, by intravenous injection of iron 
dextran.  Tumour burden was again significantly lower in this group compared to those fed an 




Figure 1.8:  Tumour burden for APC min/+ mice fed a control diet, iron deficient diet (IDD), 
iron deficient diet with intravenous iron-dextran supplementation and iron dextran (IDex) 
alone with associated histological gut cross sections highlighting tumour presence 
(boxes).[120] 
 
Thus these experiments were able to delineate the pool of iron that is responsible for 
colorectal cancer development, whereby it is excess iron within the lumen of the 
gastrointestinal tract that is driving tumorigenesis and not systemic iron.  In this setting iron 
can indeed be coined ‘ferrotoxic’ and is driving cancer.  A possible platform for therapeutic 
intervention could be around iron chelation, such that the toxic effects of iron are quenched by 





Figure 1.9: Representation of the therapeutic opportunity offered by dietary iron 
modulation.[120] 
 
In support of this, it has been demonstrated that regular blood donation is associated with 
decreased incidence of colorectal cancer development; this may be related to regular depletion 
of systemic iron concentrations.[123-126]  Although, this data suggests that systemic iron is 
still an important factor, in disagreement to Radulescu et al.[120]  With respect to removal of 
the luminal pool of iron, results from EPIC found that dietary fibre intake from the 
consumption of fruit and vegetables is inversely related to bowel cancer.[127]  This can be 
rationalised by considering the increased transit time of stools and dilution of digesta from 
fibre intake; perhaps impacting on the concentration and ability of iron to redox-react within 
the gastro-intestinal tract.[128]  The literature correlating intake of dietary fibre to digestive 
health is a controversial one.  A multicentered epidemiological study with over 1000 
participants concluded that doubling total fibre intake from foods could reduce the risk of 
colorectal cancer by 40 %’.[129, 130]  The first report linking high dietary fibre intake with 
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decreased colorectal cancer incidence was proposed by Burkitt, who observed trends in eating 
habits high-fibre low-fat diets vs. a low-fibre high fat diets; the latter correlated with elevated 
death rates due to colon cancer.[131, 132]  The underlying mechanisms for this finding is 
unclear, yet it is likely that fibres decrease transit time, dilute the colonic contents and 
stimulate the microbiome fermentation process, all of which reduced the contact between the 
intestinal contents and the mucosa, reducing the likelihood of iron participating in toxic 
reactions.[129, 133, 134]  However, caution must be taken as studies have concluded no 
effect of fibre intake and risk of colorectal cancer.[135-138]   
 
1.2.5 Iron presence within the colon 
Normally, between 0.7 – 22.9 % of iron ingested from the diet is absorbed nutritionally and as 
such the remaining iron resides within the lumen on the colon.[139]  The characterisation of 
the form of iron present within the large bowel would demonstrate the possible mechanism by 
which iron is ferrotoxic.  It can be envisaged that any iron present within the colon at this 
point of the digestive process would be bound within the digesta.  However, since the 
chemical environment of the alimentary tract is translationally in change (acidic pH within the 
stomach to a more basic pH within the small intestine) the form of the iron needs to be 
understood.  Some studies have been performed to decipher the iron species present within the 
gastro intestinal tract.[29, 31, 140, 141]  Both ferric and ferrous iron have been demonstrated 
to reach the intestinal epithelial surface.[142, 143]  It has already been discussed that iron 
solubility will be high within the presence of the acidic stomach.  Ferric iron, however, is 
remarkably insoluble at duodenal pH, immediately precipitating as ferric poly oxo-hydroxide 
(rust).[29, 144]  To slow the rate of iron hydrolysis and as such allow iron to remain soluble 
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in this region of the alimentary tract, it is proposed that a range of endogenous, low molecular 
weight ligands could chelate iron inhibiting this precipitation.[31]  Gastrointestinal mucins 
have been identified as these potential iron-solubilisers, which, with initial hydrolysis 
reactions still occurring, the mucin hinders the rate of condensation reactions within the 
lumen to inhibit nanoparticle formation.[141, 145, 146]  Despite this, these iron-hydroxide-
mucin complexes are as bioavailable as ferrous iron in the duodenum of rats.[141]  Since 
chemical pH environments are at the extremes between the stomach and the duodenum, it 
could be envisaged that these iron-composites are present throughout the rest of the 
alimentary tract, however this is not known.  There is the possibility that within the large 
intestine, iron maybe ‘free’, bound to digesta or even particulate; this area of gastrointestinal 
iron speciation requires further study.  Altogether, if indeed free iron is present in the colon, 
which is the redox-active form of iron, an iron-chelation therapy is still required.  
 
1.3 Iron chelation 
Chelation, derived from the Greek for ‘crab’s claw’, is so termed based on the resemblance 
that complexing interactions of coordinating molecules ‘wrap around’ a host ‘clasping’ it, 
akin to a claw of a crab.[147]  By definition, chelation is the process of coordination of a 
single atom, molecule or ion by more than one donor atom on a coordinating species.  This 
process of coordination is energetically driven by a supramolecular interaction, where 
coulombic, ion-dipole and dipole-dipole electrostatic contacts stabilise the interaction.[147]  
Denticity relates to the number of donor atoms present on the ligand that chemically interact 
with the guest.  Bidentate, tridentate and polydentate refer to two, three and multiple donor 
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atoms on the ligand respectively.  With respect to iron, bidentate, tridentate and polydentate 
interactions are available (figure 1.10). 
 
 
Figure 1.10: Iron chelation and denticity; (A) bidentate ligands coordinate iron in a 3:1 
complex, (B) tridentate ligands coordinate iron in a 2:1 complex and (C) hexadentate ligands 
coordinate iron in a 1:1 complex.[148] 
 
There are numerous factors that govern the type of chelation interaction between host and 
guest including the polarizability of both species, the chemical geometry imposed by the guest 
and the preferred donor atom type.  With respect to iron, the most important consideration is 
that of polarizability where Pearson’s concept of Hard and Soft Acids and Bases (HSAB) can 
be used. 
In brief, hard metal ions will favourably interact with hard donor atoms, whereas soft metal 
ions (such as mercury) will interact with soft donor atoms.[149]  Hard and soft refer to the 
polarizability of the species, with hard ions being highly charged, small and non-polarisable 
whereas soft ions are large, of low charge and readily polarisable.[147]  In Pearson’s seminal 
paper on HASB concept, ferric iron is referred to as a hard acid, where ferrous iron (being of 
less charge) is so-called ‘borderline’.  
A    B    C 
25 
 
Equally important is the geometric requirements imposed by the metal under consideration.  
The favoured coordination geometry is defined by the relative energy levels of the d-orbitals 
of the metal ion since chelation involves the donation of electrons to the metal ion, electron 
orbitals need to be available for this process to proceed.  With a focus on iron, it has been 
discussed that the two common oxidation states are Fe(III) and Fe(II), which can be regarded 
as d6 and d5 metal centres respectively (dn where n = total number of d-electrons – charge).  
When these d-orbitals interact with chelating ligands in an octahedral arrangement, the d-
orbitals become non-degenerate (the orbitals energies split to form the lowest energy/most 
stable confirmation); it is this reason why iron imposes an octahedral arrangement of donor 
atoms.  As such, if the chelating species is pre-organised to adopt this geometry upon 
interaction, the strength of coordination will be enhanced.    
 
1.3.1 Established clinical iron chelators 
The earliest use of a clinical chelating ligand was to remove toxic arsenic from arsenic-
containing syphilis therapies, and since its establishment in 1956, D-penicillamine (DPEN) 
has been utilised as a copper chelator for the treatment of copper overload in Wilson’s 
disease.[150]  Ethylenediaminetetraacetic acid (EDTA) is an approved chelator for lead 




Figure 1.11: Chemical structures of DPEN and EDTA. 
 
The first treatment for iron overload was introduced in the early 1970s, and today, 
desferrioxamine (DFO) is still used as a clinical agent.[151]  Deferiprone and deferasirox 
have been developed to supersede DFO in relation to their pharmacokinetic formulation 
characteristics.  Iron-overload, due to iron poisoning, transfusional overload, 
haemochromatosis or β-thalassemia is treated using a ‘systemic’ iron chelator, where the 
bioavailability of the iron-chelator administered dictates its effectiveness at depleting 
systemic iron levels.  Deferiprone, a bidentate hydroxypyridone iron chelator, complexes with 
iron in a 3:1 ligand:iron ratio (figure 1.12).  In light of the chelation principles discussed, 
deferiprone contained hard and soft donor atoms and the chelate angle allows for the 




Figure 1.12: Deferiprone and a 3:1 complex with ferric iron. 
 
Desferrioxamine, a multidentate iron chelator, is seldom used in clinical practice due to its 













Figure 1.13: Desferrioxamine and a 1:1 complex with ferric iron. 
 
The gold-standard for systemic iron chelation is deferasirox (EXJADE®), which is a 
tridentate ligand formation a 2:1 ligand:iron complex and perfect octahedral geometry 





Figure 1.14: Deferasirox and a 2:1 complex with ferric iron. 
 
Many iron chelators contain common chemical moieties used for iron binding such as 




Figure 1.15: Common iron binding moieties.[154]  
 
Given the association between the homeostatic changes in iron metabolism in cancer, there is 
a now significant research effort to investigate and develop iron-chelating drugs as anti-
neoplastic agents.[109, 155-158] 
 
1.3.2 Experimental iron chelators and anti-cancer activity 
Only recently has iron chelation as a novel medicinal route to cancer treatment been 
considered.  Just as the archetypal anti-neoplastic drug methotrexate starves the cell of 
essential tetrahydrofolate for DNA synthesis, an iron chelator can starve the cell of iron, 
which is required for many vital cellular activities.[159]  However, other mechanisms have 
been proposed for anti-neoplastic iron chelators including the induction of apoptosis, cell 
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cycle modulation effects and the ability to enhance iron redox cycling to produce toxic levels 
of ROS.[155] Clinical iron chelators have been explored for their use as antineoplastic 
agents.[155]  As early as 1988, DFO was found to have anti-tumour effects on human 
neuroblastoma cells.[160]  Similarly, deferiprone has demonstrated promising anti-
proliferative effects in a variety of cancer cells lines.[161, 162]  Most notably are the anti-
neoplastic activities of deferasirox.[163-165]     
Of interest the thiosemicarbazone iron chelator (experimentally known as Dp44MT) has 
demonstrated effective anti-neoplastic activity.[166, 167]  The mechanism of action remains 
to be fully elucidated, yet it has been demonstrated to invoke cell-cycle arrest and apoptosis 
and through redox-cycling processes.[168, 169]   
Despite iron chelators representing a novel route to target sites of tumorigenesis there are two 
inherent limitations of their use, specifically their likelihood to abrogate anaemia in already 
anaemic cancer patients and their associated side effects.[155, 156, 170-172]  To circumvent 
any systemic-iron depletion and to diminish the likelihood of side effects, there are an 
abundance of naturally occurring ‘dietary iron chelators’ that may have in vivo iron binding 
potential that could chelate the ‘luminal’ iron pool present within the gastro-intestinal tract. 
 
1.3.3 Metal binding fibres as dietary iron chelators; alginates and polyphenols 
The human diet consists of a significant proportion of dietary fibres, and it is estimated that 
on average a typical western diet contains 17.2 g of fibre, with a total of 12.3 mmol uronic 
acid residues (metal binding sites) per day.[173]   It is however difficult to estimate how much 
of this fibre is responsible for cation binding in vivo since other components of the diet and 
the digestive process (such as pH changes, ionic strength and colonic bacteria) would interfere 
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with metal binding; for this reason extrapolation of reports of metal binding by fibres ex vivo 
into the human setting need to be carefully justified.[173]  Despite this, there are many 
accounts of fibres altering metal bioavailability through chelation. [173-182]  Not only have 
fibres been documented to bind metals during digestive transit, but they have also been 
implicated in the binding of cholesterol, lipids and bile acids.[175, 183]  For this reason they 
have been labelled as ‘functional foods’ whereby the food plays a greater role than merely 
providing nutrition, despite originally being thought as an inert substance.[182]  
 
1.4 Alginates  
Alginates, are natural polysaccharides found in the cell walls of brown seaweeds.[184] 
‘Algin’ or now known as soluble sodium alginate, was first documented and patented by an 
English chemist in the late 19th century, which details how alginate can be extracted by 
soaking seaweed in water or dilute acid, which, following alkali treatment yielded sodium 
alginate.[185]    Alginates sourced from algae are formed of unbranched (1-4) linked β-D-
mannuronic acid (M) and α-L-guluronic acid (G), its C5 epimer (figure 1.16). 
 
Figure 1.16: Chemical compositions of G and M alginate monomeric units. 
 
The arrangement of G and M residues along the polymeric back-bone sequence is not random 
but ordered, occurring in alternating GM sequences being heteropolymeric in nature, or 
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conversely homopolymeric, with extensive M or G block sequences.[186]  The structural 
packing of these sequences and the restricted confirmations at the anomeric position of the 
ring (the β and α links) has a direct influence on the overall shape of the polymers.  Extended 
M regions are regarded as ‘ribbon-like’ whereas extended G regions are ‘buckled’ (figure 
1.17).[187] 
 
Figure 1.17: Extended M regions of alginate forming so called ‘ribbons’ and ‘buckled’ chains 
of G sections.[186] 
 
The physical properties of alginate can differ depending on their average molecular weight 
and GM sequence throughout the polymer; these structural differences give rise to a plethora 
of possible structural compositions that alginates can have. 
 
1.4.1 Alginate variation and chemical properties  
Alginate occurs naturally in seaweed in the forms of calcium, magnesium and sodium alginate 
salts.  The processes in alginate purification from seaweed involves multiple steps of washing 
and grinding to extract the raw product from the cell wall.  The process of purification can be 
varied, thus allowing for the extraction of different alginate fractions which will have 
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different chemical compositions; one individual source processed in this way can produce a 
variety of alginate types in terms of their chemical structure.[188]  Compositional differences 
are found between ‘alginophytes’ that are harvested from different locations.[189]   Alginates 
have no regular repeating unit or sequence arrangement nor can the sequence arrangement be 
described by Bernoullian statistics; simply, inferring alginate sequence from its monomeric 
composition is not possible.[190]  The use of high resolution 1H and 13C NMR spectroscopy 
does allow determination of monad composition, FM and FG, diad frequencies, FGG, FMG, FGM 
and FMM and the triad frequencies.[187, 191, 192]  Table 1.2 describes the source and 
sequence parameters of some algal alginates.[185] 
Table 1.2:  A variety of alginophytes with their respective monad and diad compositions. 
Source FG FM FGG FMM FGM,MG 
Laminaria japonica 0.35 0.65 0.18 0.48 0.17 
L. digitata 0.41 0.59 0.25 0.43 0.16 
L. hyperborean (leaf) 0.55 0.45 0.38 0.28 0.17 
L. hyperborean (stripe) 0.68 0.32 0.56 0.20 0.12 
Macrocystis pyrifera 0.39 0.61 0.16 0.38 0.23 
Durvillaea antarctica 0.29 0.71 0.15 0.57 0.14 
Ascophyllum nodosum 
 (fruiting body) 
0.10 0.90 0.04 0.84 0.06 
 
Alginates with more extreme guluronic acid and mannuronic acid compositions can be 
isolated from bacteria, namely Pseudomonas and Azotobacter as these organisms express 




1.4.2 Alginate modification 
There are two accessible modifications to the inherent alginate biopolymer; conversion of the 
monomer stereochemistry (epimerisation) and shortening of chain length (degradation).  De 
novo alginates are synthesised as poly-mannuronic acid by the polymerisation of GDP-
mannuronic acid, which is then subsequently enzymatically epimerised to the required G:M 
compositions.  Many alginate producing organisms encode more than one mannuronan C-5 
epimerase as each epimerase has its unique activity in introducing a specific sequence pattern 
to the alginate backbone.[194]  Alginate epimerases (AlgE) are able to introduce distinct G-
sequences in patterns that confer the properties required in a specific alginate tissue.  
Azotobacter vinelandii secrete seven calcium ion dependent epimerases (AlgE1-AlgE7), each 
having its own unique G-sequence introduction.[194]  AlgE1 creates MGMG stretches 
whereas AlgE6 creates GGG blocks; the other epimerases have mixed activity with some 




Figure 1.18: Epimerisation of alginate.  Top MMGG stretch is converted to a MGGG stretch. 
 
The abundance of glycosidic linkages present in alginate make them a susceptible target to 
chemical breakage and as such there has been many reported methods to shorten alginate 
chain length including gamma-radiation,[199] ultra-violet photolysis,[200] lysis 
enzymes,[201-203] and heat, acid and alkali mediated hydrolysis.[204-206]  Heating alginates 
at moderate temperatures without exceeding 100 °C results in alginate depolymerisation 
whereas heating to higher temperatures, in excess of 250 °C, alginate breakdown at the 
monomer level occurs.[207]  Depolymerisation of alginates and polysaccharides in general 
occurs via cleavage of the glyosidic bonds that link the monomeric units in the polymer chain.  
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Recent investigation have found that the rate of polymerisation of alginates increased with 
increasing temperatures, with no dependency on rate with respect to G:M composition.[208]  
In neutral conditions, either an acid catalysed or alkaline mediated hydrolysis may prevail, 




Figure 1.19: Acid-catalysed alginate hydrolysis and alkali mediate beta-elimination reactions 
to shorten alginate chain length. 
. 
Viscosity decreases at a hyperbola by time, which is unsurprising since the break of a 
glycosidic bond within an long alginate polymer chain will have profound effects on viscosity 
in comparison to a degrade product at longer time points of reaction.[209]   
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As highlighted, the variation of alginate chemical composition is extensive.  Importantly, a 
plethora of alginate compounds will have to be examined for their iron chelation ability, since 
chemical structure of alginates impacts iron metal binding ability.  
 
1.4.3  Alginate iron binding 
Iron binding by alginate within the gastrointestinal tract was first reported by Berner and 
Hood (1983) where it is stated “the potential significance of iron binding by polysaccharide 
gums is twofold.  First, a question about iron bioavailability can be raised since these gums 
generally are not digested in the small intestine where most iron is absorbed.  Secondly, the 
binding of a potent catalyst of lipid autoxidation, such as iron, could be beneficial in food 
systems subject to oxidative deterioration”. [210, 211] In this seminal paper alginates were 
demonstrated to bind iron as a function of the iron-chelate source (i.e. iron-NTA, iron-EDTA 
or ferrous sulphate) where alginate-iron chelation did not take with EDTA presence due to 
effective competition, but binding did occur with NTA.  It was established that binding by 
alginate was not strictly an ionic phenomenon since iron binding decreased with increasing 
pH levels.  Higher pH environments would increase the ionisation of the carboxylic acid 
residues present on the uronic acid monomers increasing their susceptibility to metal-binding, 
yet this was not observed.  This could also be rationalised by the fact that iron hydroxides 
(rust), which are insoluble, may have been formed at these higher pH levels, or since alginates 
gel in more acidic conditions, iron entrapment occurred and as a consequence an observed 
‘enhanced’ iron affinity at these pH’s documented.  It was also found that calcium severely 
impacted the iron binding potential of sodium alginate.   Subsequent reports demonstrating 
the iron chelating abilities of alginate in cell culture conditions and in vivo are limited.[212, 
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213]  Wöbling et al. demonstrated that a dose of sodium alginate fed to mice inhibited the 
absorption of iron by ca. 20 %.[212]  However, it was found that in the ileostomy contents of 
subjects fed 7.5 g sodium alginate, no significant differences in iron concentration was 
detected.[213]  Two more recent studies have emerged, again with conflicting conclusions.  
Firstly, in a Caco-2 model of intestinal absorption an enhancing effect of alginate on iron 
absorption was observed, augmenting ferritin expression by 10-fold; this was also found to be 
alginate dose dependent.[214]  Ferritin is an iron storage protein whose expression is 
upregulated upon elevated intracellular iron levels.  For this reason, ferritin can be used as a 
surrogate biomarker for intracellular iron concentrations.  This finding, contradicted a 
subsequent report from the same research group detailing decreased iron absorption in 
individuals administered with alginate in a randomised, single blinded, cross-over human 
trial.[215]  It is noteworthy that the alginates used in each of the studies were chemically 
different, and this may reflect the structure-activity relationships found between different 
alginates.   
Despite little advancement in physiological alginate-iron interactions, one area of research 
where alginates and iron are used extensively is in the formation of iron oxide nanoparticles 
(FeO-NPs).  Alginates, and biopolymers as a whole are routinely used in the fabrication FeO-
NPs.  Generally a three-step method is employed to synthesise FeO-NPS; i) alginate-iron 
gelation, ii) pH adjustment to form the ferrous hydroxide and iii) subsequent oxidation of the 
ferrous centre.[216-219]  High pH conditions are utilised to force the iron towards the 
formation of its hydroxide analogue.  Despite the growth of interest in this field and the range 
of biopolymers that are now utilised for this synthesis protocol (for example carrageenans, 
chitosan and cellulose), the mechanism of nanoparticle formation is still not fully understood; 
two possible modes of construction have been proposed.  The ‘site-binding model’ describes 
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the binding of iron ions to the binding site moieties on the polymeric backbone whereas the 
‘colloidal model’ suggests that the iron forms iron-oxyhydroxide precipitates which decorate 
the polymer (figure 1.20).  As inferred within the study, a combination of the two hypothetical 
models would be more likely on chemical grounds as it is improbable that these two extremes 
act independently.[220]  FeO-NPS have found roles in biomedicine for several applications 
such as i) contrast agents for MRI, ii) drug delivery and iii) magnetic induction 
hyperthermia.[221] 
 
Figure 1.20: Proposed mixed mechanisms of bio-polymer iron binding involving initial metal 
binding, subsequent nucleation, followed by nanoparticle formation.[222] 
 
The inherent chelating ability of alginates for binding iron, despite the widespread use of 
alginate-templated FeO-NP production, has not been assessed.  Limited chemical 
characterisation of the alginate-iron interaction is reported, with only one publication detailing 
the iron(III) alginate interaction and calculating a binding constant of K = 5.04 x 104 M-
1.[223]  
In vivo experiments have examined the effect of alginate iron-chelation within the 
gastrointestinal tract.  Harmuth-Hoene and Schelenz fed 10 % polysaccharide enriched diets 
(including carrageenan and sodium alginate with a specific alginate G:M composition of 
13:87) to rats housed in metabolic cages whereby faecal samples could be collected 
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throughout the duration of the experiment.  It was found that sodium alginate significantly 
decreased both calcium and iron absorption compared to control groups.[224]  This indicated 
that alginate is indeed binding iron at some point along the gastro-intestinal tract and 
hindering iron absorption across the small intestine; alginate also had an impact on calcium 
absorption.  It was also shown in both normal and iron-deficient rats that a dose of 59Fe could 
be subject to decreased bioavailability across the jejunum epithelium by half with co-
administration of 8-30 mg sodium alginate. Human studies have shown that a dose of oral 
pectin attenuated iron absorption compared to matched controls.  [225]  Even though pectin is 
a different biopolymer to alginate chemically, it is considered as a non-absorbable fibre 
providing some confidence in the ‘luminal’ mode of action sought after by sodium 
alginate.[226]  There have been a number of in vitro and in vivo experiments describing the 
effects of fibre-like, non-alginate, dietary materials on mineral absorption with some fibres 
increasing and some decreasing metal solubility and thus having varied effects on overall 
bioavailability.[173, 227-229]   
 
1.4.4  Alginate bioavailability 
Alginate absorbability at the cellular level has not been widely studied, likely due to the fact 
that alginate is chemically a fibre, based on its polymeric chemical nature and as such is 
assumed to be inert and non-absorbable.[230]  For this reason, alginate is commonly 
considered a fibre, and indeed studies have shown that alginates are non-absorbable and non-




Most algal polysaccharides are resistant to degradation by human endogenous digestive 
enzymes.[233]  A study undertaken in ileostomy patients had found that 95 % of uronic acids 
derived from alginates could be accounted for in the ileostomy contents; this does not 
however account for the fermentation of alginate and its polymeric degradation.[213]  
Alginate polymeric hydrolysis would not affect uronic acid moieties and as a consequence, 
uronic acid detection cannot be used as an indication for fermentation processes, it can be 
used as a readout for alginate presence.  Fermentation of alginate to smaller oligosaccharides 
has been documented; [231] however the microbiota able to ferment alginate required 
conditioning over time by repeated alginate exposure.  There is evidence to suggest that 
alginates may be degraded via fermentation by human faecal bacteria.[234]  These have been 
identified as anaerobic bacteria from the human colon including Bacteroides and 
Bifidobacterium.[235]  Contradictory to this, the inert nature of alginate within the 
gastrointestinal tract has been utilised for a treatment in weight management, whereby the 
very property of limited bioavailability of an indigestible formulation is key to its 
physiological, ‘fat-binding’ action.[183, 236]  Sodium alginate has been shown to cause 
significant bio-adhesion with the mucosal membrane, suggesting that the polymeric-nature of 
the alginate, the must be intact throughout gastrointestinal transit to allow adhesion to the 
epithelial mucosal layer.[237]  This, however, does not necessarily indicate the alginate is 
chemically intact in its ingested form. 
 
One extensive use of alginates is in drug delivery to control and or sustain the release of 
therapeutic agents; this again is owed to their non-absorbable nature.  Of note, it has been 
reported that the diffusion rate of release of the entrapped drug can be controlled by the 
chemical compositions of the alginate, its M:G ratio and its molecular weight.[238]   Alginate 
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forms the main ingredient of the common anti-reflux preparation Gaviscon® whereby its 
resistant nature to the stomach environment forms so-called rafts inhibiting reflux.[239]  The 
mechanism of action is reliant on the stomach acid and the calcium component of the 
formulation, since a rigid raft is formed upon the strong interaction of alginate with calcium. 
 
1.4.5  Alginate-alkali metal binding   
The calcium binding of alginates has been extensively studied owed to their use in food 
products as thickeners and gelling agents.  It is widely accepted that calcium binds to G-units 
preferentially as regions of poly-guluronic acid support a further favourable supramolecular 
interaction; cations of the perfect ionic radii will fit into so-called ‘egg-box’ junctions formed 
by the lateral interaction of alginate poly-guluronic acid strands.[240]  These junction zones 










Figure 1.21: Calcium interactions with alginate and formation of ‘egg-box’ architecture.[184] 
 
It is for this reason that alginates with higher G compositions are mostly found in food 
products since the gels formed by these alginates will be stronger and more viscous.  The 
changes in alginate structure associated with calcium interaction were monitored by circular 
dichroism spectroscopy.[241-244]  Circular Dichroism (CD) spectroscopy is a spectroscopic 
technique that uses polarised light, enabling the chirality of compounds to be probed.  
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Alginate with its many chiral carbons within the uronic acid units as well as its inherent 
chirality formed by its secondary structure in solution makes it highly applicable in the use of 
this spectroscopy. It was found that there is a strong auto-cooperative effect observed when 
calcium ions bind to G-units in which all the functional groups present (hydroxyls and 
carboxylates) participate in the chelation of calcium.  In the same study, it was demonstrated 
that the transition metals copper, cobalt and manganese only interact with the carboxylate 
groups, and the hydroxyl groups do not participate in the binding to metal ions for both the G-
units and M-units equally.[245]   
These results raise the question of the relationship between ionic radii and the strength of 
alginate chelation, and whether ionic radii of iron could be used as a predictive tool to provide 













Table 1.3: Listed values of ionic radii for group two metal ions, first row transition metals 
and group three metal ions.  LS and HS donate the electron arrangement in the d-orbitals, high 
spin and low spin respectively.[147] 
 Element Ionic radius/ pm Charge on ion  
Group 2 Be 27 2+  
 
Mg 72 2+  
Ca 100 2+  
Sr 126 2+  
Ba 142 2+  
First row 
d-block 
Cr 73 2+ LS 
80 2+ HS 
62 3+  
 
Mn 67 2+ LS 
83 2+ HS 
58 3+ LS 
65 3+ HS 
39 4+  
53 4+ 
Fe 61 2+ LS 
78 2+ HS 
55 3+ LS 
65 3+ HS 
Co 65 2+ LS 
75 2+ HS 
55 3+ LS 
61 3+ HS 
Group 13 B 88 3+  
 Al 130 3+ 
Ga 122 3+ 
Ln 150 3+ 
Tl 155 1+ 
 
It is found that the binding affinity of group II metal ions for alginate follows the series Ba2+ > 
Sr 2+ > Ca2+ ≫ Mg2+ > Be2+ indicating that the larger the ionic radii, the greater the energetic 
gain when complexation occurs in this way.[246-248]  This does however depend on the 
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composition of the alginate under investigation and the mode of interaction (i.e. if the metal 
ion allows for alginate cross-linking as with calcium).  Taking into account these 
approximations, it could be argued that iron will not conform to the egg-box model of binding 
since all energetic states of the ferrous and ferric forms are much smaller than that of calcium.  
As discussed earlier, it has been shown that cobalt and manganese only interact with the 
carboxylate units; having similar ionic radii and charge densities as iron it can be predicted 
iron will interact with alginate in a very different way to calcium.[245] 
The binding constant (K) for calcium binding to alginate was calculated to be 10.7 x 103  and 
10.6 x 103  M-1  for 64 and 46 % G-unit composition alginates respectively.[249] This is 
unsurprising since K relates to the affinity for binding within the binding site (the egg-box) 
which would be analogous for both samples. The enthalpy of interaction between the two 
samples which refers to the strength of binding was different, calculated to be -15.0 and -11.6 
kJ mol-1 respectively.[249]  This suggests that the higher the G-composition of the alginate, 
the stronger the strength of interaction with calcium.   
 
1.5  Polyphenols 
Specificity towards iron would be an ideal property of a medicinal iron chelator, and 
interactions with other metal cations may prove problematic (as with alginates); polyphenolic 
compounds are a range of compounds that have a high specificity towards iron ions.    
Polyphenol compounds are found in fruits and vegetables and form a significant constitute of 
our everyday diets.[250]  Polyphenol-containing compounds represent a huge ‘chemical 
catalogue’ of natural compounds.  They all share similar chemical moieties containing either 
catechol or galloyl units, which were described in section 1.3.2 to be the unit of choice when 
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designing chemical iron chelators.  Polyphenols of fruit and vegetable origin share a similar 
chemical base unit, namely, the ‘flavin’.  This three-membered ring system can be decorated 
in many chemical poly-hydroxyl phenol compounds which are then loosely termed 
flavonoids.  Specifically, flavanoids are non-ketone containing in contrast to the ketone 
containing flavonoid.  Flavan-3-ol is the simplest flavonoid which is also known as flavanol 
and is chemically similar to the common polyphenol (+/-)-catechin (figure 1.22). 
 
Figure 1.22: Chemical structures of flavin, flavan-3-ol and polyphenol (+)-catechin. 
 
Quercetin, the ketone-containing analogue of catechin is highly concentrated in onions.[251]  
Being of natural sources the glycosylation of these compounds is a common chemical 





Figure 1.23: Chemical structures of quercetin and rutin. 
 
Rutin (quercetin-3-rutinoside) is highly concentrated in asparagus, citrus fruit rinds and many 
berries.[252]  As it contains catechol units and also a 1,3,-hydroxy ketone moiety there are 
two possible iron binding sites. 
Anthocyanins are related to flavanols, but are ionic forms.  Anthocyanidins are the aglycone 
forms of anthocyanins.  Cyanidin-3-O-glucoside is an anthocyanin with chemical similarity to 
the polyphenol compounds discussed (figure 1.24).  Anthocyanins such as cyanidin-3-O-
glucoside are mainly found in dark fruit berries such as blackcurrant, blackberry, strawberries 
and blueberries.[252, 253] 




Figure 1.24: Chemical structure of cyanidin-3-O-glucoside and delphinidin-3-O-rutinoside. 
 
In relation to addressing polyphenolic iron-binding characteristics, a simplistic view of how 
polyphenols complex with iron would be to examine the individual iron binding moieties on 
the polyphenols alone and extrapolate the findings across the different polyphenolic 
compounds that withhold that moiety within the basic flavonoid structure. A similar study 
was performed by Khokhar et al. and specific functional groups were identified as necessary 







Cyanidin-3-O-glucoside           Delphinidin-3-O-rutinoside 
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1) Ortho-dihydroxyl groups; 
2) 5-OH and or 3-OH in conjunction with a C4 keto group; and 
3) A large number of OH groups. 
 
Figure 1.25: Chemical requirements (highlighted in red) of a flavonoid to demonstrate iron 
binding properties. 
 
These findings allow for an initial screen of the potential polyphenolic compounds to be 
tested.  With this, and in the focus of this thesis, four polyphenolic compounds were selected, 
namely, quercetin, rutin, catechin and cyanidin-3-glucoside (figure 1.26).  This compound 
selection provides a range of functionality homology to assess the potential differences in iron 








Figure 1.26: Chemical structures of (A) rutin, (B) quercetin, (C) catechin and (D) cyanidin-3-
O-glucoside. 
 
1.5.1 Quercetin iron binding 
Quercetin is markedly the most studied polyphenol with respect to its iron binding properties 
and bioavailability, undoubtedly owed to the fact that consumption of quercetin exceeds that 
of any other polyphenol (estimated between 6 – 18 mg per day).[255-259]   Quercetin has 
three potential binding sites and among the different stoichiometries accessible, namely  the 
1:1, 1:2, 2:2 and 2:3 metal: quercetin complexes; the 1:2 complex is the most energetically 
stable and as such is preferred despite not fulfilling the desired hexa-coordinate coordination 
sphere of iron ions (section 1.3).[260-262]  Using electrospray ionisation mass spectroscopy, 
the preferred complexation site for iron is that where by the hydroxyl at C3 or C5 acts as 
donor sites with the adjacent 4-carbonyl (figure 1.27).[263]  This correlates with the 
potentiometric data that suggests with most acidic proton of quercetin is indeed the hydroxyl 






Figure 1.27: Chemical structure of quercetin (3, 3’, 3’, 5, 5-pentahydroyflavone) and its 
complexes with ferrous and ferric iron. 
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Iron binding constants have been estimated for the mono- and di- iron complexes in 
physiological pH environments, and calculated to be between K = 106 – 107 M-1.[265] 
The well documented pro-radical generation nature of iron, in hand with the iron binding 
ability of quercetin means that there have been several reports of iron chelation in vitro and in 
vivo.[257, 266-272]  Quercetin in many studies has been found to be a potent inhibitor of 
intestinal iron absorption, which if mediated through iron chelation within the lumen would 
make quercetin an ideal small-molecule chelator for luminal iron chelation.  It was shown 
using microsomes from rat liver that quercetin prevented iron-induced lipid peroxidation, 
concluding on a radical blocking mechanism via iron chelation.[273]  Many anti-oxidant 
actions of quercetin have been reported.[267, 268]  Quercetin has also been identified  as a 
shuttle for labile iron, whereby quercetin binds labile plasma iron and transfers it into 
transferrin; it was also observed that quercetin decreased intracellular iron pools with the 
resultant iron-quercetin complexes able to cross the cell membrane to allow cellular 
export.[269]  Further to this, it was identified that quercetin-iron complexes can be 
transported via glucose transporters (GLUTs), whereby complexes were exported via GLUT1 
to decrease cellular iron levels.[266, 274]  Despite this wide range of reports demonstrating 
quercetin’s anti-oxidant effect via an iron-chelation mediated process in vitro, there have been 
recent reports of a direct action of quercetin on molecular targets to control intracellular iron 
metabolism.[257]  It was found that quercetin decreased intestinal ferroportin expression in 
rat duodenal cells with an associated down regulation of DMT1, yet the mechanism of this 
process was unclear.[257] Through the use of methylated quercetin analogues the chelation of 
iron by quercetin was highly reliant on the 3-hydroxy group, which maybe translatable in 




1.5.2 Quercetin bioavailability 
In general quercetin bioavailability is poor, yet reports in the literature are highly 
inconclusive.[276] In a study undertaken with ileostomy patients who were orally 
administered quercetin in different formulations, it was found that quercetin aglycone 
absorption was 24 % lower compared to the glycoside which enhanced its absorbability.[250]  
In rats fed diets with supplemented quercetin, absorption was incident within the small 
intestine however plasma levels were low.[277]  It is argued that the complex metabolic 
pathways of quercetin warrants a need to take into consideration its metabolites to get a fuller 
understanding of its degradation.  One recent study, which employed the use of a radioactive 
labelled analogue of quercetin confirmed a bioavailability of 44.8 %.[278]  This is conclusive 
evidence of the definite disposition of quercetin, since the absorbability of its metabolites 
(only if radiolabelled themselves) are considered in the whole calculation of absorbability.  
With an inconclusive yet largely low bioavailability, efforts are being made to formulate 
quercetin in a way to render its cellular absorbability much higher.[279, 280] 
Notwithstanding the conflicting evidence on quercetin bioavailability, bacterial-metabolism 
studies have been performed which have confirmed degradation by intestinal microbiota.[281-
283]  Whether this degradation produces iron-chelating fermentation bi-products that are 
themselves non-bioavailable, is unknown.  Quercetin is metabolised by Bacteroides, 
Clostridium and Eubacterium via ring cleavage reactions and dihydroxylation, to yield a 
range of phenolic acids (figure 1.28).[284, 285]  It is evident upon consideration of the 





Figure 1.28:  Chemical modification of quercetin by colonic microbiota.[278] 
 
1.5.3 Quercetin efficacy against colorectal cancer 
Both in vitro and human studies largely support an anti-cancer function of quercetin, though it 
is unknown as to whether the anti-cancer action of quercetin is directed through its iron 
chelation properties.[286] 
In one human study with a cohort of nearly 10, 000 participants, an inverse relationship 
between dietary intake of quercetin (ca. 4 mg each day) and colorectal cancer incidence was 
observed.[287]    Furthermore, flavonoid intake has been shown to decrease the risk of 
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advanced adenoma reoccurrence in  patients with a previous history of colorectal 
adenoma.[288] 
In vivo and in vitro studies also demonstrate an inverse relationship between quercetin and 
carcinogenesis.  A study performed in rats with colorectal cancer, induced using 
azoxymethane found that a 10 g kg-1 quercetin supplemented diet, dose dependently decreased 
the tumour incidence, multiplicity and size compared to the control cohort.[289]  This 
protective effect was explained through a decreased cell proliferation and apoptosis induction 
activities, which has been reported previously reducing crypt cell proliferation by 50 % in the 
small intestine of healthy rats.[290-292] These effects and mechanisms have also been 
supported by studies in vitro.[293, 294]  Of most interest is work carried out by Murphy et al., 
who, using ApcMin/+ mice reported that administration of a 0.2 % quercetin diet decreased 
total intestinal polyp formation by 67 % compared to the placebo cohort.[295]  This effect 
was attributed to quercetins ability to reduce the inflammatory response of macrophages, 
which contributes to the carcinogenic phenotype of the cell.[296]  Most recently it has been 









1.5.4 Rutin iron binding 
Rutin (quercetin-3-O-rutinoside) can be considered the glycone of quercetin (figure 1.29). 
 
Figure 1.29: Chemical similarity of rutin and quercetin. 
 
Its chemical interaction with iron has been seldom studied, yet several reports have 
documented important complexation results.[265, 298-300]  The most favourable complex of 
iron with rutin is the 1:2 metal: rutin complex, with the full octahedral coordination sphere 
completed by two coordinating water molecules.[298]  In comparison to quercetin, which has 
three iron binding sites, rutin nominally has two due to the third being blocked by the sugar 





Figure 1.30: Chemical structure of the di-rutin iron complex. 
 
The di-rutin iron complex has been shown to have iron binding constants of 4 x 1011 – 1 x 
1012 M-2.[265, 300]  Spectroscopic studies have demonstrated the inert properties of the 
ferrous-rutin complex at physiological relevant pH yet there is evidence to suggest that rutin 
is chemically labile with respect to ferric iron interaction, whereby a direct oxidation reaction 
is observed upon interaction.[299] 
 
1.5.5 Rutin bioavailability 
Degradation of rutin to quercetin has been documented within the large intestine and as such, 
in vivo activity of rutin has been reported to be mainly attributed to its metabolite 
quercetin.[297]  Rutin is poorly absorbed in the intestine; only in the large bowel does 
hydrolysis by gut microbiota take place.[301]  A human study involving the oral 
administration of 200 mg rutin revealed no rutin presence within the plasma or urine.[302]  It 
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is argued that the lower absorption profile of rutin in comparison to quercetin is due to its 
glycosylation status which hinders its bioavailability.[277, 303]   
 
1.5.6 Rutin efficacy against colorectal cancer 
Upon review of the literature supporting the anti-cancer action of rutin, it is evident that its 
effects are largely dose dependent. In mice with colonic neoplasia induced with 
azoxymethanol, the cohort fed a 4 % rutin containing diet demonstrated the fewest number of 
colonic dysplasias whereas lower concentrations displayed no discernible effects.[304]  In a 
later study, no effect was observed in the ApcMin/+ mouse fed a 2 % rutin containing 
diet.[305] Again, lower rutin diet concentrations had no chemopreventive effect in 
azoxymethane induced foci in the rat colon, compared to a higher concentration which did 
decrease foci statistically by 78 % compared to control.  Similar studies have also been 
documented.[292, 306, 307]  With respect to a mechanistic understanding of these protective 
effects, inductions of apoptosis and cell cycle arrest have been implicated.  
 
1.5.7 Cyanidin-3-O-glucoside iron binding 
The only documented evidence of Cyanidin-3-O-glucoside iron binding is in a study 
monitoring changes in peach-skin colour by the formation of iron-pigment complexes such as 





1.5.8 Cyanidin-3-O-glucoside bioavailability 
The fact that anthocyanin consumption is greatest out of all the flavanols (180 – 215 mg day-1 
cf. 23 mg day-1 for quercetin), the bioavailability and metabolism profile of cyanidin-3-O-
glucoside has been extensively studied and, in comparison to other polyphenols discussed 
here, the evidence is more consistent.[309]  Studies undertaken in animals and man suggest 
that cyanidin-3-O-glucoside is absorbable.[310-315]  Formulations containing cyanidin-3-O-
glucoside were detected in the blood stream of rats and man in their intact glycosylated 
forms.[311]  Further experimentation using nasal intubations directly into the jejunum in 
humans demonstrated that the main site of absorption is the small intestine,[313] this was 
confirmed in rats with 22 % of the administration absorbed in the jejunum and ileum.[314]  
No absorption has been documented to take place within the colon.[316]  Understanding the 
integrity of polyphenols reaching the large intestine and colon intact have been performed and 
it was found that 28 % of administrated cyanidin-3-O-glucoside reached the large intestine in 
ileostomy patients.[317]  In a complementing study, 44 % of administered cyanidin-3-O-
glucoside in humans were recovered in the faeces, albeit, metabolites of the anthocyanin; this 





         
Figure 1.31: Distribution and absorption profile of Cyanidin-3-O-glucoside (C3G).[316] 
 
Degradation of cyanidin-3-O-glucoside by the intestinal microbiota is also well understood.  
A total of 35 metabolites were identified in humans administered a radio-labelled cyanidin-3-
O-glucoside, of which 28 were found in the faeces.[319]  The microbiota in the large intestine 
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Despite the unequivocal data demonstrating cyanidin-3-O-glucoside absorbability by 
intestinal enterocytes, it is not 100 % bioavailable with some intact cyanidin-3-O-glucoside 
remaining for activity within the colon which maybe of importance. 
 
1.5.9 Cyanidin-3-O-glucoside efficacy against colorectal cancer 
There is a plethora of in vitro data which demonstrates different anti-cancer actions of 
cyanidin-3-O-glucoside albeit none rationalised by cellular iron metabolism alterations.[322-
326]  Mechanistic understanding of the results revealed possible cell-cycle arrest, inhibition of 
TNF-induced activation of cyclooxygenase and suppression of TNF-induced NK-κB-
dependent reporter gene transcription.[327]  There are no in vivo reports on the activity of 
cyanidin-3-O-glucoside in colorectal carcinoma. 
 
1.5.10 Catechin iron binding 
Despite catechin being a chemically simple compound there is considerably less data 
describing its iron binding ability.[328]  Unlike cyanidin-3-O-glucoside, this may be 
attributed to its poor iron-chelation ability since it only conforms to one of the three original 
requisites for iron binding, namely, ortho-positioned hydroxyl groups.[254]  In spite of this, a 
recent report documented the iron-binding of catechin in vitro to increase intracellular iron 
concentrations in the caco-2 model of intestinal absorption.  There are two possible 
mechanisms by which catechin maybe increasing cellular iron.  Firstly, the presence of 
catechin might be increasing the solubility of iron within the cellular environment, promoting 
its uptake at membrane-bound transport sites.[328]  Secondly, as discussed for rutin, 
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oxidation by catechin may be occurring such that any ferric iron present will be reduced to 
ferrous iron rendering it more bioavailable to the cell.[329] 
 
1.5.11 Catechin bioavailability 
Catechin has poor stability and poor oral bioavailability due to its high hydrophilicity which 
imparts low lipid solubility and hence limited penetration through the cell membrane.[330-
332]  Interestingly there are significant bioavailability differences between (+)-catechin and (-
)-catechin despite only being enantiomers.[333]  In human ileostomy studies a 350 mL 
polyphenol rich drink that contained ca. 127 μM catechin was administered and following a 
24 hour time period, ileal fluid and urine was analysed for catechin presence.[334]  It was 
concluded that catechin was non-bioavailable since > 100 % was recovered in the ileal fluid, 
and only 20 % detected within the urine of the treatment cohort.  There are many reports that 
suggest catechin is mainly non-bioavailable with slow plasma concentrations detected in 
humans post consumption.[251, 335, 336] 
 
1.5.12 Catechin efficacy against colorectal cancer 
Several in vitro reports have confirmed the antiproliferative effects of catechin, although these 
effects have been minimal.[337, 338]  These unconvincing results have been mirrored in 
epidemiological studies, with mixed conclusions correlating catechin intake and colorectal 




1.6 Summary and conclusions 
The evidence discussed eludes to the carcinogenic nature of excess, unabsorbed, ‘free’, 
luminal iron present in the colon.[93, 120]  The exact form of iron within the colon is yet to 
be elucidated, however it is known that ‘free’ iron is the redox cycling form.[54]  Exactly how 
iron is driving tumorigenesis in this setting is unknown, yet possible mechanisms have been 
proposed including the activation of Wnt and the generation of ROS.[113, 341]  It has been 
demonstrated how systemic iron chelators are widely used within a clinical setting and some 
evidence suggests anti-neoplastic activity of these plasma-circulating iron chelators.[115, 155, 
168]  Iron chelators targeted at sequestering ‘luminal’ iron have not been developed to date, 
yet a range of dietary iron chelating compounds have demonstrated iron binding activity 
although not in the setting of the colorectal cancer.[212]  If such a dietary iron chelator was to 
be used as a therapy in this setting, the design of an iron chelator would need to fulfil the 
following criteria: 
i) To be non-absorbable within the gastrointestinal tract. 
ii) To be non-fermentable by the colonic microbiota. 
iii) To bind iron with a high affinity, with selectivity, removing it from the colon. 
iv) Preferable iron binding in the colon. 
v) To be a natural, and safe for human consumption. 






1.6.1 Research hypothesis and aims 
The hypothesis formed upon consideration of the literature is such: 
Excess luminal iron present within the colon is having a detrimental effect on 
gastrointestinal health, especially in relation to colorectal cancer.  The development of a 
luminal iron chelator that will chelate and sequester excess ‘free iron’ present in the 
colon, will as such be a therapeutic platform to improve gastrointestinal health 
Such a task will require the fundamental effects on iron metabolism by iron chelators to be 
assessed as it has been discussed how iron chelation within the gastrointestinal tract can 
render iron more or less bioavailable.  This study will focus on the chelation of ‘free’ iron, 
despite the fact that it is unknown what form of iron is within the colon.  With respect to the 
pathological progression of colorectal cancer, evidence suggests that earlier detection of 
benign polyps allows for improved clinical outcomes.  Iron has been demonstrated to drive 
these initial events in carcinogenesis and as such, it could be envisaged that a luminal iron 
chelator could be given as either a chemopreventive measure to high-risk patients, or as an 
intermediary intervention for those identified with polyps or adenomas.   
The aims of the research presented in this thesis are: 
1) To assess the iron chelation ability of a range of alginate and polyphenol compounds 
and identify, through iron-binding stratification experiments, the best iron chelators 
with therapeutic potential. 
2) To examine the effects of alginates and polyphenols on iron metabolism in vitro and in 
vivo and to determine their physiological actions. 
3) To understand how iron chelation bioactivity is related to the chemical composition of 
the alginates and polyphenols.  
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A chelator which can bind iron within the colon will be novel, not only for the treatment and 
prevention of colorectal cancer but also for use in other gastrointestinal diseases that are 
exacerbated by the toxic effects of iron. 
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Alginate iron binding:  
a chemical characterisation. 
 
2.1 Introduction and aims 
Sodium alginate was chosen as a potential iron binding compound since there is evidence to 
imply that it has the desired characteristics required for a ‘luminal iron chelator’, namely non-
absorbability,[1-3] iron binding [4, 5] and safe for human consumption.  The chemical 
interaction of alginate with iron has not been fully characterised.[5-7]  The majority of reports 
of an alginate-iron interaction are around the formation of iron-oxide nanoparticles, where the 
alginate is employed as a scaffold.[8-14]  Whether this nanoparticle formation within the 
environments of the gastro-intestinal tract occurs is unknown, however in the chemical 
synthesis of such nanoparticles, harsh basic pH conditions are utilised to drive formation.[13]  
One report estimates the iron(III) alginate binding constant of K = 5.04 x 104 M-1.[5]  With 
regards to other metal ions, it is known that calcium readily coordinates with alginate with a 
strong affinity to form gels.[15-20]  It is also known that the affinity and strength of 
interaction of alginates with calcium is dependent upon alginate chemical composition; a 
factor with respect to iron binding that is unknown.[7, 20] 
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In consideration of this, the binding of iron to alginate needs be assessed at a molecular level 
in order to understand the nature of their complexation and most pertinently to establish if 
sodium alginate is a suitable candidate as an iron chelator with respect to its iron binding 
ability.  A series of alginates will be characterised, such that any differences in iron binding 
can be rationalised by the differences in their chemical composition similarly to the 
interaction of calcium with alginate. Likewise, the effect of competing metal cations also 
needs to be assessed since other metals are also found in the colon.  Thus, the aims of this 
chapter are: 
1. To determine the iron binding potential of a series of alginates with a range of 
chemical compositions. 
2. Understand the effect of competing metal ions such as calcium on iron binding. 
3. To investigate and propose a mechanism of the alginate-iron interaction using solution 
and surface modalities. 
4. Chemically characterise the alginate series to determine molecular weights and G:M 
compositions. 
 
2.2 Results and Discussion 
2.2.1 Iron binding of alginate using dialysis techniques 
Dialysis techniques were employed to screen the alginate series for their iron binding 
potential.  Alginate was confined within a dialysis membrane and incubated in a solution of 
aqueous ferrous sulphate that was in excess of the alginate molarity.  Since ferrous sulphate 
was used as the iron source, it could be suggested that some iron oxo-hydroxide would be 
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present due to ferrous irons hydrolytic nature in aqueous solutions.   The dialysis bag was 
subsequently washed to remove freely-dialysable (non-bound) iron from the alginate, to allow 
assessment of the total iron bound to alginate (method 2.5.1).  The concentration of iron that 
was used was similar to that reported in the colon (0.2 mM).[21]  Analysis of iron 
concentrations revealed that all alginates bind iron and at equal amounts under the dialysis 






























Figure 2.1: Iron concentration (mg/mg alginate) of dialysed alginate incubated in 
FeSO4∙7H2O (0.2 mM) and washed to remove non-alginate-bound iron.  Error bars denote ± 
SEM, n = 3. 
 
The alginate series tested all bind iron, with 1 g of alginate calculated to bind between 0.42 
and 0.56 g of iron(II) with a mean iron binding potential of 0.52 g of iron (II) per gram of 
alginate.  The reported molecular weight of alginate LFR5/60 is ca. 35,000 Da.[22]  The 
monomer unit size of the guluronic or mannuronic acid monomers (C6H10O7) is 194 Da, 
which calculates to 180 monomer units per alginic acid polymer.  As hypothesised earlier 
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from the coordination studies of different transition metals, the carboxylate residue of the 
uronic acid unit is the host for an iron ion and can accommodate one ferrous or ferric ion.  
This estimation can be used to calculate a total theoretical iron binding potential of 0.28 g of 
iron(II) per gram of LFR5/60.  This indicates from the results of the dialysis experiments that 
more iron is binding than a typical 1:1 monomer unit:carboxylate interaction since almost 
double the amount of iron was chelated.  An estimation for the other alginates used in this 
experiment could not be calculated as their molecular weights are unknown. 
As reviewed, the use of alginates and their interaction with calcium is well established and the 
strength of binding is known to be strong.  It is important to consider competition from other 
metal cations,  especially in the context of sodium alginate being used as a medicine to chelate 
iron within the gastro-intestinal tract as other metal cations (such as calcium) will be present 
within this environment.  With this, the extent of this competition was determined by titrating 

































































Figure 2.2:  (A) Iron concentration of dialysed alginate incubated in FeSO4∙7H2O (0.2 mM) 
with CaCl2∙2H2O titrated in at concentrations of 0-4 mM.  (B) Specific iron binding potentials 
of the alginate series at 2 mM CaCl2∙2H2O. Error bars denote ± SEM, n = 3. 
 
Iron displacement due to calcium binding to alginate is evident (figure 2.2).  This is expected 





titration of calcium demonstrates that as little as 1 mM calcium chloride is able to displace 
50% of the iron that is bound to alginate.  At the 2 mM calcium concentration (the 
concentration calculated to be present within the colon),[23] the proportion of displacement 
continues yet differences become apparent between the alginates.  Manucol LD retains 53% 
more iron than alginate LFR5/60; Protsea AFH and Manucol DH also retain significant iron-
binding at this concentration of calcium.  Iron binding by the alginates at physiologically 
relevant concentrations of calcium can be stratified as such; 
LD>DH≈AFH>KEL>RF5560≈GHB>LFR5/60.  
The rate of loss of iron from the alginate by both diffusion and also by calcium displacement 
can be measured using an amended technique of the alginate dialysis method, whereby 
alginate samples are taken periodically and iron is measured at specific time points.  This 
allows the measurement of iron loss over a timed period and the rate of loss can be calculated 
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Figure 2.3: Loss of iron from alginate (incubated originally in FeSO4∙7H2O (0.2 mM)) due to 
diffusion (subsequent incubation in water) and displacement by calcium (subsequent 
incubation in CaCl2∙2H2O (0.2 mM)) for (A) Manucol DH, (B) LFR5/60 and (C) Manugel 
GHB. 
 
As evident by the rate of loss of iron for Manucol DH, LFR5/60 and Manugel GHB (0.0008, 
0.002 and 0.012 mM min-1 respectively) there are large differences between the alginates.  
These results corroborate the initial displacement experiment, whereby the alginates that were 
most affected by calcium addition are those with the higher rates of iron loss. 
Alginate Rate of loss of Fe (mM min-1) 
Manucol DH 0.0008 
LFR5/60 0.002 





These dialysis experiments indicate that all the alginates do indeed bind iron.  It becomes 
evident that these similarities are no longer apparent when the alginates are subject to 
competition by calcium.  Manucol LD, Manucol DH and Protsea AFH retain higher 
proportions of iron binding under calcium-competitive conditions.  It could be hypothesised 
that these differences can be rationalised based on the chemical composition differences of the 
alginate series.  Calcium is known to bind to alginate arranged in the supramolecular ‘egg-
box’ structure (as discussed in section 1.4.5), whereby calcium ions have a higher affinity 
towards the G-units than the M-units along the alginate backbone.  It could be the case that 
these three alginates that retain higher iron binding under calcium-competitive conditions 
have the lower proportion G-units of the alginate series, attenuating their affinity towards 
calcium.   
 
2.2.2 Calcium-alginate Isothermal Titration Microcalorimetry 
Since it has been demonstrated that calcium impacts on the iron chelation properties of 
alginate, the affinity of calcium towards alginate was examined using Isothermal Titration 
Microcalorimetry (ITC).  ITC is a sensitive technique which measures the energetics of a 
chemical reaction or molecular interactions.   Aliquots of Ca(II) were titrated into stirred 
alginate solutions at a constant temperature of 37 °C and the heats of each titration were 





















Figure 2.4:  ITC thermograms recorded for injecting 10 μL aliquots of CaCl2∙2H2O (7.5 mM) 
into (a) Manucol LD, (b) Manucol DH, (c) Manugel GHB and (d) LFR5/60 (0.052%) at 37 °C 
in acetate buffer (20 mM, pH 5).  Alginate solutions were dialysed against acetate buffer prior 
to titration to eradicate heat changes due to pH changes and ionic-strength miss-matches 
between the titrant and titrand.  Corresponding isotherms are displayed below the 
thermograms and binding curves were plotted using a model of independent binding sites. 
 
A: Manucol LD B: Manucol DH 
C: Manugel GHB D: LFR5/60 





























































































































































Values obtained for the number of binding sites (N), enthalpy of binding (H), the binding 
constant (K) and the entropy of interaction (S) were calculated (table 2.1).    
Table 2.1:  Binding parameters obtained from alginate-calcium ITC. 
Alginate N K (M
-1
) ΔH (cal mol
-1













Manucol DH 163 ± 3.7 






-441.8 ± 32.98 23.8 





















The binding isotherms were obtained by integrating the injection peaks of calcium titration 
into alginate and subtracting the corresponding heats of dilution of Ca(II) titration into acetate 
buffer (control titration).  The ITC thermograms show a two-step binding motif, whereby the 
second step was fitted to a ‘one set of sites’ binding model (equation 2.5).  This second event 
corresponds to the binding of calcium to G-units on the alginate and egg-box formation.[20]   





















Figure 2.5: One set of sites model for fitting the binding isotherms.  This model assumes that 
a ligand can bind one or multiple binding sites of another molecule with identical affinity and 
identical binding mechanisms where Q = heat content of the solution, n = number of binding 
sites, Mt = total concentration of macromolecule in Vo , Vo = active cell volume, H = enthalpy, 
Xt = total ligand concentration and K = the binding constant. 
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The number of binding sites (N) increases as such; LFR5/60 < Manucol LD < Manucol DH < 
Manugel GHB.  Interestingly, the binding enthalpy for each alginate towards calcium follows 
the same trend identified for the binding affinity in the dialysis experiments, whereby 
LFR5/60 has the highest enthalpy for calcium binding (-1978 cal mol-1) and the lowest iron 
retention in competitive dialysis experiments.  On the other hand, Manucol LD, which has the 
lowest enthalpy of interaction (-283 cal mol-1) retains the highest iron binding when calcium 
is present in the equilibrium dialysis experiments.  This again may reflect the G:M 
composition of the alginates, where those with higher G-compositions are likely to have 
higher binding enthalpies for calcium.  The calcium binding constants (K) were all within one 
order of magnitude for each alginate.  Similar to the experiment detailed earlier, a difference 
would not be expected since the model is fitted to the binding of calcium to specifically G-
units only, which between the alginates are the same.  However, these experiments alongside 
the results generated from the dialysis experiments displays the need to determine the 
chemical composition of the series of alginates. 
 
2.2.3 Guluronic acid and mannuronic acid composition determination 
The possible range of G:M compositions of different alginates is extensive.  Not only can 
alginates have varying compositions in terms of G:M ratios, they can also vary in terms of 
their sequence structure too.  For example, a 50:50 G:M alginate may have sequence structure 
GGGMMM (block-wise arrangement) or GMGMGM (alternating arrangement) as two 
extreme examples (figure 2.6).  Determination of the G:M compositions of alginates was 
examined by i) circular dichroism spectroscopy, which reveals the relative G-unit content 
93 
 
between alginates  and ii) Nuclear Magnetic Resonance (NMR) spectroscopy, which reveals 
the absolute G:M composition.   
 
 
Figure 2.6: Chemical compositions of a 50:50 G:M alginate demonstrating extremes in 
possible sequence, featuring a blocked arrangement (top) and alternating arrangement 
(bottom). 
 
2.2.3.1 Determination of composition by circular dichroism spectroscopy 
The negative circular dichroism exhibited at ca. 210 nm gives a relative estimation of the G-
unit composition of the alginate (figure 2.7).[15] 
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Alginate CD (mdeg) at 210 nm 
Manugel GHB -49.3 
Protanal 6650 -45.4 
LFR5/60 -45.3 
Manucol DH -31.7 
Keltone -29.7 
Manucol LD -28.6 
Protsea AFH -7.4 
 




It is evident from the CD spectra that there is a wide range of alginate G-unit compositions 
throughout the alginate series, with some alginates containing 42% more G-unit monomers 
than the higher M containing alginates.  M-unit composition is immeasurable from CD 
spectroscopy.  M-units have a CD absorption at lower wavelength to G-units (ca. 200 nm), 
but the high absorptivity of G-units masks any apparent M-unit profile. Protsea AFH has a 
different profile to the other alginates within the series, with a marked attenuation of CD 
signal at 210 nm.  Protsea AFH is the only coloured alginate throughout the series, which may 
rationalise this anomalous recording.   
 
2.2.3.2 Determination of composition by nuclear magnetic resonance spectroscopy 
Despite CD spectroscopy being a convenient method for assessing relative G-content, NMR 
spectroscopy is an alternative method that can be used to determine absolute G and M alginate 
composition.  The integrals of resonances acquired by the spectrometer correlate to 
environment-specific protons on the alginate polysaccharide thus allowing absolute G:M 
ratios to be calculated.  The line-width of resonances (and thus overall peak height) obtained 
from NMR is inversely related to the tumbling time (τ) of the molecule.  Large polymers that 
are viscous in solution will have a low tumbling rate and thus high τ, and so signal-to-noise 
ratios for alginate resonances within the 1H NMR will be low.  Heating the sample alleviates 
this as alginates acquire more kinetic energy, become less viscous and have a decreased 
tumbling time.  This increases the signal-to-noise ratio observed and as such all NMR spectra 




Figure 2.8: Comparison of 1H NMR spectra for the alginate series, (a) Manucol LD, (b) 
Manucol DH, (c) Manugel GHB, (d) Protanal RF6650, (e) Keltone, (f) Protsea AFH and (g) 
LFR5/60 at 90 °C in D2O. 
 
Spectra resonances are broad for alginates due to their inherent hydroxyl content.  At 90 °C 
the residual DOH resonance does not interfere with the assignment peaks, allowing 
integration of the G(H1) and M(H1) protons (method 2.5.5) (figure 2.10). 
 







Determination of integrals under the resonances at specific ppm values is proportional to the 
number of hydrogens in the environment which that resonance represents.  Since the signals 
for the G(H1) and M(H1) anomeric protons at 5.6 ppm and 4.8 ppm respectively are well 
resolved, the G:M ratio of each alginate can be determined.  Different analyses for the 
determination of uronic acid composition have been reported whereby integration at the 
following ppm values calculates the ratio of G:M: 
A) G(1H):M(1H) = ∫ 5.1-6.0 ppm : ∫4.68-4.64 ppm [24] 
B) G(1H):M(1H) = ∫ 5.1-5.0 ppm : ∫4.72-4.68 ppm[25] 
C) G(1H):M(1H) = ∫ 5.1-6.0 ppm : ∫4.6-4.67 ppm[26] 
Integration of the peaks at these signals and setting ∫G(H1) = 1 reveals the absolute G:M ratio of 












Table 2.2: Integration of 1H NMR analysis of each alginate in the series according to 
different protocols described above (A, B and C).[24, 26, 27] 
Alginate Protocol ∫M %G %M χ ̅ (%G) 
Protsea AFH 
A 1.82 35 65 
29 B 2.17 31 69 
C 3.74 21 79 
Manucol LD 
A 1.45 40 60 
38 B 1.38 42 58 
C 2.1 33 67 
Manucol DH 
A 1.16 53 47 
40 B 1.22 55 45 
C 2.28 70 30 
Keltone 
A 0.83 55 45 
46 B 1.04 49 51 
C 1.85 35 65 
Manugel GHB 
A 0.77 56 44 
53 B 0.59 63 37 
C 1.37 41 59 
Protanal RF6650 
A 0.47 68 32 
60 B 0.60 62 38 
C 1.08 48 52 
LFR5/60 
A 0.41 71 29 
62 B 0.58 63 36 
C 0.96 51 49 
 
Analysis revealed a range of G:M compositions; with the lower %G alginates Protsea AFH 
and Manucol LD containing 29 and 38% G-units respectively to the highest, LFR5/60, which 
has 62 % G content.  The results obtained from CD spectroscopy mirror the results here 
verifying the alginate compositions (figure 2.7). 
It is evident by comparing the results from the dialysis and calcium ITC experiments with the 
composition results found here that alginates with higher G-unit content have a stronger 
affinity for calcium than those with more M-unit composition.  It is thus implicit that an 




2.2.4 Determination of alginate molecular weight by analytical ultracentrifugation  
To fully characterise the alginates, their molecular weights were also determined.  Analytical 
ultracentrifugation (AUC) relies on sedimentation forces to enable the calculation of 
molecular weight.  The method is applicable to small compounds that are hundreds of daltons 
in weight to larger polymeric compounds and thus is ideally suited to alginate biopolymers 
where conventional mass spectrometery techniques fail.[28]  Alginates were all characterised 
by sedimentation velocity experiments by analytical ultracentrifugation to establish their 
molecular integrity using a least squares method.[29]  A sedimentation velocity experiment 
involves high speed centrifugation to sediment the solute (in this case alginate) towards the 
bottom of the cell sample chamber (method 2.5.6).  The rate of movement of the solute can be 
measured and the rate of movement is proportional to the molecular mass of the alginate 




Figure 2.10: Sedimentation coefficient distribution profiles obtained from sedimentation 
velocity experiments for (a) Protanal RF6650 (b) Keltone (c) Manugel GHB (d) Manucol DH 
(e) Protsea AFH (f) Manucol LD (g) LFR5/60 and (h) all alginate samples at one 
concentration (0.7 mg mL-1). S is Svedberg and 1 S = 10-13 sec. 
 
The alginate that exhibited the lowest sedimentation coefficient (2.0 ± 0.1 S) was LFR5/60 
whereas Protanal RF6650 had the highest value (3.1 ± 0.2 S) indicating the lowest and highest 
molecular weight of the series.  All the alginates demonstrated unimodal distributions 
indicating homogeneity throughout the series, with no alginates having compositions of 
variable molecular weight entities.  
The weight average molecular weight of the alginate series was estimated from the 










ideality arising from co-exclusion and polyelectrolyte effects (which normally are non-
significant under conditions of high dilution), each alginate was run at different 
concentrations (0.2 -5.0 mg mL-1) such that weight average molecular weight values can be 
obtained (figure 2.11). 
 
Figure 2.11: Plots of the apparent weight average molecular weight (Mw, app) against 
concentration c (mg mL-1): the conventional plot (Mw, app vs c), for (a) Protanal RF6650 (b) 
Keltone (c) Manugel GHB (d) Manucol DH (e) Protsea AFH  (f) Manucol LD and (g) 
LFR5/60. 
 
Alginate molecular weights corroborate the relationship of increasing sedimentation 











Table 2.3: Average molecular weight values of alginates obtained by analytical 
ultracentrifugation. 
Alginate Sedimentation rate (S) Molecular Weight (kDa) 
Protanal RF6650 3.1±0.2 230±10 
Keltone 2.9±0.2 220±15 
Manugel GHB 2.6±0.1 180±18 
Manucol DH 2.5±0.1 170±6 
Protsea AFH 2.3±0.2 155±5 
Manucol LD 2.2±0.1 145±5 
LFR5/60 2.0±0.1 74±3 
 
Interestingly, these results also verify the N values (binding site number) obtained from the 
ITC experiments, where longer polymeric alginates were identified with more calcium 
binding sites.  However, it is important to note that N values will also depend on the G:M 
ratio of the alginate. 
   
2.2.5 Alginate iron binding profiles using UV-Vis spectroscopy 
With the series of alginates fully characterised, chemical iron binding analysis could be 
performed.  UV-Visible spectroscopy allows changes in absorbance or wavelength shifts to be 
monitored with the continual introduction of iron; the spectral change observed corresponds 
to a binding event.  Provided an excess of guest (iron) is titrated into the host (alginate) and 
saturation of binding is reached, binding constants can be calculated by fitting the data to 
relevant binding equations.  Alginates with their viscous and gelling nature are not ideal 
candidates for spectroscopic titrations since any gelling of the alginate would result in light 
scattering and absorption values would not represent a binding interaction.  Thus the smallest 
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molecular weight alginate LFR5/60, with its low viscosity, was selected for UV-Visible 
titrations (method 2.5.7).  Titration of an aqueous solution of Fe(III) to an aqueous solution of 
sodium alginate LFR5/60 revealed the growth of a band at 270 nm (figure 2.12).  Since 
Fe(III) was used in this experiment in its aqueous form, it is likely that iron oxo-hydroxides 
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Figure 2.12: (A) UV-Visible titration spectra of FeCl3∙6H2O (10 mM) titrated into LFR5/60 
(0.1 % w/v).  (B) UV-Visible normalisation spectra of FeCl3∙6H2O (10 mM) titrated into an 
equal volume water control.  (C) Difference spectra (iron-alginate titration normalised by the 
equimolar iron-water titration) indicating the profile changes upon addition of iron.  (D) 
Absorption at 273nm plotted against iron concentration to obtain a binding curve and fitted to 
a 1:1 binding equation. 
 
The titration of iron(III) (iron oxo-hydroxides) into alginate revealed a distinctive profile 
change with a band growth at 280 nm with sequential additions of iron.  Iron oxo-hydroxide 
























such, an equimolar control titration was recorded and subtracted from the alginate titration.  
This so called ‘difference spectra’ would only show absorption changes if an interaction was 
incident, which did indeed reveal growth of a band at λmax = 273 nm.  This indicates an 
interaction between iron and alginate under the conditions of the titration.  The λmax  values 
can be plotted against the final iron molarity to acquire a binding plot, to which a binding 
curve based on a model of 1:1 binding can be fitted (figure 2.14). The binding constant was 
calculated to be K = 1 x 103  ± 280 M-1.  This value is comparable to that found previously 
(5.04 x 104 M-1 ) by Sreeram et al,.[5] 
 
 
Figure 2.13: Equation used for the least squares quadratic curve to fit the binding data, 
whereby ligand concentration ([H]), the maximal response (ΔImax) and iron concentration 
([G]) were initially set and iterations were made to acquire the best fit. 
 
The peak at 280 nm on the UV-Vis spectra has previously been reported as identification of 
an iron-oxide species, attributed to a ligand-to-metal charge transfer electronic transition 
originating from the OH- ligands to the Fe ion.[30]  This suggests that an iron-oxide form of 
iron may be present upon binding to alginate under these conditions.  
 
2.2.6 Alginate iron binding using Isothermal Titration Microcalorimetry  
Similarly to estimating calcium-alginate interactions using isothermal titration 
microcalorimetry (ITC), iron titrations were performed to examine the overall strength of the  
interaction of iron with alginate LFR5/60.  This alginate was selected due to its lower gelling 
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propensity.  An adapted protocol that determined metal binding constants of other 
biopolymers in aqueous conditions was used, whereby aliquots of aqueous iron(III) chloride 
were titrated to a solution of LFR5/60 and a drop in the integrated heats of each addition is 
observed (method 2.5.3) (figure 2.14). 
 
Figure 2.14:  Isothermal titration microcalorimetry thermogram of 8 μL injectants of 
FeCl3∙H2O (5 mM) into LFR5/60 (0.04 mM) at 37 OC with a binding curve plotted once the 
heats have been integrated. 
 
Saturation of iron binding by alginate occurred at a molar ratio of iron:alginate of 3:1, with a 
5 times excess of iron used to ensure saturation of all the binding sites on the alginate. Data 



































analysis revealed two binding events between alginate and iron with the estimated binding 
constants calculated as K1 = 1 x 106 and K2 = 3 x 104 M-1 respectively.  Entropy is positive in 
both cases (18.4 and 23.2 cal mol-1 K-1), which is due to the increased ordering of the alginate 
when iron complexes.  This suggests that not all of iron’s hydration sphere is displaced upon 
coordination.  Enthalpy values were found to be exothermic for both binding events (-704 x 
104 and -1548 cal mol-1) as expected for these conditions.[12, 14] 
It is interesting to note that K2 (N=3) is 100 times stronger than K1 (N=1).  This may elucidate 
a binding mechanism whereby there is an initial binding of iron ions followed by alginate 
reorganisation to accommodate further iron ions to bind.  Structural reorganisation of alginate 
polymers during metal binding is commonplace and was discussed earlier for that of calcium, 
and this may rationalise the high entropy values obtained in these titrations. 
 
2.2.7 Iron-alginate binding by circular dichroism spectroscopy 
Since CD spectroscopy proved useful in the determination of alginate G:M composition and it 
has been demonstrated how CD spectroscopy allowed the conformational changes to be 
probed during calcium titrations and the formation of the egg-box model of binding, it would 
be beneficial to undertake similar experiments with iron.  Alginate-iron complexes were 
isolated using similar equilibrium dialysis experiments as in section 2.3.1.  The CD spectrum 
of the isolated LFR5/60-Fe bound complexes shows the appearance of a peak at λ = 280 nm, 




Figure 2.15: CD spectra of alginate-iron composites isolated via equilibrium dialysis. 
 
The peak in the CD, as verified by the UV-Vis spectra, is attributed to iron-hydroxide (Fe-
OH) presence.[30]  As discussed, a CD signal is only observed by chiral compounds, of 
which iron is not.  However, once a non-chiral iron becomes complexed to a chiral host it can 
exhibit an induced CD signal, which is observed here.  This induced signal observed is 
indicative of iron oxo-hydroxide binding and confirms that the changes observed in the UV-
Vis spectrum are attributed to the alginate binding to Fe-OH species in solution.   
 
2.2.8 Conformational changes of alginate upon iron complexation 
The polymeric nature of alginates enables an elaborate range of confirmations and structures 







































demonstrated that alginate can template the formation nanoparticles, yet in these experiments 
iron-centred nanoparticles are fabricated using chemically controlled conditions.[13]  Here, 
utilisation of the dialysis technique ensures simple mixing of the alginate with iron making 
the interaction much more physiologically relevant.   The solution studies undertaken thus far 
have provided insights into the mechanism of iron binding.  More iron ions bind to alginate 
than a typical 1:1 carboxylate unit:iron interaction.  Circular dichroism spectra revealed 
alginate structural reorganisation upon iron binding, and analysis alongside UV-Vis 
spectroscopy indicates the presence of an iron-hydroxide species.  Isothermal titration 
microcalorimetry demonstrated that two distinct binding events occur upon iron 
complexation.   
 
2.2.8.1 Alginate-iron structural morphology analysis by scanning transmission electron 
microscopy 
Alginate iron complexes, as prepared by the equilibrium dialysis technique were used in the 
scanning transmission electron microscopy (STEM) studies; these complexes were prepared 
similarly to those used in the CD spectroscopy experiments for direct comparison.  LFR5/60-
iron complexes (50 μL) were drop cast onto the copper TEM grid and the excess collected 
underneath and dried to completion before visualisation (method 2.5.8).  The alginate-iron 
complexes were initially imaged at low magnification, which revealed a long range extended 
gel-like network suspended over the holey-carbon film (present on the grid) (figure 2.16 A).  
Within this gel-like network, brighter features could be observed that were much denser in 
composition.  Further magnification into these denser regions revealed the presence of 
spherical nano-particulate composites with a broad size distribution and a mean diameter of 
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1.78 ± 0.70 nm (figure 2.16 C and D).  The range of structures observed and broad size 
distribution can be attributed to the method of formation (simple mixing), which is 

















Figure 2.16: (A) low magnification, high-angle annular dark-field (HAADF) image of gel-
like alginate network with dense particulate sites and (B) bright-field (BF) image of gel-like 
alginate network with dense particulate sites.  (C) Higher magnification of the dense sites 
revealing nanoparticulate matter. (D) Higher magnification of the nanoparticles.  (E) 






It can be hypothesised that iron is binding to alginate within the binding sites along the 
alginate backbone, which is forming the long-stranded gel-like network that was visualised 
within the STEM.  Then within the gel structures, denser regions are present.  It could be 
inferred that in these regions, alginate is initiating iron nucleation sites supporting 
nanoparticle formation (figure 2.17 D).  Dialysis studies detailed earlier, demonstrated that 
more iron was bound than the calculated 1:1 alginate:iron interaction supports these results.    
With respect to the ITC results, the two binding events may relate to the initial iron binding 
along the alginate backbone and the collapse of the alginate to form iron nanoparticles at a 
critical point of iron complexation.  Control experiments were performed where iron only was 
examined, which revealed no nano-particulate matter; this indicates that it is likely that ‘free’ 
iron (as opposed to particulate iron) is binding to alginate initially, and then templated into 
nanoparticles.   
 
2.2.8.2 Nanoparticle composition analysis by STEM and EDX 
Circular dichroism and UV-Visible spectroscopy both indicated the presence of iron in its 
hydroxide form bound to alginate.  Ultra high resolution STEM enabled the visualisation of 
the nanoparticles present at the highest magnification which revealed lattice structures within 




Figure 2.17: Fourier transform analysis of high-angle annular dark-field HAADF-STEM 
images of single nanoparticles with lattice structures present. 
 
The arrangement of atoms within the lattice structure could be further analysed by Fast 
Fourier transform and it was found that the lattice arrangements matched those of Fe2O3 
(hematite), with atomic spacing calculated to be between the range 1.47 to 2.97 Å.[8]   
Hematite, which is an iron oxide mineral, rationalises the presence of iron oxo-hydroxide 
species initially binding to alginate and depicts the binding mechanism as a whole.  Iron 
initially binds to alginate in its hydroxide form.  At a critical iron concentration and at specific 
points along the alginate backbone, nucleation sites are formed where by alginate collapses 
upon the condensation of iron-hydroxide to form iron-oxide rich nanoparticles (figure 2.18).  
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It is important to note that electron beam energy can affect samples under investigation during 
examination in an electron microscope.  Electron beam damage can result in structural and/or 
chemical particle-phase conversion.  This could indeed result in a phase conversion from, for 
example, a ferrihydrite particle to a haematite arrangement found here.  The electron dose 
received at the highest magnification was 9.8 x 106 electron nm-2, which is within the range 
for this phase transition to occur.[32] 
 





To confirm the elemental species present within the dense particulate areas found within the 
extended gel-like network, Energy-Dispersive X-ray spectroscopy (EDX) was carried out on 
the alginate-iron dialysis extracts (figure 2.19) 
 
Figure 2.19: EDX mapping of iron-alginate dialysis composites with iron, oxygen, sodium 
and copper signals obtained and highlighted. 
 
EDX demonstrates that both iron and oxygen is localised in the same region of the alginate-
iron complex, further verifying iron-oxide presence within the nanoparticles.  Sodium is also 
somewhat localised, arising from the inherent sodium alginate and copper was the control 









2.3   Conclusions and summary 
All the alginates in the series tested chelated iron.  This is unsurprising since alginates are 
poly-anionic and are electrostatically attracted to cationic metal ions.  It can be concluded 
from these experiments that the affinity and capacity to bind iron is similar for all the 
alginates tested, despite there being a plethora of alginate compositions in terms of G:M ratio 
and molecular weight.  Alginate stratification is however quantifiable with respect to their 
iron binding under calcium competitive conditions.  Alginates with higher M-unit content 
were shown to withhold their iron affinity compared to alginates with greater G-unit 
composition.  This result was verified when calcium binding constants were obtained which 
demonstrated that alginates with higher G:M ratios have stronger binding enthalpies towards 
calcium chelation.  There was no correlation found between molecular weight and iron 
affinity.  It could be argued that larger molecular weight alginates with greater chain lengths 
will have more conformational strain associated with molecular structure changes to 
accommodate metal binding than smaller chain length analogues.  However, these 
experiments have generated no evidence to suggest this.  Lastly with respect to interactions at 
a molecular level, it can be confirmed that iron and calcium do indeed share the same binding 
site, however this does not mean that they bind to alginate in the same mode (i.e. the ‘egg-
box’ model). 
Iron binding parameters were derived from spectroscopic and calorimetric experiments, 
calculating iron binding constants for sodium alginate LFR5/60 as K = 1 x 103  and K1 = 1 x 
106 and K2 = 3 x 104 M-1 respectively.  These values are relatively low for a host-guest 
interaction (cf. K > 1030 for some bacterial siderophores).[33]  However, the interpretation of 
the data and analysis of results relies upon a 1:1 host:guest interaction approximation since an 
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equation describing nanoparticle formation would be complex.  As well as this, it is important 
to consider alginates not as discrete chemical units with discrete binding sites, but to view 
them more as proteins where their secondary structure forms metal binding sites; more 
simply, the interaction of iron with a carboxylate moiety may be strong but this is 
immeasurable in the face of the whole alginate polymer collectively binding iron.   
Of most interest is the observation that alginates form nanoparticles under the simple mixing 
conditions employed.  The use of alginates to fabricate nanoparticles under chemically forcing 
conditions is commonplace, yet there is no evidence of nanoparticle formation by simple 
mixing of the reactants.  The solution and surface techniques utilised allows a mechanism of 
nanoparticle formation to be proposed whereby alginate initially binds to iron either as an 
aqueous hydroxide or binds to alginate as iron where it is converted to an iron oxo-hydroxide.  
Subsequently, at a critical concentration of iron loading the alginate collapses and forms a 
nucleation site where iron hydroxide condensation can take place to form iron-oxide centred 
nanoparticles; the whole process templated by alginate (figure 2.20).  This mode of 
nanoparticle formation provides evidence for the combination of the ‘site binding mode’ and 










The original hypothesis of this study detailed the characteristics required of a luminal iron 
chelation, which are; i) must bind iron, ii) be non-absorbable and non-fermentable, iii) be 
specific towards iron with a high affinity and iv) must be natural and safe for human 
consumption, two of these characteristics have been assessed here.  All alginates examined 
bind iron and characterisation analyses have shown that a good range of alginate chemical 
composition has been utilised in this screen.  The binding of iron chemically is not strong, yet 
the chelation of iron by alginates form nanoparticles which may have important physiological 
consequences.  The cellular processing of nanoparticles depends on many factors including 
nanoparticle size, composition and coating and thus these structural changes may change the 
bioavailability and could in fact make them bioavailable; this will need to be assessed.[34]  
How the iron chelated to alginate is transformed to an iron oxide may have a fundamental 
importance in quenching the toxic effects of iron and since ferritin stores iron in this form it 
can be viewed as being physiologically inert.[35]   
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With respect to binding specificity it can be concluded that an alginate with a low G-unit 
composition would be the ideal candidate for iron binding (for example Manucol LD or 
Protsea AFH).  The contribution of G-unit calcium binding would render a high G:M ratio 
alginate incompetent as a luminal iron chelator since it would have a greater affinity towards 
calcium ions and any iron chelation would be displaced by calcium.   
It is important to take into account that these chemical stratification studies, regardless of the 
physiological conditions employed, may not be paralleled in vitro and in vivo.  As such, these 
stratification experiments must be carried out in vitro and in vivo, yet data produced thus far 
indicates that Manucol LD may be the best candidate for iron chelation.  
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2.5 Experimental methods 
2.5.1 Equilibrium dialysis experiments 
Sodium alginates, Manucol LD (LD), Manucol DH (DH), Manugel GHB (GHB), LFR5/60, 
Protsea AFH (AFH), Protanal RF6650 (RF6650) and Keltone (KEL) (0.1% w/v) in DI H2O, 
(10 mL) were concealed within a dialysis membrane (MWCO= 12, 400, 33 mm flat width) 
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using dialysis clips and immersed in aqueous FeSO4∙7H2O (0.2 mM) in DI H2O (750 mL) 
with or without CaCl2∙2H2O (ranging concentrations 0-4 mM) in DI H2O (750 mL) for 210 
min and washed in deionised water for a subsequent 30 min.  All experiments were performed 
in triplicate with n=3 per experiment.  Iron content was assessed using the ferrozine assay.  
For the kinetic studies where alginate samples were taken over a time course, access to the 
dialysis bag was opened after incubation in an FeSO4∙7H2O solution (1 mM) in DI H2O (750 
mL) for 210 mins and clamped to allow open-ended immersion into either CaCl2∙2H2O (2 
mM) in DI H2O (750 mL) or DI H2O only (750 mL) and 200 μL samples taken at set time 
intervals over 90 min.  Iron content was assessed using the ferrozine assay.   
For production of samples for CD and STEM, LFR5/60-Iron was prepared as above with 
incubation in FeCl3∙7H2O (10 mM) in DI H2O (750 mL) for 120 min and washed in DI H2O 
for a subsequent 120 min. 
2.5.2  Ferrozine assay for the determination of iron concentration 
A ferrozine stock solution was prepared consisting of sodium ascorbate (0.23 M, 0.91 g) 3-(2-
Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid monosodium salt hydrate ‘ferrozine’ 
(10 mM, 0.089 g) and sodium acetate (2.0 M, 13.77 g) in DI H2O (122 mL).  Each alginate-
iron sample (200 μL) was mixed with the Ferrozine stock (600 μL) and plated in triplicate 
into a 96 well plate.  The absorbance was read at λ = 450 nm.  Iron concentrations were 
determined by producing a calibration curve by dissolving iron at specific concentrations (0-1 





2.5.3 Isothermal Titration Microcalorimetry 
For the assessment of calcium-alginate binding, alginates were dissolved (0.052 % w/v) in 
acetate buffer (20 mM, pH 5) and hydrated overnight to ensure complete dissolution.  These 
alginate solutions were then dialysed against acetate buffer (1000 mL, pH 5) for 24 hours, 
with the dialyses buffer used to prepare the calcium solutions so that there were no pH 
differences or ionic strength mismatches; before use, all solutions were degassed at 35 °C.  
Aliquots of CaCl2∙2H2O (10 μL, 7.5 mM) were titrated into a solution of alginate or acetate 
buffer at 37 °C with a cell chamber volume of 1360 μL.  A total of 28 injections were 
performed, with an interval of 1000 s between each titration; the initial titration was set to 2 
μL and was discarded for the data analysis; this is common practice in ITC experiments.  The 
stirring speed was set at 286 rpm with an initial 60 s delay and a reference power set to 10 
μcal s-1.  Measurements were performed on a VPITC MicroCalorimeter and data were 
analysed using MicroCal LLC ITC/Origin software package.    
For the assessment of iron-alginate binding an aqueous solution of FeCl3∙6H2O (5 mM) in DI 
H2O was titrated in increments of 8 μL aliquots into an aqueous solution of LFR6/50 (0.07 
mM) in DI H2O; all solutions were degassed at 35 °C before use. The cell temperature was set 
to 37 °C, a stirring speed of 286 rpm and a 10 µcal s-1 reference power with  the initial 
injection being small (2 μL) and discarded in the data analysis.  A delay of 350 sec between 
each injection was set to allow the energy difference to reach back to baseline.  To account for 
the high energy changes associated with iron titration into water (the control titration), these 
heat integrations were subtracted from that of the alginate-iron titration and the subsequent 




2.5.4  Circular dichroism spectroscopy 
For the determination of G:M composition, aqueous alginate solutions (0.1 % w/v) in DI H2O 
(10 mL) were prepared and hydrated overnight to ensure complete dissolution.  CD 
measurements were recorded on a Jasco J-810 CD spectropolarimeter (4 accumulations, 1 s 
response) using a 1 cm path length, blackened quartz cell.  Spectra were recorded at an 
internal temperature of 20 °C.  
2.5.5 Nuclear Magnetic Resonance Spectroscopy 
1H NMR spectra were recorded on a Bruker AVIII400 spectrometer at 90 °C.  Spectra were 
obtained using a pulse repetition time of 5/6 s and a 30 ° pulse angle with a partial 
presaturation of the HOD signal.   Alginate solutions (10 mg in 1 mL deuterium oxide 
(2H2O)) were prepared under nitrogen.  Nitrogen was subsequently bubbled through the 
sample for 30 min upon complete dissolution.  Chemical shifts were calculated with respect to 
3-(trimethylsiyl)-propionic-2,2,3,3-d4 acid sodium salt at the internal standard.  Offline NMR 
analysis was performed on MestReNova LITE software.   
2.5.6  Analytical Ultracentrifugation 
Sedimentation velocity and sedimentation equilibrium in (AUC) were performed in a 
Beckman Optima XL-I analytical ultracentrifuge equipped with Rayleigh Interference Optics 
and a 30 mW laser wavelength λ = 675 nm. 12 mm optical path length double sector 
(solution/reference solvent) cells were used in an 8-hole rotor run at speeds between 40,000-
45,000 rev min-1, at a temperature of 20 °C.  Scans were taken every 1 min and capture by a 
CCD camera.  Sedimentation coefficients and sedimentation coefficient distributions were 
then evaluated using the SEDFIT algorithm of P. Schuck.  Sedimentation coefficients, s (in 
Svedberg units S, where 1 S = 10-13 s) measured in the buffer were corrected to standard 
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conditions of the density and viscosity of water at 20 °C using a standard formula, to give s20,w 
values (where the 20,w means corrected to the density and viscosity of water at 20 °C).   
In order to correct for solution non-ideality s0 20,w values are measured at a series of 
concentrations and extrapolated to zero concentration to give s20,w using the “Gralen” 
formula: 
1/s20,w   = (1/s020,w).(1 + ksc)                                                                                                   
Where ks is the concentration dependence coefficient. 
2.5.7  UV-Vis Spectroscopy 
Absorption spectra were recorded on a Varian Cary50 or Varian Cary5000 spectrometers with 
300 nm min-1 increment rates using 1 cm path length quartz cuvettes.  Increments of varying 
volumes of FeCl3∙6H2O (10 mM) were titrated into a stirred solution of LFR5/60 (0.1% w/v) 
in DI H2O, allowed to equilibrate for several seconds and then scanned.  Measurements were 
taken up to a point of saturation.  To correct for the absorption of aqueous-iron species at the 
wavelengths of interest difference absorbance spectra were obtained by correction of the 
alginate titration with the equimolar iron-water control titration. 
2.5.8  Scanning Transmission Electron Microscopy 
LFR5/60-iron samples used for STEM/EDX were made using the equilibrium dialysis 
technique as described earlier.  Due to the viscous nature of the sample, TEM grids were 
loaded with 50uL of sample and excess sample was drawn from underneath, effectively 
pulling the sample through the gird.  This produced a thin sample coverage over the grid with 
many sampling areas. 
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Electron microscopy images were taken using a 200kV FEG Jeol 2100F scanning 
transmission electron microscope fitted with a CEOS aberration corrector. Images were 
simultaneously acquired in high angular annular dark field (HAADF) and bright field (BF) 
mode using the Gatan DigitalMicrograph software package. 
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Alginate iron chelation in vitro 
and in vivo. 
 
3.1  Introduction and aims 
Confirmation of the iron binding abilities of alginate warrants further study into their iron 
chelation ability in a cellular and physiological setting.  There is inconsistency within the 
literature reporting the effect of alginate on iron metabolism, suggesting both enhancement 
and reduction of iron uptake both in vitro and in vivo.[1-4]  With such little and inconsistent 
evidence surrounding alginate modulation of iron homeostasis, further investigation is 
required. 
Chemical data presented in chapter 2 suggests iron binding potential, which is dependent 
upon alginate composition.  However, whether these differences have any effect ultimately on 
cellular iron metabolism is not known.  Furthermore, the cellular localisation of alginate in 
vitro needs to be verified; therapeutic iron chelation will be useless if alginates are absorbable 
at a cellular level.  The aims of this study are thus: 
1. Determination of the absorbability of alginate in cell culture conditions. 
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3.2  Results and discussion 
3.2.1 Assessment of alginate bioavailability 
An important property of alginate that must be confirmed to ensure specific luminal iron 
chelation is that of non-absorbability.  Alginate must not be able to permeate the cell 
membrane as intracellular iron chelation or systemic iron chelation is not desired. 
 
3.2.1.1 Alginate FITC conjugation 
As a method to localise alginate in cellulo and to assess the absorbability of alginate, the 
fluorophore fluoresceinamine (FITC-NH2) was chemically conjugated to alginate.  The 
reactivity of the carboxylates present on the alginate were utilised for a well-established 






Figure 3.1: Reaction scheme of FITC-NH2 conjugation to alginate under peptide coupling 
conditions. 
 
Alginate is water soluble and as such is an ideal candidate for these coupling conditions.  
Sodium alginate LFR5/60 was stirred at room temperature in solution with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and n-hydroxysulfosuccinimide sodium salt 
(Sulpho-NHS) for 24 hours to produce a bright orange coloured solution.  This crude mixture 
was dialysed extensively to ensure complete removal of any unreacted materials.  The loss of 
fluorescence within the dialysate was monitored using UV-Vis spectroscopy, with complete 
loss of free fluorophore evident after dialysis against 35 L of water over a period of 12 days.  
Photophysical studies on the starting alginate reactant and conjugated alginate (FITC-
LFR5/60) revealed emission and absorption profile changes upon reaction, indicative of 
conjugation and chemical change (figure 3.2).  FITC-LFR5/60 has a λmax = 490 nm whereas 
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the non-conjugated FITC has a λmax = 450 nm; changes in the luminescence spectra are also 
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Figure 3.2:  (A) Luminescence and UV-Vis spectra of the fluorescent alginate, FITC-
LFR5/60 product and starting reactants, LFR5/60 and FITC where λex = 440 nm and a 455 
nm filter is used.  Spectra recorded with FITC concentration normalised samples (0.86 μM) 
(B) Image of FITC-LFR5/60 in normal light and under λ = 365 nm UV light. 
 
Percentage modification was calculated to assess the amount of fluorophore attachment; this 
was to ensure the extent of conjugation was kept minimal such that alginate chemical 
structure changes were not significant.  A molar modification of 6% was estimated using a 
combination of the phenol-sulphuric acid assay and absorption intensities to assess alginate 
and FITC concentrations respectively.[5]  This would suggest a sufficient fluorescence 
attachment with approximately 10 of the calculated 180 uronic acid residues modified with a 






3.2.1.2 Monitoring of fluorescent alginate FITC-LFR5/60 in vitro 
Fluorescence microscopy was employed to determine cellular localisation of FITC-LFR5/60.  
RKO colon carcinoma cells were co-cultured with FITC-LFR5/60 for 24 hours on 
microscope slides and thereafter the condition media was removed and cells thoroughly 
washed prior to fixation with formaldehyde (method 3.5.8).  One experimental group were 
subject to a cellular permeabilisation step using saponin prior to culture with FITC-LFR5/60; 
this would act as the positive control effectively allowing fluorescent alginate to enter the cell.  
Cells were co-stained with Hoechst and DeepRed cellular stains to define the nucleus and 






Figure 3.3:  Confocal image selection with images taken from three fluorescent channels; 
blue, green, and far red at λ = 364, 488 and 633 nm respectively.  Top row is control where no 
alginate was cultured with cells,  middle row is FITC-LFR5/60 + iron treated cells, and the 
bottom row is FITC-LFR5/60 treated with cell-membrane permeabilisation. 
 
Confocal image analysis revealed that no FITC-LFR5/60 was present inside of the cell 
confirming the non-bioavailability of sodium alginate under these physiological conditions.  
However, negligible FITC-LFR5/60 could be localised at the cell periphery; this finding 
authenticates the application of alginates in mucoadhesive preparations.  When cells were 
membrane-permeabilised and co-cultured with FITC-LFR5/60, green fluorescence was 
evident throughout the cell, indicating the limited bioavailability of alginate in non-
permeabilised cells.  This result defines alginate as a non-absorbable bio-polymer and that if 
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chelator.  However, it has been demonstrated that alginate can be degraded by specific colonic 
bacteria.[6, 7]  As such, these experiments do not preclude that alginate fermentation by the 
colonic microbiome does not take place, but does indicate that alginate would not be 
absorbable in its intact form. 
 
3.2.2 Manucol LD binds iron in vitro 
It has been confirmed that all alginates chemically bind iron and that under conditions of 
cationic competition, some alginates retain higher iron binding affinities than others.  It is 
important to consider that in the following in vitro experiments cell culture conditions were 
employed whereby conditioned media contains inorganic salts (such as calcium (0.2 g L-1 , 1.4 
mM) and magnesium) and is buffered at pH 7.3.  This may have an influence on the alginate 
activity in this setting and results may not parallel those found chemically despite 
physiological conditions employed at every possibility.  
 
3.2.2.1 Total cellular iron concentration by ferrozine assessment 
The simplest method of determining cellular iron content is to exploit the ferrozine ligand that 
allows the colourimetric visualisation of iron; the use of this spectrophotometric reagent is 
validated and widely used (method 3.5.9).[8]  RKO cells were challenged with a ferrous iron-
enriched media (100 μM FeSO4∙7H2O + 500 μM sodium ascorbate) with or without sodium 
alginate Manucol LD, Manucol DH, Manugel GHB, LFR5/60, Keltone, Protanal RF6650 and 
Protsea AFH (LD, DH, GHB, LFR5/60, KEL, RF6650 and AFH respectively, 0.3% (w/v)) 
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Figure 3.4: Total iron concentrations as assessed by the ferrozine assay in RKO cells cultured 
with or without the alginate series for 24 hours.  Error bars denote ± SEM, n = 3. * denotes 
statistical significance, p < 0.05 versus iron only control. 
 
RKO cells treated with iron resulted in cellular iron loading to contain a concentration of ca. 
50 nM total cellular iron; the basal levels of iron within the control group were not 
measureable by this assay.  It was found that Manucol LD significantly decreased cellular iron 
loading by 62% (p < 0.05), indicating iron chelation under these conditions.  Interestingly, no 
other alginates demonstrated this behaviour with either no-change or an increase in total 
cellular iron levels observed. 
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In comparison to the chemical analysis of iron binding it was demonstrated that Manucol LD 
was least effected by calcium in competition studies and here this alginate is the only one 
from the series examined to attenuate cellular import of iron.  It was concluded that an 
alginate with an analogous chemical composition to that of Manucol LD would be the best 
choice for a luminal iron chelator and results here support this conclusion.  Increases in total 
iron concentrations by alginates are assessed further in section 3.2.5, however, this increase in 
total cellular iron may not be a true increase in intracellular iron.  It may be argued that 
alginates that have chelated iron are incorporated onto the cell membrane due to their 
polymeric and mucoadhesive nature, as evident from the confocal microscopy; simplistically, 
the alginates are ‘sticking’ to the cell membrane.  Hence this assay is measuring total cellular 
iron (including intracellular iron and any iron associated with the cell), producing a 
misleading apparent increase in measured iron concentration.  A better and more validated 
experiment would only measure intracellular iron or biomarkers thereof such as the estimation 
of ferritin expression.    
 
3.2.2.2 Iron chelation analysis by ferritin expression 
RKO cells were challenged with an iron-enriched media (100 μM FeSO4∙7H2O + 500 μM 
sodium ascorbate) with or without sodium alginate (ManLD, ManDH, ManGHB, LFR5/60, 
KEL, RF6650 and AFH 0.3% (w/v)) and after 24 hour incubation period, the cells were 
washed and lysed for protein extraction.  Western blotting revealed that ferritin expression in 
RKO cells treated with iron was higher than that of control media as expected, since 
expression would be augmented to store the increased intracellular iron.  If iron chelation was 
taking place by the alginates then this increased ferritin signal would be dampened, since the 
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Figure 3.5:  Ferritin expression in RKO cells incubated with iron challenged with or without 
the alginate series.  Data points represent mean fold change in protein expression, normalised 
to β-actin, relative to control.  Error bars denote ± SEM, * denotes statistical significance, p < 
0.03, n = 3. 
 
Alginate Manucol LD statistically decreased the iron-mediated induction of ferritin 
expression by 60% (p < 0.05) compared to the iron only control.  The other alginates in the 
series tested had no statistical effect on ferritin expression.  This suggests that iron is being 





corroborates that of the ferrozine assessment, where Manucol LD was highlighted as the only 






































































Figure 3.6:  Ferritin expression in RKO cells incubated with iron challenged with or without 
the alginate series as examined by ferritin ELISA. Data points represent mean fold change in 
protein expression, error bars denote ± SEM, n = 2. 
 
In light of the dialysis experiments performed in section 2.2.1, the effect of Manucol LD on 
ferritin expression is unsurprising since this alginate retained the highest iron binding affinity 
within the competition experiments (which should be compared here since there will be 
significant competition from other metal ions present within the media).  With this 
comparison, it may be the case that the other alginates within the series may bind iron at 
lower concentrations of iron present within the stimulation media.  That is, if their binding 
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capacity has not been saturated from calcium coordination.  As such RKO cells were again 
challenged with an iron enriched media, but at lower iron concentrations (10 fold and 100 fold 
lower) than previous (100 μM, 10 μM and 1μM FeSO4∙7H2O + 500 μM, 50 μM and 5 μM 
sodium ascorbate) in the absence or presence of sodium alginate (LD, DH, GHB, LFR5/60, 
KEL, RF6650 and AFH 0.3% (w/v)) and after 24 hour incubation period, the cells were 





















Fe LD DH GHB LFR5/60 KEL RF AFH
[Fe] = 1 uM
[Fe] = 10 uM

























Figure 3.7: Ferritin expression in RKO cells incubated with iron (at concentrations of 100, 10 
and 1 μM) challenged with or without the alginate series.  Data points represent mean fold 
change in protein expression, normalised to β-actin, relative to control.  Error bars denote ± 
SEM, * denotes statistical significance, p < 0.05, n = 3. 
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As evident by the reduction in ferritin expression, other alginates apart from Manucol LD now 
exhibit in vitro iron chelation potential at these lower concentrations of iron, however it is 
important to note that Manucol LD is the only alginate in the series to significantly reduce 
ferritin expression at the 1, 10 and 100 μM iron concentrations by 70, 88 and 68 % (p < 0.05) 
respectively.  Manucol DH, Manugel GHB and LFR5/60 all show significant ferritin 
expression reductions at the 10 μM iron incubation concentrations attenuating expression by 
58, 47 and 92 % (p < 0.05) respectively.  This demonstrates the enhanced iron binding affinity 
observed by Manucol LD in comparison to the other alginates in the series.    
 
3.2.2.3 Iron chelation analysis by TfR1 expression 
To verify the chelation effect of Manucol LD in vitro, Transferrin Receptor 1 (TfR1) 
expression was assessed using western blotting (figure 3.8).  TfR1 is an alternative biomarker 
for intracellular iron concentrations whereby in events of low intracellular iron TfR1 
expression is upregulated to sequester transferrin-bound circulating iron.  Similarly to the 
protocol for ferritin expression, RKO cells were challenged with an iron-enriched media (100 
μM FeSO4∙7H2O + 500 μM sodium ascorbate) with or without sodium alginate (Manucol LD 
0.3% (w/v)) and after 24 hour incubation period the cells were washed and lysed for protein 




























Figure 3.8: Transferrin expression in RKO cells incubated with iron challenged with or 
without Manucol LD (0.3% (w/v)).  Data points represent mean fold change in protein 
expression, normalised to β-actin, relative to control.  Error bars denote ± SEM, * denotes 
statistical significance, p < 0.05, n = 3. 
 
Analysis of the western blots revealed that Manucol LD statistically increased TfR1 
expression by ca. 50% (p < 0.05) compared to iron alone, indicating that this alginate is 








3.2.3 Caco-2 monolayers as an intestinal model for iron absorption 
Caco-2 cells and their use in monolayer in vitro assays are used extensively in the 
pharmaceutical industry in bioavailability and uptake studies.[9]  The human colon carcinoma 
cell line (Caco-2) spontaneously differentiate and polarise under standard culture conditions 
in vitro, complete with microvilli, expression of brush border associated enzymes and the 
presence of tight junctions.[10]  This unique property can be used to model the human 
intestine epithelium when used in combination with bicameral chamber transwell 
polycarbonate membrane culture dishes (figure 3.9).  
 
Figure 3.9: Diagrammatic representation of caco-2 monolayers within the bicameral chamber 
co-cultured with iron challenged with or without alginate. 
 
This method allows the assessment of the transit of iron across the cell monolayer.  Iron 














Labile Iron Pool 
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intestinal lumen), the cell monolayer (which represents the intestinal epithelium) and the basal 
chamber (which indicates movement into the blood).  
3.2.3.1 Manucol LD decreases intracellular iron in caco-2 epithelium monolayers  
Caco-2 cells, that were grown for 20 days post confluency to allow formation of intestinal-
modelled epithelium, were challenged with an iron-enriched, radioactive spiked (59Fe, 10 000 
CPM) media (100 μM FeSO4∙7H2O + 500 μM sodium ascorbate) with or without sodium 
alginate (Manucol LD 0.3% (w/v)) and after 24 hour incubation period, the cells were washed 
























Figure 3.10:  Iron concentration within the caco-2 cells of the monolayer when incubated 
with iron and challenged with or without Manucol LD (0.3% (w/v)).  Error bars denote ± 
SEM, * denotes statistical significance, P < 0.05, n = 3. 
Manucol LD significantly decreased intracellular iron concentrations by 70% (p < 0.05) 
within the Caco-2 monolayer indicating that Manucol LD is chelating iron in the 
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physiological conditions of this intestinal model.  This extent of iron modulation was 
similarly found in the results obtained from the ferritin expression, TfR1 expression and 
ferrozine experiments in RKO cells treated with Manucol LD. 
The iron concentrations within the apical compartment of the Caco-2 model could be 
measured over the period of the incubation by taking aliquots of the media from these upper 
compartments at specific time points.  The concentration of iron would be proportional to the 
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Figure 3.11:  Iron concentrations at 30 min, 4 hours and 24 hours of the apical compartment 
of the caco-2 monolayer for cells treated with iron, challenged with or without Manucol LD 
(0.3% (w/v)).  Error bars denote ± SEM, * denotes statistical significance, p < 0.05, n = 3.  
Note: apparent increase in the Manucol LD apical compartment is due to volume changes 
between the apical and basolateral and a concentration of the alginate-iron complexes within 




Co-incubation with Manucol LD at both 4 and 24 hours inhibited cellular uptake by the Caco-
2 cells by 60% (p < 0.05) compared to the iron alone control.  These results validate the 





















3.2.5 Alginates increase intracellular iron concentrations 
With a goal of iron chelation, a focus on alginates decreasing cellular iron concentrations has 
been highlighted thus far; however it is apparent that throughout the experiments performed, 
some alginates have actually increased intracellular iron concentrations.  This is unsurprising, 
since it has been discussed how alginates are forming nanoparticles under these conditions 
and iron-nanoparticle formation has been described as therapeutic intervention for iron 
deficiency anaemia.[11-16].  Throughout the experiments undertaken, different alginates have 












Table 3.1:  Table of experiments and relative increases in intracellular iron or protein 
expression normalised to iron only controls. Ferrozine refers to experiments in section 3.2.2.1, 
Ferritin expression, ELISA and 1 mm ferritin refers to experiments in section 3.2.2.2. 
 
 
Alginates such as Manucol DH and Protanal RF6650 both show the most evidence of 
enhancing intracellular iron concentrations.  Interestingly, this enhancement effect is most 
pronounced for all the alginates, apart from Manucol LD, in the ferrozine experiments.  This 
observation was rationalised earlier, whereby actual iron concentrations are measured and not 
intracellular iron specifically. There are several possibilities as to why increased intracellular 
iron concentrations are observed.  Firstly, iron-loaded alginate gel networks as identified by 
STEM could be incorporating into the cell membrane at the cell surface, pseudo-loading the 
cell with iron causing this apparent increase in cellular iron concentration.  This rationality 
seems plausible based on the evidence provided by confocal microscopy which demonstrated 
that some alginate-iron composites could be localised to the cell periphery.  Secondly, as 
discussed the alginate-iron nanoparticles are being endocytosed into the cell, yet these iron-
rich nanoparticles may not be sensed by the regular mechanisms akin to when iron normally is 
imported.   And lastly, it has previously been reported that metal-Tf conjugated nanoparticles 
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could become internalised via transferrin mediated uptake.[17]  This is unsurprising since 
transferrin acquires iron and stores it in an iron-oxide form; the same composition of the 
alginate iron-oxide nanoparticles determined by STEM (section 2.2.8).     
 
3.2.5.1 Examination of alginate mucoadhesive properties  
Alginate iron-composites which are loosely associated with the cell membrane may explain 
the high iron concentrations overserved by the ferrozine assay when RKO cells were 
challenged with iron and alginate.  Coupled to the finding that negligible alginate was 
localised to the cell membrane by confocal microscopy, it is highly plausible that these 
apparent elevated total cellular iron concentrations were indeed a consequence of so-called 
alginate ‘sticking’.   
In order to assess this, different cell culture techniques were utilised.  Firstly, RKO cells were 
challenged with iron and Manucol DH (the alginate to have the most increase total cellular 
iron) as previously in the ferrozine assay, yet instead of two cell washes performed before 
lysis, cells were increasingly washed and cells lysed after each wash procedure.  These 
washes would remove any alginate-iron composites that were loosely associated with the cell 





























Membrane Wash  
Figure 3.21: 59Fe CPM iron concentration in RKO cells treated with iron and Manucol DH 
and increasingly washed. 
 
It is apparent that iron-associated to alginate is ‘sticking’ loosely to the cell membrane, since 
there is a ca. 25% decrease in iron concentration between wash number 2 and 7.  To confirm 
this, an ex vitro chelation step was employed, whereby alginate would have the opportunity to 
chelate iron present in the media without direct contact with the cells.  To perform this, 
analogous culturing conditions were employed, yet the addition of Manucol DH was confined 
behind a dialysis membrane and incubated for 24 hours before removal of the alginate and co-
incubation with cells (method 3.5.18).  This protocol would allow Manucol DH to bind iron 
and then subsequently it could be removed from the culturing medium, such that if any iron 
was chelated by the alginate, iron concentrations would be lower and ferritin expression 

























Figure 3.22:  Intracellular iron concentration in RKO cells incubated with iron (100 μM) 
challenged with or without Manucol DH, or conditioned media (‘pre-chelated’ with Manucol 
DH).   
It is evident that Manucol DH is indeed decreasing intracellular iron uptake when pre-
chelation is allowed to take place and subsequent cellular contact is restricted.  This result 
further demonstrates the mucoadhesive effect of specific alginates, increasing the peripheral 
iron concentration around the cell which may be why increased intracellular iron 
concentrations are observed. 
 
3.2.5.2 Electron microscopy of endocytosed nanoparticles 
Transmission electron microscopy would provide the best confirmation of endocytic 
nanoparticles or association of iron-loaded alginate with the cell membrane.  With this, RKO 
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cells were treated as previously described (method 3.5.5), washed and subsequently fixed 
before being embedded into resin and ultrathin sections (50 nm).  Staining with uranyl acetate 
to improve cellular contrast was utilised (figure 3.23 (1)), however since iron has a low 
atomic number and thus z-contrast, the uranyl cell staining may mask any iron contrast and as 








Figure 3.23 (1): Transmission electron micrographs (70 – 90 nm slice width) of RKO cells 
co-cultured with Manucol DH (0.3 % w/v) and iron (100 μM + 500 μM sodium ascorbate). 
(A) Stained cell, (Ai) Magnification at cell membrane to an endocytic process.  (B) 















Figure 3.23 (2): Transmission electron micrographs (70 – 90 nm slice width) of RKO cells 
co-cultured with Manucol DH (0.3 % w/v) and iron (100 μM + 500 μM sodium ascorbate). 
(C) Unstained cell, (Ci) Magnification at cell membrane to bright contrasting entities at 
further magnification (Cii). 
 
Cellular staining with uranyl acetate rendered the contrast of the cell too dark to visualise 
small iron nanoparticles, however this allowed for clear vesicle formation at the initial 
processes of endocytosis (figure 3.23 A and Ai).  Within the extracellular space, near the cell 








STEM in section 2.2.8.1 (3.23 B).  Examination of these strands revealed the presence of 
small dense areas scattered amongst the chains, that were ca. 5 nm in diameter, a similar size 
to the nanoparticles found within the dense condensation areas reported earlier (3.23 Bi).  
This corroborates the previous chemical results that alginates are indeed nucleating 
nanoparticles, even here in the physiological conditions employed for cell culture.  
Noteworthy is the localisation of these nanoparticle-enriched strands near the cell membrane.  
This is in agreement with the confocal microscopy reported earlier (figure 3.3) and could 
suggest the incorporation of the iron-loaded alginate polymer onto the cell membrane 
periphery.  The clarity of the images improves when cellular staining is not employed, and 
much darker, highly contrasting particles can be visualised (3.23 C and Ci).  The size of these 
particles are ca. 100 nm in length, much bigger than the nanoparticles found previously; these 
cannot be confirmed as iron nanoparticles, yet there is a trend to higher localisation 
concentrations around the cell periphery.  The endocytic uptake of iron nanoparticles by 








3.3 Conclusions and summary 
The work presented in this chapter has confirmed the use of sodium alginate, specifically 
Manucol LD as a potential luminal iron chelator.  Conjugation of a fluorescent probe to 
sodium alginate allowed direct visualisation and localisation in cell culture which 
interestingly established two properties of alginate.  Firstly, and most pertinent to this study 
since iron chelation is required within the lumen of the colon, is the non-absorbable nature of 
alginate; this corroborates the positive findings of its non-bioavailability previously 
reported.[1, 2, 19, 20]  Secondly, despite lack of evidence for intracellular alginate negligible 
alginate could be localised to the cell periphery at the membrane; this result confirms the 
mucoadhesive nature of alginate.  Interestingly, transmission electron microscopy identified 
the presence of iron-loaded alginate strands containing nanoparticulate matter analogous to 
that identified in scanning transmission electron microscopy previously.  This was situated at 
the cell periphery further confirming these localisation results.  The possibility of endocytic 
uptake of iron nanoparticles has been confirmed previously,[18]  and microscopy studies here 
have eluded to this possibility in the case of alginate-coated iron-oxide nanoparticles.    
In vitro Manucol LD decreased ferritin expression by 60%, decreased total cellular iron by 
62%, restored TfR1 expression to control and decreased absorption of iron into Caco2 cells by 
70%; this was the only alginate to have consistent iron chelation properties.  These data 
reflect the iron binding abilities of alginates in vitro previously reported, yet Manucol LD was 
not utilised in these experiments.[1-4]  





excretion; the exact property desired.   
 
   since sodium ascorbate was employed alongside ferrous sulphate for all 
experiments, it can be inferred that the ‘free’ ferrous ion would be present within solution, 
making this species of iron available for chelation by alginate. 
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Cellular uptake of alginate-coated iron-oxide nanoparticles and the apparent ‘sticking’ of 
Manucol DH to the cell membrane may explain the iron-chelation experiments where some 
alginates notably increased total cellular iron.  It could be inferred that some alginates, such as 
Manucol DH, have greater adhesive properties than others.  In fact, this adhesive nature was 
the cause of the apparent increase in total cellular iron correlating to a greater ‘sticking’ to the 
cell membrane.  These mucoadhesive properties have been analysed for different alginates 
and indeed the affinity of ‘sticking’ is reliant upon alginate composition.[24, 25]  It could be 
inferred that this is the reason for some reports of alginates enhancing iron absorption in 
vitro.[3] These sticking effects were confirmed by a series of experiments, which identified 
that when you indeed measure the iron chelation ability of alginates in vitro and not their 
adhesive properties they had similar iron binding affinity.  Manucol DH has similar iron 
binding activity as Manucol LD in pre-chelation experiments, however the mucosal adhesive 
properties of Manucol DH would make it a poor medicinal chelator since this alginate would 
produce a high local concentrations of iron close to the intestinal mucosa and may allow 
participation of free-radical reactive oxygen species. With respect to nanoparticulate 
endocytosis of alginate-coated iron-oxide nanoparticles, it could be the case that only specific 




Manucol LD appears to be an ideal candidate for luminal iron chelation.  As such, the results 
presented thus far have identified a medicinal candidate that meet the criteria originally set 
out, namely; i) must bind iron, ii) be non-absorbable and non-fermentable, iii) be specific 
towards iron with a high affinity and iv) must be natural and safe.  The next sensible step 
would undoubtedly be tests in man.  
However, the physicochemical properties that underpin the unique nature of Manucol LD are 
unknown.  Alginate G:M composition and molecular weight have been determined, and 
exclusivity is apparent throughout the series.  However, the chemical familiarity between 
Manucol LD and Manucol DH is appreciable, yet these two alginates demonstrate significant 
activity differences with respect to iron chelation.  This difference could be rationalised on 
G:M sequence structure along the alginate backbone, with Manucol LD possessing the 
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3.5 Experimental methods 
3.5.1  Cell culture 
Cell lines were cultured in an incubator at 37 °C with a 5% CO2 atmosphere and 95% relative 
humidity.  RKO cells were grown in Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with Foetal Calf Serum (10% (v/v)) and penicillin (100 U ml -1) and 
streptomycin (0.1 mg mL-1).  Caco2 cells were grown in similar conditions except the 
medium was supplemented with non-essential amino acids (1% (v/v)).  Cell culture 
experiments were performed in a laminar flow tissue culture cabinet using aseptic technique.  
Mycoplasma testing was performed to ensure cells remained un-infected and cells were 
discarded after extensive passage. 
All cells lines utilised were adherent cells and as such they were passaged at approximately 
90% confluence.  For RKO and Caco2 cells, this was performed by aspirating the cell culture 
medium, washing with sterile phosphate buffered saline (10 mM, pH 7.4) and incubating with 
trypsin EDTA (5 mL, 0.05% w/v) for ca. 5 min until cells had detached.  Trypsin was 
deactivated by the addition of growth medium (5 mL), cells were disaggregated by tituration 
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and the subsequent suspension was centrifuged for 5 min at 1500 rpm.  The cell pellet was 
then resuspended in growth medium and reseeded into new growth flasks.   
3.5.2  Cell plating 
For experimentation, cells were obtained in suspension as per above.  From this cell 
resuspension, cells were seeded into either 6 well, 12 well or 96 well plates at a standard 
concentration of 1 x 105 cells mL-1 (2 mL, 1 mL or 100 μL for each well type respectively).  
Cell density was calculated using a haemocytometer by counting a representative sample of 
the cells within the window of view.  Cells were plated in their respective growth medium and 
incubated for 24 hours before experimentation.  
3.5.3  Iron cell co-incubation experiments 
In cell experiments where iron co-incubation was required, a standard protocol was employed.  
An iron stock was created by dissolving FeSO4∙7H2O (108.9 mg, 10 mM) and sodium 
ascorbate (396 mg, 500 mM) into DI H2O (40 mL), with the resultant solution dark purple in 
colour.  The iron stock was then filtered through a 0.2 μm syringe filter so that it was suitable 
for use in vitro.  This stock was then diluted into growth medium at a standard concentration 
to create an iron-stimulated medium that contained 100 μM Fe(II) and 500 μM sodium 
ascorbate, equating to a 1:100 dilution.  This was a standard protocol employed whenever 
cells were cultured with iron unless stated otherwise.     
3.5.4  59Fe experimentation 
Experiments involving the use of radioactive iron were typically set up as previously 
discussed, with iron and alginate containing culturing mediums produced following the 
described methods.  To create 59Fe iron mediums, the stock of iron (FeSO4∙7H2O (108.9 mg, 
172 
 
10 mM) and sodium ascorbate (396 mg, 500 mM)) into DI H2O (40 mL) was spiked with 
59FeCl3 to reach ca. 10,000 counts per minute (CPM) per well.  This was then used as 
previously, with a 1:100 dilution into growth medium.  Cell incubation was performed as 
described to the specific experiment.  Upon cell lysis, conditioned media was removed and 
cells were washed twice with Versene (1 mL, 0.2 g L-1 EDTA in PBS) with the remaining 
volume of the cell void using a 1 mL pipette.  Cells were then lysed in HEPES-saline lysis 
buffer (150 μL, 10 mM, pH 7.4, NaCl 0.9% (w/v)).  To count for radiation content, a specific 
amount of the sample under investigation (usually ca. 100 μL) was transferred into a 
scintillation tube and scintillation fluid (1 mL) was added.  Radiation CPM counts were 
normalised to protein concentration as determined in the BCA protein assay.  
3.5.5  Alginate co-incubation experiments 
In cells experiments where alginate co-incubation was required, a standard protocol was 
employed.  Alginate stocks were created whereby alginate (0.6 g) was vigorously mixed in a 
tissue culture hood in sterile filtered DI H2O (30 mL) that was heated to 37 °C.  The solution 
was vigorously shaken for a further 5 min and then incubated at 37 °C until full dissolution 
was achieved.  To create alginate stimulation media, alginate stock (1.5 mL) was mixed with 
growth medium with or without iron stimulation (8.5 mL) to create a resultant 0.3 % alginate 
medium.  It is important to note that some alginates, due to their viscous nature were 
transferred whilst warm and sufficient time was given for all alginate solutions to move out of 
necessary transfer pipettes.  This was a standard protocol employed whenever cells were 





3.5.6  Western blotting  
Cells were plated in 6 well plates according to the protocol above; cells were plated in 
triplicate for all conditioned cultures used.  Cells were incubated in iron and or alginate 
containing growth mediums for time points according to the experimental conditions.  After 
this time, conditioning media was aspirated and cells were washed x2 in PBS (2 mL) and the 
remaining volume of the well void.  Subsequently, cells were lysed in RIPA lysis solution 
(1% 4-Nonylphenyl poly(ethylene glycol) (w/v), 0.5% sodium deoxycholate (w/v), 0.1% 
sodium dodecyl sulphate (w/v), between 150 – 200 μL depending on cell confluency) on ice.  
Cell lysates were sonicated for 5 min and protein concentrations determined using the Pierce 
BCA protein assay (detailed below).  Cell lysates were prepared for blotting by adding 
calculated amounts to 5x Laemmli loading buffer (Tris pH 6.7 0.0625 M, glycerol 10% (v/v), 
sodium dodecyl sulphate 2% (w/v), 2-Mercaptoethanol 1% (v/v) and bromophenol blue 
0.001% (w/v)) and heated at 100 ⁰C for 5 minutes.  The concentration of protein added was 
calculated such that 20 μg of protein would be added to each well in the gel. 
Sodium dodecyl sulphate- polyacrylamide gels for electrophoresis were prepared utilising two 
gel phases (stacking and a resolving phases) in order to achieve optimum resolution of 
proteins.  The resolving gel was made by mixing deionised H2O (1.9 mL), Tris buffer (10 mL, 
pH 8.8, sodium dodecyl sulphate 0.2% (w/v)), acrylamide/ bisacrylamide (8.1 mL, 30%/8%), 
ammonium persulphate (0.03 g) and tetramethylethylenediamine (80 μL).  This was mixed 
rapidly and poured into the glass cast, covered with a small amount of 2-propanol (500 μL) 
and left aside to set.  The stacking gel was placed on top and made by mixing deionised H2O 
(3.7 mL), Tris buffer (10 mL, pH 6.8, sodium dodecyl sulphate 0.2% (w/v)), 
acrylamide/bisacrylamide (1.3 mL, 30%/8%), ammonium persulphate (0.03 g) and 
tetramethylethylenediamine (80 μL).  In both instances, the reagent amounts were sufficient 
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to cast two gels which were 12.5 % in total acrylamide content; 12.5 % gels were utilised to 
probe ferritin expression.  If TfR1 was under investigation, 10% gels would be used, and as 
such the resolving gel would consist of deionised H2O (3.5 mL), Tris buffer (10 mL, pH 8.8, 
sodium dodecyl sulphate 0.2% (w/v)), acrylamide/bisacrylamide (6.5 mL, 30%/8%), 
ammonium persulphate (0.03 g) and tetramethylethylenediamine (80 μL).  . 
Laemmli buffer protein samples were pipetted into their appropriate wells, and gels were run 
initially through the stacking gel for 15 min at 90 V and then increased to 180 V through the 
resolving gel in an electrophoresis running buffer made with Tris (25 mM, pH 8.3), glycine 
(0.192 M) and sodium dodecyl sulphate (0.01% (w/v)).   
Protein resolved gels were then transferred onto Hybond PVDF membranes which were 
prepared by pre-soaking in methanol for one minute, and then washed in transfer buffer which 
was made using Tris (48 mM), glycine (39 mM), sodium dodecyl sulphate (0.0375% (w/v)) 
and methanol (20% (v/v)).  Transfer was undergone in the same buffer, in a cooled transfer 
tank, for 90 min at 90 V.  Following transfer, the membranes were blocked for one hour in 
Tris-buffered saline tween made from Tris (150 mM, pH 8.0), sodium chloride (150 mM) and 
Tween-20 (0.05% (v/v)) supplemented with dried milk powder (5% (w/v)).  The membrane 
was then incubated in the primary antibody (Ferritin light-chain, 1:5000 dilution, Abcam 
(AB69090) or β-actin, 1:5,000 dilution, Abcam, (AB8226) TfR1, 1:1000, Invitrogen (H68.4)) 
overnight at 4 ⁰C with constant agitation.  Membranes were subsequently washed repeatedly 
with TBST (20 mL) each with a wash period of 10 minutes.  The membrane was then 
incubated with the appropriate secondary peroxidase conjugated antibody (1:10,000 dilution, 
Jackson Laboratories) for 45 min again in TBST supplemented with dried milk powder (5 
%(w/v)).  A final wash procedure was performed using TBST (20 mL) for five repetitions.   
175 
 
The membranes were exposed to an ECL detection reagent (5 mL, GE Healthcare) for five 
minutes, gently rubbing the reagent over the sealed membranes prior to development.  
Developed westerns were analysed using ImageJ image processing software. 
3.5.7  Synthesis of fluorescently conjugated alginate 
Sodium alginate LFR5/60 (0.32 g, 9.0 μM) was dissolved in a solution of phosphate buffered 
saline at pH 7.4 (50 mL).  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (0.018 g, 92 μM) 
and n-Hydroxysulfosuccinimide sodium salt (0.02 g, 92 μM) was added to the alginate 
solution and stirred for two hours.  Once mixed, fluoresceinamine (0.0319 g, 92 μM) was 
added to form a bright yellow solution.  The reaction was left to stir in darkness for 24 hours; 
the resultant solution was opaque orange in colour.  Free, unreacted fluorophore was removed 
by dialysis; one wash in deionised H2O (3.5 L) at 4 ⁰C for 24 hours, three washes in NaCl (3.5 
L, 1 M) for 24 hours each, then a subsequent six washes in deionised H2O (3.5 L) for 24 hours 
each.  The loss of free fluorophore was monitored by UV-Vis absorption of the dialysate.  
Once purified, the pH of the solution was adjusted to 7.4 and stored in the dark at 4 ⁰C until 
required.  
3.5.8  Confocal microscopy 
Slides for confocal microscopy were prepared by growing RKO cells on 22 mm cover slips 
placed in individual wells of a six well cell culture plate.  Cells were seeded in six well plates 
according to the method described above.  Once established, the growth medium was 
removed and fluorescent-alginate loaded medium (0.04% fluorescent alginate, 100 μM 
FeSO4∙7H2O and 10 μM sodium ascorbate) was added and incubated for 24 hours.  After this 
period a nuclear stain, Hoechst 33450 (NucBlue Live Cell Stain, Life technologies) was added 
and a cell plasma membrane stain (CellMask Deep Red plasma, Life technologies) at 1 drop/1 
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mL media and 3 μg/ mL media concentrations respectively.  The medium was removed and 
the cells were washed three times with 2 mL phosphate buffered saline.  Fixation was 
undergone using a 4% paraformaldehyde solution (pH 7.4) at room temperature for eight 
minutes.  The paraformaldehyde was removed and slides washed with 2 mL PBS and then 
placed, cell side down, onto a small amount of SureFade (Life technologies) on a microscope 
cover slide and sealed using nail varnish.   
3.5.9  Cellular iron content by the ferrozine assay 
Cells were plated in 6 well plates according to the protocol above; cells were plated in 
triplicate for all conditioned cultures used.  Cells were incubated in iron and/or alginate 
containing growth mediums for time points according to the experimental conditions using 
the methods described above.  After this time, conditioning media was aspirated and cells 
were washed X2 in PBS (2 mL) and the remaining volume of the well void. Cells were lysed 
in HEPES-saline lysis buffer (150 μL, 10 mM, pH 7.4, NaCl 0.9% (w/v)).  A ferrozine stock 
solution was prepared by mixing sodium acetate (17 mM, 13.8 g), L-sodium ascorbate (4.6 
mM, 0.91 g) and 3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid monosodium 
salt hydrate (0.18 mM, 0.09 g) into DI H2O (122 mL).  The cell lysate was thoroughly mixed 
and 90 μL was aspirated and mixed with of a trichloroacetic solution (200 μL , 20% (w/v)), 
which was then heated at 100 ⁰C for 10 min and then centrifuged at 12000 RPM for five 
minutes to pellet the protein precipitate.  The supernatant was aspirated and 200 μL was 
added to 600 μL ferrozine stock solution and mixed thoroughly and absorbance read on a 
plate reader at λ=550 nm.  All results were standardised to protein content using a protein 




3.5.10  BCA protein assay 
Cell lysates (10 μL) were added in triplicate to a 96 well plate as were set protein calibration 
solutions (2, 1, 0.5 and 0.25 μg μL-1), to which a working solution consisting of reagent A and 
reagent (A:B mixed in a 50:1 ratio) was added (200 μL).  Following an incubation period of 
30 min at 37 °C, absorbance was read on a plate reader at λ=550 nm.   
3.5.11  Ferritin ELISA 
The Spectro Ferritin MT kit was utilised as an additional means of quantifying intracellular 
ferritin expression to western blotting.  Cells were lysed in RIPA lysis solution (1% 4-
Nonylphenyl poly(ethylene glycol) (w/v), 0.5% sodium deoxycholate (w/v), 0.1% sodium 
dodecyl sulphate (w/v), between 150 – 200 μL depending on cell confluency).  Cell lysates 
were sonicated for 5 min at and protein concentrations determined.  According to the 
manufacturers protocol, cell lysates (10 μL) were added to individual wells with a standard set 
of ferritin calibration solutions (10 μL, 6, 20, 60, 200, 600 and 2000 ng mL-1.  To this, 
unconjugated antihuman ferritin (200 μL) was added before incubating for 2 hours with 
agitation.  Wells were subsequently washed with DI H2O before the addition of 200 μL 
substrate solution and a further incubation for 30 min.  After this, potassium ferricyanide (100 
μL, 0.24 % (w/v)) was added to develop the colour with absorption read at λ=490 nm and 
λ=595 nm.  Absorption values at λ=595 nm were subtracted from values obtained at λ=490 
nm, and all values obtained for ferritin concentration were normalised to protein 
concentration.  
3.5.12  Luminescence spectroscopy 
UV-Vis absorption spectroscopy measurements were performed on a Varian Cary 5000 
spectrometer at a 300 nm min-1 acquisition rate.  Samples were prepared in 1 cm quartz 
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cuvettes.  Luminescence measurements were executed on an Edinburgh Instruments FLS920 
spectrometer, with a 450 W xenon arc lamp illumination source.  Samples were prepared in 
quartz cuvettes with entirely transparent faces and appropriate long-pass filters to eliminate 
second-order photon scattering.  
3.5.13  Caco-2 monolayer  
Caco-2 cells were routinely cultured according to the protocol above.  Prior to 
experimentation, Caco-2 cells were seeded (2 mL) into pre-treated and dried collagen-coated 
(200 μL, 10% (v/v) in 0.5%(v/v) acetic acid) 6-well transwell inserts at a concentration of 4 x 
10 cells mL-1.  Cells were grown for 14 days post confluency, with a media change every 
other day in both the apical and basolateral chambers.[10] 
24 hours prior to challenge with iron and alginate, cell medium was changed to FCS-free 
MEM (containing epidermal growth factor, 20 μg L-1, triiodothyronine, 0.05 μM, piperazine-
N,N’-bis[2-ethanesulfonic acid] 10 mM, hydrocortisone, 11 μM, sodium selenite, 0.02 μM 
and insulin 0.87 μM.[26]  After incubation, cells were stimulated with iron as per the protocol 
above, however the iron-containing medium was spiked with 59FeCl3 to reach ca. 10,000 
counts per minute (CPM) per well. Alginate containing media was prepared as per the 
protocol above.  To the apical layer, FCS-free MEM with iron with or without alginate (2 mL) 
was added and to the basolateral membrane FCS-free MEM (containing apotransferrin 50 μg 
mL -1, 2 mL) was added.  At 30 min, 1, 2, 4 and 24 hour time points samples (200 μL) were 
removed from the apical and basolateral membranes.  After the 24 hour time point the 
medium was removed and the cells were washed three times with 2 ml Versene (0.2g L-1 
EDTA in phosphate buffered saline), and lysed in RIPA lysis solution (1% 4-Nonylphenyl 
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poly(ethylene glycol) (w/v), 0.5% sodium deoxycholate (w/v), 0.1% sodium dodecyl sulphate 
(w/v), 500 μL). 
Samples collected were assessed for iron concentration using scintillation counting.  To do 
this, a set amount of sample (usually 100 μL) was added to scintillation tubes and scintillation 





3.5.17  Transmission electron microscopy 
Cell sections for TEM analysis were generated as follows.  RKO cells were grown in 6 well 
plates and treated with iron or alginate according to the protocols above.  After incubation, 
cells were washed with PBS (x3 2 mL) and subsequently incubated with glutaraldehyde in 
sodium cacodylate buffer (2.5 % (w/v) 500 μL) and stored at room temperature until 
processed further.  Sampling and sectioning of the cells onto TEM grids, mounting and 
staining was undertaken by University of Birmingham Electron Microscopy services and the 
technical team of Dr. Paul Verkade (University of Bristol). 
3.5.18 Ex vitro iron chelation 
To prepared so-called ‘pre-chelation’ conditioned medium, alginates (9 mL, 2% (w/v), in DI 
H2O) were confined within a dialysis membrane and immersed in iron containing media (51 
mL, 100 μM Fe(II) and 500 μM sodium ascorbate); equilibrium dialysis was performed for 24 
hours at 37 °C with intermittent agitation.  The resultant supernatant was aspirated and used 
immediately as conditioned media in subsequent experiments alongside normal ‘non pre-
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Alginate chemical modification:  
an understanding of iron chelation 
bioactivity. 
 
4.1 Introduction and aims 
The current understanding of alginate chemical composition has been determined by 
analytical ultra-centrifugation (AUC) and nuclear magnetic resonance spectroscopy (NMR) to 
reveal the inherent molecular weight and specific G:M compositions respectively (table 4.1). 
Table 4.1:  Molecular weight and G:M composition of the alginate series tested (see sections 
2.2.3 and 2.2.4 for further details). 
Alginate Molecular Weight (kDa) G:M composition 
Protanal RF6650 230 ± 10 60:40 
Keltone 220 ± 15 46:54 
Manugel GHB 180 ± 18 53:47 
Manucol DH 170 ± 6 40:60 
Protsea AFH 155 ± 5 29:71 
Manucol LD 145 ± 5 38:62 
LFR5/60 74 ± 3 62:38 
 
It is clear that, despite a range of alginates tested, the range of distribution of molecular 






Figure 4.1: Schematic representation of the range of distributions of molecular weight and 
G:M compositions of the alginate series.  Grey shaded areas represent where the majority of 
MW and G:M compositions are represented along the scale. 
 
On reflection of these chemical characteristics and the observed iron chelation properties, it is 
apparent that defining chemical iron binding by simple molecular weight and G:M 
composition differences to allow stratification is not possible; a more complex structure-
activity relationship is dictating bioactivity. A purely chemical understanding of how 
molecular weight and thus polymer length affects iron chelation would be rationalised on the 
grounds of sterics and entropy.  Specifically, the larger the alginate the more ordered the 
system becomes to coordinate iron; a disfavourable action in entropy energetics.  Likewise, 
the bigger the alginate the more likely the polymer is going to sterically encounter itself when 
coordinating to iron; again unfavourable in terms of electrostatics.  On these grounds it could 
be concluded that as alginate molecular weight increases iron chelation ability decreases; this 
has indeed been reported (as discussed in section 1.4).[1]  A more ‘bio-chemical’ view of the 
interaction would disregard the thermodynamics of coordination and focus on how the 





complex; indeed the formation of secondary and tertiary structures is highly reliant on the 
sequence of the protein under investigation, or the alginate in this case.  In view of this, 
depolymerisation of Manucol LD to smaller molecular weight components would 
demonstrate if polymer chain length dictates iron-chelation ability.  Accessing alginates with 
different MG sequences to Manucol LD (with the same molecular weight) would demonstrate 
whether purely the specific molecular weight of Manucol LD holds iron chelation activity or 
if M:G composition also influences iron binding. 
Following on from this, it is unapparent why Manucol LD has the desired bioactivity when 
chemically it is not grossly dissimilar to Manucol DH.  Of note, Manucol DH and Manucol 
LD are extracted from the same raw material (albeit different ‘fractions’ from the same 
seaweed).  To assess why this is the case, further experimentation into structure-activity 
relationships will need to be pursued alongside a thorough chemical characterisation of the 
alginates.  This would reveal any specific chemical differences between these two apparently 
similar alginates.  Thus the aims of this study are: 
1. Examine the effect of molecular weight modified Manucol LD and Manucol DH 
on iron-mediated ferritin expression. 
2. Determine the effect of G-enrichment (epimerisation) of Manucol LD on iron-
mediated ferritin expression. 
3. Determine the specific GM sequence of Manucol LD and Manucol DH using high 
resolution NMR. 
Not only will these details provide an understanding of the chemical ‘make-up’ that endows 





alginates to be ‘super iron-binders’ and thus provide the blue-prints for next generation 
alginate chelators. 
 
4.2  Results and discussion 
4.2.1 Alginate molecular weight effects on iron chelation 
Manucol DH is similar to Manucol LD in terms of M:G ratios (cf. 60:40 vs. 62:38) yet is a 
larger polymer (cf. 180 vs 145 kDa).  Degradation of Manucol DH would provide an alginate 
with a similar molecular weight to Manucol LD and the same G:M ratio.  Heat degradation of 
alginates provides an easy route to creating shorter polymer length products allowing some 
control over size prediction by analysing molecular weight changes using viscosity. 
Molecular weight is related to viscosity through two empirically determined constants, α 
(which depends on the polymer-solvent pair and temperature) and K (which describe the size, 
shape and rigidity of polymers) (figure 4.2). 
[𝜼] = 𝑲𝑴𝒘𝜶 
Figure 4.2: Mathematical relationship between intrinsic viscosity ([𝜂]) and molecular weight 
(Mw) which are dependent on the constants K and α. 
 
The intrinsic viscosity [𝜂], can be obtained from a series of viscosity parameters, namely the 
reduced (𝜂red), specific (𝜂sp) and inherent (𝜂inh) viscosities which, when extrapolated to infinite 
dilution using the Huggins and Kraemer approaches, the intrinsic viscosity is taken as the 






4.2.1.1 D-glucuronic acid effects on ferritin expression 
Prior to any controlled degradation of Manucol DH or Manucol LD, a control experiment was 
performed to determine the effects of degradation of alginate to its infinite point. Such an 
experiment would certify if the templating and coordinating effect imposed by the polymeric 
nature of the alginate is responsible for its iron chelation ability.  The monomeric acid 
building blocks, namely D-glucuronic acid (DGA), was utilised for iron chelation studies.  As 
such, RKO cells were co-cultured with iron (FeSO4·7H2O, 100 μM) with or without DGA 
(0.1, 0.3 % (w/v)) and analysed for iron concentration using both ferritin expression (as a 
surrogate biomarker for intracellular iron concentrations) and the ferrozine reporter to reveal 



























































Figure 4.3: (A) Ferritin expression in RKO cells incubated with iron challenged with or 
without DGA (0.1, 0.3 % (w/v)).  Data points represent mean fold change in protein 
expression, normalised to β-actin, relative to control.  Error bars denote ± SEM. (B) Ferrozine 
reporter assay demonstrating intracellular iron concentrations of RKO cells challenged with or 
without DGA (0.1, 0.3 % (w/v)). Error bars denote ± SEM. 
 
There was no significant ferritin repression or decrease in intracellular iron concentrations 









acid iron binding unit from alginate alone is not sufficient to chelate iron and display 
bioactivity.  This was also verified by utilising radioactive iron-59, whereby the same 
culturing conditions were employed but spiking with 59Fe allowed for a sensitive detection of 


















Figure 4.4: Iron concentrations of RKO cells when incubated with iron and challenged with 
or without DGA (0.1, 0.3 % (w/v)).  Error bars denote ± SEM. 
 
As expected, no differences in intracellular iron concentrations were observed.  These results 
considered together are unsurprising since it has been demonstrated that alginates are 







4.2.1.2 Heat degradation of Manucol DH and Manucol LD 
A method of characterising alginate degradation products (ADPs) and to determine their 
molecular weights would be to use viscosity measurements.  Since physical molecular weight 
measurements of the alginate series are available, calibration of these molecular weights 
against their viscosity would allow facile characterisation of ADPs.  Viscosity is related to 
molecular weight through various proportionality constants.  The relative viscosity (ηr) 
describes the ratio of viscosities sample:solvent.  From this, the specific (ηsp) the reduced 
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Figure 4.5: Mathematical relationships between the specific viscosity (I), reduced viscosity 
(II) and inherent viscosity (III) and the Huggins and Kraemer approximations (IV and V).  
Extrapolation to zero-concentration allows the intrinsic viscosity to be approximated (VI). 
 
As the concentration dependence of the reduced viscosity and the inherent viscosity 
approaches zero, intrinsic viscosity can be obtained.  This is formally known as the Huggins 
and Kraemer approximations. 
Another approximation of the intrinsic viscosity can be used, namely the Solomon & Ciuta 





















) √𝟐𝜼𝒔𝒑 − 𝐥𝐧( 𝜼𝒓𝒆𝒍) 
Figure 4.6:  The Solomon & Ciuta approximation of intrinsic viscosity. 
With this, the intrinsic viscosities for lower molecular weight alginates (Manugel GHB, 
Manucol DH, Manucol LD and LFR5/60) were obtained (figure 4.7) 









Figure 4.7: Intrinsic viscosity plot for (a) Manugel GHB, (b) Manucol DH, (c) Manucol LD 
and (d) LFR5/60 in DI H2O at different concentrations, using Huggins (red), Kraemer (green) 
and Solomon-Ciuta (blue) extrapolations. 
 
The calculated mean [𝜂] values were plotted against the molecular weight values obtained 
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Figure 4.8: Plot of apparent molecular weight as obtained by AUC against intrinsic viscosity.  
Error bars represent ± SEM on each axis. 
 
It is evident that as molecular weight decreases, intrinsic viscosity decreases which is 
predictable since the smaller the compounds, the faster the flow rate.  The calibration line 
MW = 0.015 x [η] + 93.5 can be used to determine the molecular weights of the ADPs 
obtained through heating.   
 
4.2.2 Heat degradation of Manucol DH 
Manucol DH was subject to hydrolysis by heating.  Manucol DH was heated at 100 ⁰C for 5, 
12, 20, 30, 60, 90, 120 and 180 mins which degraded the alginate to shorter molecular weight 









The subsequent ADPs were subjected to the Huggins and Kraemer approximations to 















Figure 4.9:  Intrinsic viscosity plot for (a) 5 min, (b) 12 min, (c) 20 min, (d) 30 min, (e) 60 
min, (f) 90 min, (g) 120 min and (h) 180 min heating times at a temperature of 100 °C in DI 
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The relative viscosity decreases as expected with longer heating times, and the mean values 
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Figure 4.10:  (A) Manucol DH ADP decreases with heating time at 100 °C. (B) Plot of 








These experiments allow the calculation of the heating time of Manucol DH that would yield 
a Manucol DH ADP that was similar in molecular weight to Manucol LD.  According to the 
calibration of intrinsic viscosity change against degrade heating time, heating Manucol DH 
for 172 min would provide an intrinsic viscosity value of 1200 mL g-1, which would give a 
molecular weight similar to that of Manucol LD at 145 kDa. 
To examine the molecular weight distribution spread across the Manucol DH ADPs, size 
exclusion chromatography using Sephadex G25 was employed (method 4.5.3).   Monitoring 
of the reduced ends of alginate hydrolysis that absorb at λ = 232 nm would provide some 
insight into the distribution of ADP products generated through heating.  Specifically, 
whether single distinct degradation products are formed, or a spread of molecular weight 
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Figure 4.11: Gel chromatography chromatogram of Manucol DH ADPs ran on Sephadex 
G25 column with an aqueous NaCl (0.2 M) eluent. 
 
It is apparent in comparison to the control that has a high large molecular weight component 
(at ca. 250 mL) and the smallest small molecular weight component (at ca. 590 mL) that there 
are no components between these molecular weights.  Since a unimodal distribution for 
Manucol DH was observed in the analytical ultracentrifugation studies, this smaller molecular 
component can be regarded as insignificant.  It can be seen that heating Manucol DH does not 
only increase the number density of this smaller molecular weight component, but there is 
also a trend to increase the number and distribution range of degrade products between these 
two distinctive entities (ca. 300 – 550 mL).  There is a distinctive peak (ca. 475 mL) for 
several degrade mixtures, which is most prominent for the 180 min degrade, a similar heating 





4.2.2.1 In vitro iron chelation by heat degraded Manucol DH 
Manucol DH (2% (w/v)) was heated at 100 ⁰C for 20, 40, 60, 80, 160, 180 and 250 mins with 
estimated intrinsic viscosity values of 4365, 3707, 3148, 2673, 1390, 1181, 666 mL g-1 and, as 
such, molecular weights could be calculated as 164, 160, 156, 153, 145, 144 and 141 kDa 
respectively for the ADPs using the calibration equation determined between these two 
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Figure 4.12: Line of calibration between Manucol DH and Manucol LD for the determination 
of ADP molecular weight.  Error bars represent ± SEM. 
 
The resultant ADPs were subsequently utilised in cell culture, whereby RKO cells were 
challenged with iron, with or without the Manucol DH ADPs (0.3 % (w/v)) for 24 hours 






                       
 
 
Figure 4.13:  Ferritin expression in RKO cells incubated with iron, challenged with or 
without Manucol DH ADPs (0.3 % (w/v)).  Data points represent mean fold change in protein 
expression, normalised to β-actin, relative to control.  Error bars denote ± SEM, * denotes 
statistical significance, p < 0.05, n = 3. 
 
Co-culturing RKO cells with native Manucol DH does not demonstrate any iron chelation 
effects as described previously.  Heat degradation of Manucol DH for 20 and 40 mins and 
subsequent co-culture of these ADPs on RKO cells also reveals no iron binding ability.  
However, heat degradation for 80 and 160 min statistically reduced iron-mediated ferritin 










































































































































and 160 min degraded Manucol DH to a molecular weight approximately of Manucol LD and 
bioactivity (i.e. a diminishment in iron-mediated ferritin expression) was observed.  However, 
further degradation (250 min) resulted in a loss of this bioactivity, yet with huge experimental 
error.  Longer heating times of Manucol DH would not yield shorter ADPs due to the almost 
linear relationship (x = o) of the line of best fit between [𝜂] and degrade time at these longer 
time points.  To determine whether molecular weight ADPs that are smaller in molecular 
weight than Manucol LD, Manucol LD itself was used for heat degradation studies. 
 
4.2.3 Heat degradation of Manucol LD 
Manucol LD was heated at 100 ⁰C for 5, 20, 30, 60, 120 and 180 mins which degraded the 
alginate to shorter molecular weight components with a progressive decrease in relative 
viscosities (figure 4.15 A). The subsequent ADPs were subject to the Huggins and Kraemer 






















Figure 4.14:  Intrinsic viscosity plot for (a) 5 min, (b) 20 min, (c) 30 min, (d) 60 min, (e) 120 
min and (f) 180 min heating times at a temperature of 100 °C in DI H2O, using Huggins (red), 
Kraemer (green) and Solomon-Ciuta (blue) extrapolations. 
 
As expected, relative viscosity decreases with longer heating times, and the mean values for 
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Figure 4.15:  (A) Manucol LD ADPs relative viscosity changes with heating time at 100 °C. 
(B) Plot of intrinsic viscosity against heating time.  Error bars denote ± SEM.  Red lines 








Depolymerisation decreases with time as described previously.  Calibration between heating 
time and change in [𝜂] allows approximate molecular weight values for ADPs to be 
calculated.   
 
4.2.3.1 In vitro iron chelation by heat degraded Manucol LD 
Manucol LD was heated at 100 ⁰C for 20, 40, 60, 80, 160, 180, 250 mins with estimated 
intrinsic viscosity values of 1096, 1027, 962, 902, 695, 652 and 519 mL g-1 respectively and 
as such, molecular weights could be calculated as 109, 108, 107, 106, 103, 102 and 100 kDa 
respectively for the ADPs. 
The resultant ADPs were subsequently utilised in cell culture, whereby RKO cells were 
challenged with iron, with or without the Manucol LD ADPs (0.3 % (w/v)) for 24 hours 











































































































Figure 4.16: Ferritin expression in RKO cells incubated with iron challenged with or without 
Manucol LD ADPs (represented as heating times in mins).  n = 3.  * denotes statistical 
significance, p < 0.05. 
 
It is apparent that there were no ferritin expression changes between native Manucol LD 
incubation and the ADPs.  These results would suggest that either the molecular weight 
dependence on iron binding (at lower molecular weight values of Manucol LD) is not 
important, or that the molecular weight of these specific ADPs are still within in the range for 
bioactivity.  The molecular weight change from native Manucol LD (cf. 145 kDa) to 109, the 
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20 min ADP is big, and any differences in iron chelating ability would likely be observed in 
this hydrolysis process.  The subsequent ADP molecular weights (cf. 108-100) have a very 
little distribution of change in molecular weights and as such, it is unsurprising that no 
differences in bioactivity are observed.  Iron binding activity may not only be dictated by 
molecular weight but also G:M ratio composition.   
 
4.3.4 Production and validation of epimerase enzyme AlgE1 
Ertesvåg et al. previously described the cloning, expression and production of eight alginate 
epimerases from 8 different epimerase genes from Azotobacter vinelandii.[3, 4]  Specifically, 
the algE1 gene was cloned into pTrc99A plasmids for the expression of AlgE1 in E.coli cells 
(method 4.5.4).  DNA sequencing of the gene insert was conducted to confirm the presence of 
the algE1 gene inserts within the recombinant plasmids (method 4.5.5).  BL21 E.coli cultures 
were transformed with algE1 and subsequently induced to produce the AlgE1 enzyme 
(method 4.5.6).  The expressed and harvested AlgE1 enzyme was purified using ionic-








Figure 4.17: Purification chromatogram of AlgE1 epimerase from BL21 E.coli expressing 
bacteria using a gradient NaCl eluent (0-1 M). λabs = 280 nm. 
 
A range of well-defined peaks were denoted fractions I – V.  Since circular dichroism was 
previously utilised successfully in the determination of G-content for the alginate series 
(section 2.2.3.1), it was subsequently employed here to screen purified AlgE1 fractions for 
epimerisation activity.  Manucol LD (0.1% (w/v)) was subject to enzymatic action from 
fractions I through to V and subsequent Manucol LD G-unit content was examined by CD 
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Figure 4.18: CD spectra of Manucol LD and Manucol LD exposed to the epimerase activity 
of protein fractions collected I to V.  An experimental control was run to ensure alginate 
structure was not influenced by the experimental conditions employed and compared to an 
alginate-only control. 
 
Epimerase fractions II and III were observed to have the most epimerase activity, with 
conversions estimated of 90 % and 92 % respectively.  These enzymatic fractions were 
utilised for the epimerisation of Manucol LD in subsequent studies. 
 
4.2.4.1 Epimerisation of Manucol LD 
With a view to utilising epimerised Manucol LD (EpLD) in subsequent cellular studies, 
optimisation of the epimerisation protocol was undertaken, and a successful yet somewhat 
convoluted process of epimerisation was found (method 4.5.9).  Briefly, co-culturing 





however it was identified that enzymatic action ceased at these high alginate concentrations.  
As such, lower concentrations and higher volumes were used with subsequent purification 
and concentration in vacuo.  This method yielded a solid EpLD which was fortuitous since 
normalisation on concentration was possible and the extent of modification could be 























Figure 4.19:  Circular dichroism spectra and representative UV-Visible spectra of Manucol 



















Treatment of Manucol LD with AlgE1 resulted in a 60 % conversion of the mannuronate 
units to guluronate units on EpLD, resulting in a new M:G ratio of 23:77; the highest G-unit 
concentration alginate out of the series.  There was also very little absorption present at λ = 
280 nm on the UV-Vis indicating little AlgE1 contaminant.   
EpLD was used in cell culture to assess iron chelation ability in comparison to native 
Manucol LD.  With this, RKO cells were challenged with an iron-enriched media (100 μM 
FeSO4∙7H2O + 500 μM sodium ascorbate) with or without sodium alginates Manucol LD or 
EpLD (0.3 % (w/v)) and after a 24 hour period, the cells were washed and lysed for protein 
extraction.  Western blotting revealed that ferritin expression in RKO cells treated with iron 
was higher than that of control media only, as expected.  Manucol LD diminished ferritin 
expression by 57 % compared to iron only control (cf. 60 % in previous studies).  EpLD did 
not chelate iron in vitro, and ferritin expression was equal to levels of the iron only control.  
This demonstrates the dependence of M:G ratio and/or MG sequence of the alginate in its iron 











Figure 4.20:  Ferritin expression in RKO cells incubated with iron, challenged with or 
without Manucol LD and EpLD (0.3 % (w/v)).  Data points represent mean fold change in 
protein expression, normalised to β-actin, relative to control.  Error bars denote ± SEM, * 
denotes statistical significance, p < 0.05, n = 3. 
 
4.2.4.2 High resolution NMR of Manucol DH and Manucol LD 
It has been demonstrated that there is a reliance on specific M:G composition for iron binding 
capability, as verified by epimerising Manucol LD to which a loss in activity is observed.  It 
has also been detailed that there is some trend to increase Manucol DH bioactivity upon lysis.  
This leads to the understanding that alginate MG sequence has the most influence on iron 
binding potential, and the gold-standard to test this would be to manipulate Manucol DH in 













































task in de novo alginate synthesis.  Another way to approach this would be to demonstrate 
that even though Manucol LD and Manucol DH have similar M:G compositions, they have 
dissimilar sequence homology.  Sequencing alginate strands, monomer by monomer, is 
impossible.  However, with the use of high resolution NMR it is possible establish the monad, 
diad and triad fractions of alginates (method 4.5.10) (figure 4.21).  Such data would allude to 














Monad, diad or 
triad Relation to frequencies Fraction of sequence 
𝐆 𝟎.𝟓(𝑨+𝑪+𝟎.𝟓(𝑩𝟏+𝑩𝟐+𝑩𝟑)) FG = G/(M+G) 
𝐌 𝑩𝟒+𝟎.𝟓(𝑩𝟏+𝑩𝟐+𝑩𝟑) FM = M/(M+G) 
𝐺𝐺 0.5(𝐴+𝐶−0.5(𝐵1+𝐵2+𝐵3)) FGG = GG/(M+G) 
MG = GM  0.5(B1+B2+B3) FGM = FMG =  MG/(M+G) 
MM B4 FMM = MM/(M+G) 
GGM = MGG  (B1)0.5(B1+B2+B3)/(B1+B2) FGGM = FMGG = GGM/(M+G) 
MGM (B2)0.5(B1 +B2 + B3)/(B1 + B2) FMGM = MGM/(M+G) 
GGG GG – GGM FGGG = GGG/(M+G) 
 
Figure 4.21: Typical NMR spectra of alginate with labelled resonances A, B1, B2, B3, B4 
and C denoting specific hydrogen environments for the calculation of alginate monad, diad 
and triad frequencies.[6] 
 
NMR spectra for Manucol LD and Manucol DH were acquired and analysed using the 
correlations described and transformed free-induction decays were fitted to lorentzian curves 






Alginate FG  FM FGG  FMM  FGM FMG  FGGG FMGM FGGM FMGG  
Manucol 
LD 31.0 69.0 13.4 51.4 17.6 17.6 7.1 11.4 6.2 6.2 
Manucol 
DH 33.0 67.0 13.3 47.4 19.7 19.7 6.6 13.0 6.7 6.7 
 
Figure 4.22: Plots of the experimental (red) and simulated (blue) NMR spectra of alginate 
(A) Manucol DH and (B) Manucol LD for the region of protons 1 and 5 of mannuronic acid 
and glucuronic acid.  The monomer type leading to this chemical shift is underlined whereas 
the proton position is shown as the index number.   
 
 
Depending on the protons 1 and 5 of each alginate, the chemical shift of these environments is 
unique. The fitted line width for the signal at 5.05 ppm was 9.0 and 9.6 Hz for Manucol DH 
and Manucol LD respectively, whereas a value of 4.8 was used for the remainder of the 
signals. The fitted intensities used to calculate the composition were area under the curve 
values and therefore independent of line width variations.  Simulated lorentzian lines fitted 
the experimental acquired data well and revealed that the M:G ratio for Manucol LD and 





Manucol DH was 69:31 and 67:33 respectively; a subtle difference as previously found.  The 
fraction with the biggest difference was that of the MM content with a ca. 8% more MM diads 
in Manucol LD compared to Manucol DH.  
 
4.3 Conclusions and summary  
Results from this study can be summarised as follows: 
i) Heat degradation of Manucol LD to smaller molecular weight products does not 
alter its iron affinity properties. 
ii) Heat degradation of Manucol DH to smaller molecular weight products, similar to 
that of Manucol LD does impart iron chelation potential. 
iii) Epimerisation of Manucol LD to a higher %G alginate abolishes its iron binding 
abilities. 
iv) Manucol LD differs from Manucol DH mostly in compositional differences in the 
fraction of MM diads. 
It seems a plausible rationale that Manucol LD, in resemblance of biological proteins, has a 
tertiary and secondary structure that forms an iron binding pocket or cavity; this structure is 
formed by the specific MG sequence of the alginate.  This iron binding site acts as the 
nucleation site for iron deposition and nanoparticle formation as discussed previously.  If this 
were the case, then alteration of the M:G ratio and thus MG sequence on Manucol LD would 
disrupt the formation of this binding site; this has indeed been demonstrated.  It has also been 
identified that Manucol DH and Manucol LD do indeed have different sequence homologies, 
which strengthens the case for a strict MG sequence required for iron chelation.  Lysis of 





an iron binding pocket is accepted, since lysis would need to take place at critical structural 
points to disrupt the tertiary structure formation. 
The importance of polymer length on iron binding ability has been demonstrated when you 
consider the results obtained from Manucol DH lysis experiments, since lysis to smaller 
(Manucol LD sized) products does generate iron chelation activity.  This infers that there is 
some reliance on molecular weight, and as hypothesised, a combination of both is likely to 
determine iron binding capabilities.  Degradation to smaller molecular weight products would 
be interesting, yet since degradation decreases with time, increasing the heating time would 
not necessarily decrease molecular weight to any extent; other methods of lysis would need to 
be utilised (i.e. alginate lyase enzymatic treatment).  
In summary, iron chelation by alginates is not dependent on M:G ratio, MG sequence or 
molecular weight alone, but a combination of all three variables dictates iron binding 
potential.  Manucol LD is unique in its iron binding abilities.  To fully understand why this 
alginate demonstrates such desired activity would require complete alginate GM sequencing, 
followed by extensive computer-modelled conformation calculations to illustrate the exact 
solution structure of this alginate.  If such studies revealed the presence of a high-affinity iron 
binding pocket, the sequence structure that imparts the iron binding site could be examined, 
and if possible, complete sequence-specific alginate synthesis would construct the ideal iron-
chelating compound.  Simple manipulation techniques here have provided a top-down route 
to understanding how chemical composition does affect iron binding properties, and until 
these highly sophisticated techniques become routine procedures Manucol LD remains the 
best alginate iron chelator.  Perhaps an alginate molecular weight of 145 kDa and a G:M 
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4.5 Experimental 
4.5.1 Western blotting and cell work for ferritin expression 
For experimental procedure see experimental section 3.5.6. 
4.5.2 Heat degradation and viscosity measurements 
Since the read-out of alginate degradation fractions requires cellular incubation for ferritin 
expression, simple heat degradation whereby no additives are required (i.e. enzymes or 
chemicals) pose the cleanest and easiest route to acquiring alginate degrade products (ADPs). 
For the production of Manucol LD and Manucol DH heat degrade products alginates (2 x 10-3 
g mL-1) were dissolved into DI H2O (100 mL) with high spin vortex mixing at room 
temperature and stirred vigorously for 3-5 hours until complete hydration was evident.  
Alginate aliquots (10 mL) were heated at 100 °C for set time points on a heat block (Techne 
DRI-BLOCK) and immediately cooled on ice and stored at 4 °C until viscosity measurements 
were performed.   
All viscosity measurements were performed at 25 °C in a constant temperature water bath and 





(usually from 0.1 – 1 mg mL-1).  Viscosities were measured on a Cannon-Ubbelohde glass 
viscometer (Cannon instruments), size 50, with a kinematic viscosity range of 0.8 – 4 mm2 s-1.  
Measurements were made in duplicate for each concentration measured.  Alginate samples 
were equilibrated for 30 min prior to measurement and filtered using a 0.45 μm syringe filter 
to remove any contaminants.   
4.5.3 G25 chromatography 
Gel filtration experiments were performed at 20 °C using a SephadexTM G-25 fine (26/100) 
column, with a height of 100 cm and a diameter of 26 mm, equalling a column volume of ca. 
670 mL, which was attached to an AKTATM purifier FPLC purification system (GE 
healthcare).  A 5 mL loop was utilised at the injection site, with alginate samples (2 mg mL -1, 
5mL) injected prior to filtration.  The flow rate was 4 mL min-1 with a working pressure of ca. 
0.2 MPa.  The eluent was aqueous sodium chloride (0.2 M) which was filtered and de-gassed 
before use.  The column was primed with eluent and thoroughly washed between runs.  
Elution samples were passed through a UV-visible detector set to λ = 280 and 230 nm. 
4.5.4 Plasmid extraction 
Agar blocks inoculated with JM 109 containing plasmid pHH1 encoding AlgE1 was donated 
from Helga Ertesvåg (Norwegian University of Sciences and Technology).  Bacterial stocks 
were produced, which were subsequently plated on an ampicillin-enriched agar plate to obtain 
single colonies.  These were cultured overnight and plasmids were extracted using a QI Aprep 







4.5.5 Gene sequencing 
Prior to sequencing, DNA concentrations were obtained using a NanoDrop 1000 
Spectrophotometer.  DNA samples were mixed with forward and reverse primers (Eurofins 
MWG Operon) before DNA sequencing was conducted by the functional genomics 
department (University of Birmingham). 
Primer name Base length Sequence 5’ to 3’ GC content 
(%) 
M13_Puc_rev_primer 23 AGCGGATAACAATTTCACACAGG 44 
pBAD_rev_primer 18 GATTTAATCTGTATCAGG 33 
  
A restriction digest of the purified plasmid was also performed using the restriction enzyme 
Nco1 and the resultant digest was separated on a 0.8% agarose DNA gel.   
 
4.5.6 E.coli transformation 
E.coli bacterial strain BL21 was used for the expression of AlgE1.  BL21 were mixed with the 
plasmid DNA (containing the algE1 gene insert) and transformed by heat shock at 42 °C for 1 
min 45 sec.  Transformed bacteria were then plated onto ampicillin-enriched agar plates and 
incubated overnight at 37 °C, thereafter single colonies were selected and subsequently 
cultured overnight in ampicillin (0.5 μL mL-1) supplemented LB broth to generate starter 






4.5.7 AlgE1 production and purification 
For the production of large amounts of AlgE1, LB broth (x2 1000 mL, 25 g) supplemented 
with ampicillin (100 μg uL-1) was autoclaved prior to use.  A starter culture consisting of LB 
broth (x2 10 mL) inoculated with the glycerol stock was incubated overnight, which was then 
transferred into growth LB broth and incubated at 37 °C with slight agitation until an optical 
density of 0.4 at λ = 600 nm was reached.  At this point, the growth cultures were induced 
with isopropyl β-D-1-thiogalactopyranoside (IPTG) (0.5 mM) and incubated at 25 °C for a 
further 3 hours.  The bacteria were subsequently harvested and pelleted by centrifugation at 
6000 RPM at 4 °C (Avanti J-20XP, Beckman Coulter) and the obtained cell pellet was 
disrupted with continuous aspiration cycles in MC buffer (20 mL) containing protease 
inhibitors (1 tablet, Roche).  MC buffer consisted of MOPS (20 mM, pH 6.9) and CaCl2∙2H2O 
(2.2 mM). At this stage, the cells could be frozen at – 80 °C or purified further.  The BL21 
cell suspension (20 mL) was disrupted by pressure using an emulsiflex homogeniser (Arestin) 
at 18,000 PSI at 4 °C.  The subsequent cell slurry was centrifuged at 250,000 RPM for 45 
mins (Avanti J-20XP, Beckman Coulter) to remove cell debris and the supernatant collected 
ready for purification. 
The supernatant was filtered through a 0.2 μm sized filter, prior to loading onto the column 
(25 mL).  The filtered crude extract was purified on a HiTrap Q Sepharose HP column 
(Pharmacia) which was pre-equilibrated with MC buffer.  Elution of the epimerase was 
achieved using a continuous NaCl gradient (0.1 – 1.0M) in MC buffer; AlgE1 eluted between 







4.5.8 Assessing for activity of AlgE1 
To screen the purified enzyme fractions for epimerisation activity, aqueous Manucol LD 
(0.1%, (w/v)) in DI H2O (5 mL) was prepared.  Manucol LD solution (2 mL) was mixed with 
the enzyme fractions (1 mL) and MOPS buffer (80 mM, 1 mL) supplemented with 
CaCl2∙2H2O (4 mM).  The resultant mixture was incubated at 37 °C for 2 hours.  To quench 
the epimerisation, EDTA (50 mM, 500 μL) was added and the subsequent mixtures were 
transferred to dialysis membranes (MWCO= 12 400, 33 mm flat width).  Solutions were 
dialysed against DI H2O (1000 mL) for three 24 hour incubation periods at 4 °C.  The 
resultant solutions were used directly in the circular dichroism spectrometer.  CD 
measurements were recorded on a Jasco J-810 CD spectropolarimeter (4 accumulations, 1 s 
response) using a 1 cm path length, blackened quartz cell.  Spectra were recorded at an 
internal temperature of 20 °C.  
4.5.9 Epimerisation of Manucol LD for cell culture use 
Aqueous Manucol LD (0.2%, (w/v)) was prepared in DI H2O (100 mL) to which, MOPS 
buffer (180 mM, 25 mL) supplemented with CaCl2∙2H2O (40 mM) was added and the enzyme 
fractions identified with activity (20 mL) was also added.  The resultant solution was gently 
agitated at 37 °C for 24 hours, before enzyme deactivation was initiated with the addition of 
EDTA (0.5 M).  The mixture was cooled to 4 °C and transferred to a dialysis membrane to 
allow the Ca-EDTA complexes to dialyse out.  Dialysis was carried out at 4 °C in 4000 mL 
DI H2O for three 24 hour incubations.  The subsequent alginate product was aspirated, pH 
adjusted to pH = 7.4, and concentrated in vacuo to an intermediate volume of ca. 50 mL.  At 





RPM for 10 min to a pellet, and the supernatant dried in vacuo to completion.  The resultant 
product was glass-like, clear and solid. 
4.5.10 High resolution NMR 
Alginate samples Manucol DH and Manucol LD were prepared by dissolving alginates (0.5 g) 
into D2O aliquots (1 mL) and stirred vigorously to ensure complete dissolution.  The solutions 
were transferred to NMR tubes, and slightly centrifuged to move the sample to the bottom of 
the sample tube. 
1H NMR spectra were acquired on a Bruker Avance III 600MHz instrument equipped with a 
5mm TCI Cryoprobe. The residual solvent resonance was further suppressed using a NOESY 
presat pulse sequence. A total of 32 transients and 16 steady state scans were acquired with 
16384 complex data points. The spectral width was set to 7184 Hz and the sample 
temperature to 340 K.  The free induction decays were multiplied with a 0.3 Hz broadening 
exponential window function and zero filled to 32768 real data points prior to Fourier 
transformation. They were then manually phase and baseline corrected, using a spline 
baseline correction. Signals for the anomeric protons of the different alginate constituents 
were fitted to lorentzian lines. All data processing and analysis was performed using the 
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Polyphenolic iron complexation:  
a chemical and cellular study. 
 
5.1 Introduction and aims 
Similar to alginates, dietary iron chelators include the vast class of compounds known as 
polyphenols.  Being small molecular weight compounds, their effect on cellular iron 
metabolism could be one to enhance iron bioavailability or to decrease cellular iron 
concentrations (both through possible solubility changes, chelation or direct protein 
modulation mechanisms).  Such contrasting mechanisms are observed with two dietary iron 
chelators, tannic acid and ascorbic acid.[1, 2]  The four polyphenol complexes selected for 
this study (screened using the requirements for iron binding set out by Khokhar et al.)[3] were 
quercetin, rutin, cyanidin-3-O-glucoside and catechin.   The preceding literature review based 





Table 5.1: Summary of iron binding properties, bioavailability and anti-neoplastic effects for 
the polyphenols assessed (summarised from section 1.5). 
Polyphenol Iron binding ability Bioavailability Anti-carcinogenic potential 





Rutin Confirmed.  Strong binding ability. Low. 
Limited evidence but 
mainly inconclusive. 
Cyanidin-3-O-
glucoside No evidence. 
Absorbable and 
highly metabolised, 
yet presence within 
large intestine 
confirmed. 
In vitro evidence of 
some effects. 
Catechin Limited evidence. Very poor. Limited evidence. 
 
It is apparent that polyphenol bioavailability is a complex field of study, despite this there are 
reports of the listed polyphenols reaching the large intestine.[4-9]  This allows the selected 
four polyphenol candidates to be assessed for their iron binding potential.  Thus, the aims of 
this chapter are to: 
1) Understand the chemical iron-binding nature of the listed polyphenols; 
2) Examine how these polyphenol compounds impact on cellular iron metabolism. 
3) Rationalise these iron-binding properties and delineate mechanisms that may 
contribute towards an anti-carcinogenic potential. 
 
5.2 Results and discussion 
5.2.1 Assessment of iron binding by isothermal titration microcalorimetry 
Isothermal titration microcalorimetry is ideally set up to probe interactions of iron with 
polyphenols and since physiological conditions can be employed throughout the titration, this 
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increases the relevancy of results upon translation into an in vitro setting.  However, the use 
of these neutral pH environments in the presence of iron require specific titration controls 
since the titration of acidic aqueous iron solutions titrated into a pH = 7 solution will produce 
considerable heat changes.  With this aliquots of either aqueous iron(III) chloride or iron(II) 
sulphate were titrated into a stirred solution of polyphenol (0.05 mM) at a temperature of 37 
°C in a physiological pH 7.0 buffer with the relevant control titration (iron into buffer only) 


























































































































































A: Quercetin + Fe(II) Ai: Quercetin  
+ Fe(III) 
B: Rutin + Fe(II) Bi: Rutin + Fe(III) 
Figure 5.1: (1) Thermograms and corresponding isotherms for iron (II) binding to (A) 
quercetin and (B) rutin with titrations for iron (III) binding to (Ai) quercetin and (Bi) 
rutin.  Control titrations and recorded heats were subtracted from the respective 




    























































































































































































































glucoside + Fe(II) 
Ci: Cyanidin-3-O-
glucoside + Fe(III) 
D: Catechin + Fe(II) Di: Catechin 
+ Fe(III) 
Figure 5.1: (2) Thermograms and corresponding isotherms for iron (II) binding to (C) 
cyanidin-3-O-glucoside and (D) catechin with titrations for iron (III) binding to (Ci) 
cyanidin-3-O-glucoside and (Di) catechin. Control titrations and recorded heats were 
subtracted from the respective experiments.  The solid lines represent the curve fitting 




Isotherms were fitted using models of host-guest interactions that best fitted the data.  It is 
evident that quercetin is binding iron in these environments.  For both ferrous and ferric iron 
the number of binding sites on quercetin was estimated to be N = 0.63 and 1.16 respectively, 
indicating one preferred iron binding site on quercetin in parallel to that found in previous 
work.[3, 10]  Iron binding constants were K = 8.3 x 105 and 3.86 x 106 M-1 for ferrous and 
ferric iron binding respectively.  The higher affinity of interaction with ferric iron than ferrous 
can be rationalised based on electrostatics, with a greater charge density on iron (III) 
enhancing the columbic interaction between the host and guest.  These iron binding constants 
match those previously reported.[11]    
For rutin, iron complexation mechanisms were interesting.  Iron binding by rutin could only 
be demonstrated with ferrous iron; no iron binding was evident with ferric iron.  This could be 
attributed to the oxidative nature of rutin in the presence of iron whereby interaction proceeds 
via a chemical reaction rather than complexation.[12]  Isotherms for ferrous iron interactions 
with rutin were best fitted using a two-site model of binding.  This is interesting since in rutin, 
the glycone of quercetin, the most favourable iron binding site is blocked by the rutinoside 
due to steric hindrance.  In part, iron complexation would occur via the two remaining iron 
binding sites of which one is strong (K = 3.2 x 108 M-1) and one is weaker (K = 2.2 x 104 M-1).  
It can be eluded that the C5 OH – C3 keto would complex iron with the greater affinity 
compared to the C3’-C4’ OH on ring B due to greater electron density at this moiety.  This 
corroborates the structural chemical differences identified earlier.[3]  For both cyanidin-3-O-
glucoside and catechin, no appreciable iron binding parameters could be obtained.  For 
cyanidin-3-O-glucoside, it was documented that considerable structural rearrangements take 
place at neutral pH conditions which could yield non-iron chelating products.[13]  A slow 
redox reaction between ferrous iron and catechin has been reported, which could contribute to 
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the lack of iron binding observed by ITC.[14]   Both catechin and cyanidin-3-O-glucoside do 
not possess the 5-OH or 3-OH in conjunction with the C4 keto group which was identified as 
an important iron-binding moiety in flavonoids.[3] 
 
5.2.2 Assessment of iron chelation by ferritin expression 
The assessment of cellular biomarkers of intracellular iron concentration would allude to the 
iron chelation abilities of the selected polyphenols in vitro.  The assessment of ferritin levels 
would demonstrate as to whether iron chelation was taking place in the extracellular media to 
limit iron absorption and hence decrease iron-mediated ferritin expression.  To interrogate 
this, RKO cells were challenged with an iron rich media (100 μM FeSO4∙7H2O + 500 μM 
sodium ascorbate) with or without the polyphenols (quercetin, rutin, cyanidin-3-O-glucoside 
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Figure 5.2:  Expression values for RKO cells co-cultured with quercetin, rutin, cyanidin-
3-O-glucoside and catechin for ferritin (A-D) respectively. Concentrations of polyphenols 
co-cultured with iron without iron were 200, 20, 2 and 0 μ M respectively.  Data points 
represent mean fold change in protein expression normalised to β-actin, relative to control.  




Quercetin statistically decreased ferritin expression at higher concentrations (200 μ M) by 
51% (p < 0.05) compared to the iron only control.  There was some trend to decrease ferritin 
expression at the lower incubation concentrations of quercetin yet this was not significant.  
This data is suggestive of an iron chelation effect of quercetin in vitro, which is in agreement 
with other in vitro data detailed previously.[15-17] 
The rutinoside of quercetin (rutin) had identical effects to quercetin with respect to iron 
modulation in vitro by decreasing ferritin expression by 54% statistically (p < 0.05) at 200 
μM incubation concentrations but having no significant effects at lower concentrations.  This 
data would suggest that despite the glycosylation status of rutin in comparison to quercetin, 
no iron chelation differences are observed in vitro.  This identically is also reflected in the 
ITC experiments where both polyphenols were able to chelate ferrous iron with similar iron 
binding constants.   
Cyanidin-3-O-glucoside and catechin demonstrated no iron chelation abilities in vitro as no 
discernible changes in ferritin expression were found; this corroborates the lack of iron 
binding affinity identified in the ITC results (figure 5.1 (2)). 
 
5.2.2.1 Assessment of intracellular iron concentrations by 59Fe experiments 
Assessment of the surrogate biomarkers for intracellular iron concentration (such as ferritin) 
provide an understanding of cellular iron concentrations, yet only for iron that is accessible to 
IRE/IRP binding.  Practically, this means that there would be no discrimination between iron 
chelation taking place extracellularly, whereby subsequent iron-polyphenol complexes remain 
extracellular or the converse whereby iron chelation is taking place, yet the polyphenol iron 
complex can shuttle between an intracellular state or extracellular one.  Simply it may be the 
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case that even though a decreased intracellular iron concentration is observed by ferritin, iron 
concentrations maybe higher if the polyphenol-iron complex cannot be sensed by IRE/IRP2.  
With respect to the polyphenols examined here this is significant since the absolute 
bioavailability of the polyphenol or the iron complexes are not fully understood.  To examine 
the effect of this radioactive 59Fe was employed in similar conditions as to the protein 
expression studies since 59Fe levels will reflect actual intracellular iron concentrations 




























Figure 5.3:  Intracellular 59Fe iron concentrations for RKO cells treated with (A) quercetin, 
(B) rutin, (C) cyanidin-3-O-glucoside and (D) catechin at 200, 20, 2 and 0 μM concentrations.  
* denotes statistical significance (p < 0.05)  vs. iron only control.  Error bars denote ± SEM, n 
= 12. 
 
It was found that quercetin statistically decreased intracellular 59Fe by 21% and 18% (p < 
0.05) at the 200 and 20 μM incubation concentrations respectively. These results verify the 
ferritin expression findings, suggesting that quercetin is indeed chelating iron extracellularly 
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discussed however that quercetin iron complex can readily efflux the cell and the experiments 
performed here do not rule out the possibility that quercetin is chelating intracellular iron.  In 
both cases quercetin is chelating iron which is subsequently non-intracellular.  Conversely, it 
is demonstrated that the rutin-iron complex is intracellular since at co-incubation 
concentrations of 200 and 20 μM an increase in 59Fe of 78% and 27% are found respectively.  
This infers that despite the fact that rutin is chelating iron, as evidenced by decreased ferritin 
expression, the chelated iron is non-IRP2 sensed despite accumulating within the cell.  The 
site of iron chelation maybe questioned as the combination of these data suggest it either 
intracellular or extracellular iron chelation.  The rutin-iron complex may also be able to 
traverse the cell membrane.  Considering it has been established that rutin has a low 
bioavailability, it is possible that the rutin-iron complex is able to traverse the cell membrane 
or perhaps, the bioavailable-metabolite of rutin is able cell membrane permeable.  
Cyanidin-3-O-glucoside, despite showing no bioactivity in the iron chelation and ferritin 
expression studies, did in-fact induce a 20% decrease (p < 0.05) in intracellular iron 
concentration only at the 200 μM cyanidin-3-O-glucoside.  This may reflect the poor affinity 
of cyanidin-3-O-glucoside for iron, whereby no diminishment in ferritin expression was found 
but a small decrease in intracellular iron levels was evident. 
Catechin, despite eliciting no iron chelation results previously did decrease intracellular iron 
concentrations dramatically by 35, 22 and 14% at 200, 20 and 2 μM incubation concentrations 
statistically compared to control (p < 0.05).  This result is confusing since no decrease in 
ferritin was associated with this response.  It has however been documented how catechin is 
able to induce iron release from ferritin.[18]  It could be speculated that catechin is not 
binding iron initially, allowing ferritin expression.  Upon ferritin synthesis and subsequent 
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iron-storage, catechin is able to sequester this iron removing it from the cell.  This is the only 






5.2.4 Anti-oxidant action  
It is well established that polyphenols have anti-oxidant properties.[19, 20]  It was discussed 
earlier that there are several mechanisms to anti-oxidant action, with one invoking the 
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chelation of iron to limit its catalytic redox activity in Fenton type reactions.[16, 21]  In order 
to elucidate whether the anti-oxidant effects of these polyphenols is provided through an iron 
chelation mechanism, a series of experiments were performed to delineate the polyphenol role 
(method 5.4.6).  Firstly, to confirm the anti-oxidant action of these polyphenols in the 
presence or absence of iron, RKO cells were pre-incubated with an intracellular ROS- 
activatable fluorescence ligand and subsequently challenged with the polyphenol series with 











































































































Figure 5.7: Intracellular ROS 
concentration in RKO cells co-
cultured with the polyphenols 
series, with or without iron for 
(A) 3 hours, (B) 12 hours and 
(C) 24 hours.  Iron only and 
media were used as 
experimental controls.  * 
denotes statistical significance, 
p < 0.05.  ○ denotes statistical 
significance (p < 0.05) vs. iron 
only control.  ◊ denotes 
statistical significance (P < 
0.05) vs. media only control.  








The first finding is that iron is not catalysing ROS formation in these cells, since incubation 
with iron does not induce ROS formation to levels greater than when no iron was present; the 
basal levels of ROS in RKO cells must be constitutively high.[22, 23]  Co-culturing with 
polyphenol only, without iron, all the polyphenols statistically decreased intracellular ROS 
formation (except rutin and quercetin at 24 hours).  This demonstrates the direct anti-oxidant 
activity of the polyphenols, which is iron independent.  It can be seen that there was elevated 
ROS levels present when cells were co-cultured with iron as expected.  At three hours post 
incubation, quercetin, cyanidin-3-O-glucoside, catechin and rutin decreased ROS formation 
by 40, 26, 36 and 26 % respectively.  At 24 hours of exposure, quercetin, cyanidin-3-O-
glucoside, catechin and rutin diminished ROS production by 26, 32, 22 and 21 % 
respectively.  In this case cyanidin-3-O-glucoside was the polyphenol with the highest anti-
oxidant activity, and since this polyphenol demonstrated no iron binding activity, the ROS-
quenching ability of this polyphenol is likely to be a direct mechanism.  From these 
experiments it is difficult to demonstrate if any ROS-sequestering activity is associated with 
iron chelation since all the polyphenols diminish ROS levels directly. 
In order to probe the mechanism further, RKO cells were pre-loaded with iron for 12 hours 
prior to co-culture with the polyphenol compounds.  In this experiment, since the cells would 
have high cellular iron contents prior to exposure to the polyphenol compounds where no iron 
was present, results would demonstrate the ability of the polyphenol to enter the cell and bind 
iron, where, if an iron-chelation mediated mechanism of antioxidant activity was occurring, 
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Figure 5.8: Intracellular ROS 
concentration in RKO cells 
co-cultured with or without 
iron for 12 hours prior to 
culturing with the 
polyphenols series, without 
iron for (A) 3 hours, (B) 12 
hours and (C) 24 hours.  
Control incubations include 
iron co-culture for 12 hours 
followed by media only, or 
media only throughout. * 
denotes statistical 
significance, p < 0.05 vs. no 
iron pre-load.  Error bars 




Evidently, whether cells were pre-loaded with iron or not, in both cases ROS concentration 
was significantly lower in all cases to their respective controls (p < 0.05).  When iron was pre-
loaded, in comparison to the non-preload case where polyphenol was added only, at three 
hours, all the polyphenols demonstrate increased ROS production in the presence of iron 
compared to polyphenol only; increases of 35, 24, 26 and 19% were calculated for quercetin, 
cyanidin-3-O-glucoside, catechin and rutin respectively.  However, as time progresses and at 
24 hours of incubation, no polyphenols demonstrate a statistical increase in ROS production 
when cells are iron-loaded.  This suggests two possibilities; 1) that all the polyphenols over 
time are able to quench the effects of the high pre-loaded cellular iron generating ROS or, that 
2) the ROS-scavenging effects of the polyphenols is saturated and hence both conditions 
reach equal levels of ROS.  If it were indeed hypothesis 1, that all the polyphenols over time 
are quenching ROS in this time dependent manner, a way to determine if this was through 
their iron chelation ability would be to repeat the experiment, but incubated iron-preloaded 
cells with polyphenols already bound to iron.  If their ROS quenching ability over time did 
not occur, then it could be suggested that this is because they alleviate ROS levels through an 
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Figure 5.9: Intracellular 
ROS concentration in 
RKO cells co-cultured 
with or without iron for 12 
hours prior to culturing 
with the polyphenol 
series, with iron (white 
bars), for (A) 3 hours, (B) 
12 hours and (C) 24 hours.  
Control incubations 
include iron co-culture for 
12 hours followed by 
media only, or media only 
throughout, or media with 
iron. * denotes statistical 
significance, p < 0.05 vs. 
no iron pre-load.  Error 







As detailed, when cells are loaded with iron, and then incubated with polyphenol initially, the 
pre-loaded cells have more ROS associated with them than their non- iron-preloaded 
counterparts.  After time (24 hours) the difference in ROS concentrations is elevated, and 
ROS levels in both groups are equal and this suggests that over time, the polyphenols may be 
inhibiting the ROS generation potential of iron.  If this was through an iron chelation 
mechanism, then saturating their iron binding potential would result in no amelioration of 
these ROS levels between the two groups.  Based on this hypothesis, it is found that for 
quercetin and catechin this seems to be the case.  Since cyanidin-3-O-glucoside and rutin have 
statistically elevated ROS levels at longer time periods, compared to when they are not iron-
loaded, this would suggest that they require iron-chelation for their ROS reducing ability.  
Considering this experiment as a whole, by loading the polyphenols with iron, their ROS 
diminishing activity decreases, with all increased ROS levels detected at 3 hours of incubation 
for all the polyphenols, specifically, quercetin, cyanidin-3-O-glucoside and rutin demonstrate 
a 26, 24, 31 and 39% increase in ROS production.  At 24 hours, this representation shifts, and 
only quercetin and catechin are able to restore ROS levels to their original values; suggestive 
that at these later time points, antioxidant activity does not involve an iron chelation 
mechanism. 
 
5.2.5 Iron redox activity  
A simple way of quantifying polyphenolic affinity for iron would be to employ a competitive 
ligand that yields a colourful complex upon coordination with iron; the ferrozine ligand is 
able of achieving this (method 5.4.7).  The significance of this experiment is that ferrozine 
will only coordinate with ferrous iron.  Using ferrous iron as the iron source will detail which 
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polyphenol compounds chelate iron the best in these competition studies.  On the other hand, 
using ferric iron as the iron source will detect if any polyphenol compounds are having redox 
activity to oxidise iron to its ferrous form.  In this experiment, polyphenol compounds were 
introduced into pH = 7 buffer solutions with the ferrozine ligand, with either ferric or ferrous 
iron and incubated over night to mimic the conditions used in vitro (figure 5.10). 
Using ferrous iron to determine the extent of iron chelation, cyanidin-3-O-glucoside displayed 
no iron-chelation ability paralleling the findings using ITC.  Quercetin, catechin and rutin 
chelated iron by 14, 18 and 20 % respectively compared to control.  When ferric iron was 
used as the iron source, under these pH = 7 buffered conditions, all polyphenols demonstrated 
some redox activity, with rutin, catechin, cyanidin-3-O-glucoside and quercetin increasing 





































Figure 5.10: Redox potential of iron(II) and iron(III) in the presence of polyphenolic 
compounds. * denotes statistical significance (p < 0.05) with respect to the relevant control.  
Error bars represent ± SEM, n = 3. 
 
5.3 Conclusions and summary 
The results obtained here highlight the complexity of polyphenolic iron chelation both 
chemically and within the physiological conditions in vitro and in vivo.  Calorimetric 
experiments identified that under physiological conditions only quercetin and rutin are able to 
bind iron, with catechin and cyanidin-3-O-glucoside demonstrating no iron-binding activity.  
With respect to redox activity however, cyanidin-3-O-glucoside and quercetin were able to 
redox react with ferric iron to form ferrous iron.  Catechin, rutin and quercetin all 
demonstrated iron binding ability in the ferrozine assessment of iron binding.  These three 
polyphenols demonstrated similar activity when intracellular iron was assessed as they 








as well as quercetin, however it was found that rutin increased intracellular iron 
concentrations.  
Rutin was found to increase intracellular iron concentrations, yet diminish ferritin 
concentrations alluding to iron-chelation with the rutin-iron complex becoming intracellular.  
As discussed the nature of this is confusing and further work needs to be carried out to verify 
why this is the case. 
Considering all the experiments involving iron modulation it can be concluded that quercetin 
presents itself as the ideal iron chelator for luminal iron chelation; it bound both Fe(II) and 
Fe(III) in the ITC experiments; it reduction in iron-mediated ferritin expression and in 
inhibited intracellular iron concentrations.  Iron chelation activity was not demonstrated in 
vivo however, which is disappointing since in vitro studies identified quercetin as an iron 
chelator.  As discussed earlier, polyphenol iron chelation is very much dependent on 
concentration and environment and this may be the reason why in vitro results were not 
reflected in mice. 
The anti-oxidant activities and mechanisms of the polyphenols are complex.  If you describe 
the results obtained here without and prior knowledge of iron binding by the polyphenols used 
the following conclusions can be made.  All polyphenols are able to reduce the ROS 
generation potential of iron when co-cultured with iron.   When you pre-load cells with iron, 
and then subsequently expose them to the polyphenols, all the polyphenols in the short term 
demonstrate a diminished effect of antioxidant activity by observed increases in intracellular 
ROS concentrations.  The polyphenol which augmented ROS the most was quercetin at the 
short term (this maybe because its mechanism is through an iron binding process, which is 
unable to take place when iron is intracellular).  At 24 hours, the antioxidant ability of the 
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polyphenols was restored back to the non-iron-preloading state.  By repeating this experiment 
but blocking the polyphenol iron binding site by adding iron, in the short term all the 
polyphenols further lost their ability to reduce ROS.  In the long term, both quercetin and 
catechin were able to restore lower ROS concentrations; this is interesting since these were 
the two polyphenols that reduced total cellular iron concentrations.  
The results presented demonstrate a dominance of a non-iron chelation mechanism of ROS 
diminishment, since all the polyphenols tested had ROS reducing activity when they were 
pre-loaded with iron, even polyphenols identified as having no iron binding activity.  This 
mechanism of ROS sequestration is becoming more accepted, with a direct action of 
polyphenols reducing intracellular ROS levels.[21, 24] 
In summary, polyphenols represent a complex and diverse range of naturally occurring 
compounds.  Their digestive bioavailability and degradation by colonic microbiota make them 
a difficult collection of potential luminal iron-chelators to assess; it has however been 
established that, despite lack of conclusively there is evidence to suggest presence within the 
colon. 
Iron binding capabilities have been established with quercetin demonstrating high iron 
binding affinities.  These results were parallel in vitro yet in vivo no iron chelation ability was 
evident; this reflects the complex nature of the bio-distribution and metabolism of 
polyphenols in vivo. 
With regards to the original aim, specifically, ‘to develop a colonic iron chelator, that will 
chelate excess, free iron, present within the colon, rendering it inert’ it can be concluded that 
quercetin may indeed fit this requisite.  The iron modulatory effects of quercetin in vitro are 
interesting, and alongside the report of quercetin supplementation attenuating the progression 
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of cancer in ApcMin/+ mice, warrants further research into the precise mechanism of 
action.[25]  Whether iron is toxic in the colon by generating ROS is unknown, yet the anti-
oxidant nature of the polyphenols here have been established in a colorectal cancer cell line.  
These results are preliminary in understanding the role of these polyphenols in modulating 
iron homeostasis, yet with the abundance of possible iron-chelating polyphenols much more 
experimentation is required to fully understand physiological polyphenol iron binding.  
 
5.4 Experimental  
5.4.1 Chemicals and reagents 
Cyanidin-3-O-gluocoside (MW = 484.3) was purchased from Polyphenols Laboratories AS 
and met purification specifications.  Rutin trihydrate (MW = 664.6), quercetin (MW = 
302.24) and (+)-catechin hydrate was purchased from Sigma Aldrich; specific catechin 
concentration was determined using UV-Visible spectroscopy and its specific extinction 
coefficient.  Chemicals were used as purchased with no further purification.  Intracellular 
ROS ligand was purchased from LifeTechnologies. 
5.4.2 Isothermal Titration Microcalorimetry 
Assessment of polyphenol-iron binding, quercetin, rutin, and catechin were dissolved in 
DMSO to produce a 0.05 M stock solution.  Cyanidin-3-O-glucoside was reconstituted in DI 
H2O to produce a 0.05 M stock solution.  Polyphenols were diluted in potassium phosphate 
buffer (0.1 M, pH = 7, 4.6 g HNa2O4P∙12H2O, 1.6 g H2KO4P and 2.9 g NaCl) in DI H2O 
(1000 mL) to a concentration of 0.05 mM.  Iron chloride solution was prepared by dissolving 
FeCl3∙6H2O (0.5 mM, 0.054 g) in aqueous HCl (0.1 M) and for ferrous sulphate which was 
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prepared by dissolving FeSO4∙7H2O (0.5 mM, 0.056 g) in aqueous HCl (0.1 M).  All solutions 
were degassed at a temperature of 35 °C for 5 min before use.  Aliquots of ferric or ferrous 
iron (10 μL, 0.5 mM) were automatically titration into a solution of polyphenol at a 
temperature of 37 °C with a cell chamber volume of 1360 μL.  A total of 40 injections were 
performed, with a time interval of 500 s between each subsequent injection; the initial titration 
was set to 2 μL and was discarded in the data analysis.  The stirring speed was set to 307 rpm 
with an initial delay of 60 s and a reference power set to 10 μcal s-1.  Measurements were 
performed on a VPITC MicroCalorimeter and were analysed using MicroCal LLC ITC/Origin 
software package.   
Control titrations were recorded whereby the exact parameters as above were employed, yet 
buffer only was present in the titration chamber; the heats of these titrations were subtracted 
from the respective experiments.  Data fitting was performed using the MicroCal LLC 
ITC/Origin software package according to the model of best fit for each data set. 
5.4.3 Ferritin western blotting 
RKO cells were routinely cultured as previously described in section 3.4.   
Sterile polyphenol stock solutions were created by dissolving quercetin, rutin and catechin 
(0.05 M) in NaOH (0.2 M) and vortexing until complete hydration was evident.  Cyanidin-3-
O-glucoside was also formulated into a stock solution (0.05 M) in DI H2O.  An iron stock 
solution was creating by dissolving FeSO4∙H2O (108.9 mg, 10 mM) and sodium ascorbate 
(396 mg, 500 mM) in DI H2O (40 mL); the resultant solution was dark purple in colour.  To 
create polyphenol stimulation media, polyphenol stocks (60, 6 and 0.6 μL) were mixed with 
growth medium (15 mL) to create resultant 200, 20 and 2 μM polyphenol-containing 
mediums.  To mediums requiring iron, iron stock (150 μL) was added to the relevant 
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mediums and mixed.  For experimentation, cells were seeded into 6 well plates at a standard 
concentration (1 x 105 cells mL-1, 2 mL) and incubated for 24 hours before growth medium 
was replaced with stimulation media (2 mL).  Cells were incubated for 24 hours and 
subsequently washed x2 in PBS (2 mL) and the volume of the well void.  Subsequently, cells 
were lysed in RIPA lysis solution (1% 4-Nonylphenyl poly(ethylene glycol) (w/v), 0.5% 
sodium deoxycholate (w/v), 0.1% sodium dodecyl sulphate (w/v), between 150 – 200 μL 
depending on cell confluency) on ice.   
Western blotting procedure was performed as described earlier in section 3.6 
5.4.4 Cellular 59Fe uptake studies 
Experiments involving the use of radioactive iron were typically set up as previously 
discussed, with polyphenol and iron containing culture solutions produced following the 
described methods.  To create 59Fe iron mediums, the stock of iron was spiked with 59FeCl3 to 
reach ca. 10,000 counts per minute (CPM) per well; this was then used as previously 
described with a 1:100 dilution into the polyphenol-containing growth medium.   
Cells were seeded into 12 well plates at a standard concentration (1 x 105 cells mL-1, 1 mL) 
and incubated for 24 hours before growth medium was replaced with stimulation media (1 
mL).  Cells were incubated for 24 hours and subsequently washed x2 (2mL) in Versene (0.2 g 
L-1 in PBS) and the volume of the well void.  Cells were then lysed in HEPES-saline lysis 
buffer (150 μL, 10 mM, pH 7.4, NaCl 0.9% (w/v)).  To count for radiation content, a specific 
amount of the sample under investigation (usually ca. 100 μL) was transferred into a 
scintillation tube and scintillation fluid (1 mL) was added.  Radiation CPM counts were 
normalised to protein concentration as determined in the BCA protein assay (as described 
previously in section 3.6.  
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5.4.6 Reactive oxygen species assay 
Several perturbations of this experiment were carried out: 
i) Polyphenol incubation with or without iron 
RKO cells were seeded into 96 well plates at a standard concentration (1 x 105 
cells mL-1, 100 μL) and incubated for 24 hours before growth medium was 
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removed.  Cells were subsequently washed x3 with PBS (200 μL).  The ROS 
ligand (Cm-H2DCFDA, 50 μg) was dissolved in 100% ethanol and made to a 
working concentration (5 μM) in PBS) and was pipetted onto the cells (100 μL) 
and incubated for 1 hour.  After this time period, a baseline reading was taken 
(t=0) at λ = 485/535 nm.  The ROS ligand was removed from the cells and again, 
cells were washed x3 with PBS (200 μL) before the addition of the polyphenol 
containing media with or without iron (as prepared in the above protocol).  Time 
points were recorded at 3 hours, 12 hours and 24 hours.    
 
ii) Preload with iron followed by polyphenol incubation 
RKO cells were seeded into 96 well plates at a standard concentration (1 x 105 
cells mL-1, 100 μL) and incubated for 12 hours before the addition of ferrous 
sulphate (1 μL, FeSO4∙7H2O, 100 μM in DI H2O) and subsequently incubated for a 
further 12 hours.  Iron-rich growth medium was removed and Cells were 
subsequently washed x3 with PBS (200 μL).  The ROS ligand (Cm-H2DCFDA, 50 
μg) was dissolved in 100% ethanol and made to a working concentration (5 μM) in 
PBS) and was pipetted onto the cells (100 μL) and incubated for 1 hour.  After this 
time period, a baseline reading was taken (t=0) at λ = 485/535 nm.  The ROS 
ligand was removed from the cells and again, cells were washed x3 with PBS (200 
μL) before the addition of the polyphenol containing media (catechin, rutin, 
cyanidin-3-O-glucoside and quercetin, 20 μM) without iron (as prepared in the 
above protocol).  Time points were recorded at 3 hours, 12 hours and 24 hours.    
 
iii) Preload with iron following by polyphenol with iron incubation 
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The same protocol as outlined in (ii) was undertaken, yet upon incubation in the 
polyphenol containing media, iron (FeSO4∙7H2O, 100 μM) was present.  
In each experiment, a control plate containing polyphenol only with no cells was prepared 
such that the absorption arising from the polyphenols could be subtracted.   
5.4.7 Redox activity assay 
For the assessment of redox acivty,  quercetin, rutin, and catechin were dissolved in DMSO to 
produce a 1 mM stock solution.  Cyanidin-3-O-glucoside was reconstituted in DI H2O to 
produce a 1 mM stock solution.  Polyphenols were diluted in potassium phosphate buffer (0.1 
M, pH = 7, 4.6 g HNa2O4P∙12H2O, 1.6 g H2KO4P and 2.9 g NaCl) in DI H2O (1000 mL) to a 
concentration of 12.5 μM such that the resultant volume was 4 mL.  To this, ferrozine solution 
(5 mM, 200 μL) was added and vigoursly mixed.  Ferric iron (FeCl3∙6H2O) or ferrous iron 
(FeSO4∙7H2O) was prepared (1 mM in 0.1 M HCl) of which 25 μL was added and the 
resultant mixture vortexed.  Solutions were incubated in the dark for 24 hours at 37 °C.  After 
this period, solutions were well mixed and pipetted in triplicate onto a 96 well plate ready for 
reading on a plate reader at λ = 550 nm.  In order to account for the absorption observed due 
to the inhert absoabtive nature of the polyphenols, alike concentrations were mixed as above 
without the additon of the ferrozine ligand.  These were similary read and the values 
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Conclusions and future work. 
 
 
There is a clear role for iron in the pathogenesis of intestinal disease, most notably in 
colorectal cancer and inflammatory bowel disease.  Iron, with its ability to catalyse the 
formation of damaging redox species, alongside its ability to have direct effects on cellular 
oncogenic processes and also its requirement in proliferating cells justifies iron as a target for 
therapeutic intervention.  However, it is unknown how iron is contributing to an inflammatory 
and carcinogenic phenotype.  In addition, the form of iron present within the large intestine 
that is driving this process is unknown.  Regardless of this, it has been demonstrated that 
excess iron present within the intestinal lumen is responsible for the development of 
colorectal cancer, and the development of a luminal iron chelator is sought. 
To achieve luminal iron chelation, the therapeutic compound must not demonstrate any 
cellular absorbability and it must chelate iron to render its toxic nature inert.  Of the dietary 
iron chelators tested herein, Manucol LD has been identified as the ideal therapeutic agent 
that demonstrates the stated characteristics.   
 
The chemical composition that imparts Manucol LD 
with this bioactivity was probed and it was identified that Manucol LD contains a unique iron 
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binding structure, formed from a specific sequence arrangement of its chemical monomer 
units.  Iron binding within this cavity results in efficient chelation, where it has been 
identified that the form of iron within this unit is an iron-oxide nanoparticle.  This formatting 
of iron into nanoparticles endows Manucol LD with its desired physiological properties.   
In order to fully validate Manucol LD as a luminal iron chelator the next step would be to test 
the tolerability and efficacy of this compound in man.  Formulation of Manucol LD would 
need to be carefully investigated as specific luminal iron within the colon needs to be 
targeted.  Alongside in vivo studies, it would also be scientifically worthwhile probing the 
iron-chelation mechanism of Manucol LD further and demonstrating its anti-neoplastic 
activity was mediated through an iron chelation mechanism.   Using the techniques 
established in this thesis would allow the modification of any alginate and, with subsequent 
composition analysis, the chemical requirements of an alginate that bestows it with its iron-
chelation ability would be identified; such information would allow synthesis of ‘next 
generation’ luminal iron chelators that may have an ever great affinity towards iron. 
Looking towards the future, the influence of diet on the intestinal microbiome is currently 
becoming an evermore popular research area, and as such it could be speculated that iron is 
generating a carcinogenic phenotype through the modulation of intestinal microbiota.  If this 
were the case, then a new area of study understanding the role of iron in manipulating the gut 
flora enterotype could be established.  Alginates such as Manucol LD may have efficacy in 
this respect, acting as pre-biotic through its iron chelation ability.  In light of this, the major 
form of iron present within the large intestine must be characterised, since this information 
will be central in understanding how iron may be modulating the gut environment.  
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In conclusion, alginate Manucol LD has been established as a novel luminal iron chelator.  
The work presented here demonstrates the rationale in utilising these types of natural 
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Abstract
Alginates are a class of biopolymers with known iron binding properties which are routinely
used in the fabrication of iron-oxide nanoparticles. In addition, alginates have been impli-
cated in influencing human iron absorption. However, the synthesis of iron oxide nanoparti-
cles employs non-physiological pH conditions and whether nanoparticle formation in vivo is
responsible for influencing cellular iron metabolism is unclear. Thus the aims of this study
were to determine how alginate and iron interact at gastric-comparable pH conditions and
how this influences iron metabolism. Employing a range of spectroscopic techniques under
physiological conditions alginate-iron complexation was confirmed and, in conjunction with
aberration corrected scanning transmission electron microscopy, nanoparticles were
observed. The results infer a nucleation-type model of iron binding whereby alginate is
templating the condensation of iron-hydroxide complexes to form iron oxide centred nano-
particles. The interaction of alginate and iron at a cellular level was found to decrease cellu-
lar iron acquisition by 37% (p < 0.05) and in combination with confocal microscopy the
alginate inhibits cellular iron transport through extracellular iron chelation with the resulting
complexes not internalised. These results infer alginate as being useful in the chelation of
excess iron, especially in the context of inflammatory bowel disease and colorectal cancer
where excess unabsorbed luminal iron is thought to be a driver of disease.
Introduction
Alginates are a diverse class of biopolymers extracted from brown algae that are composed of
1–4 linked β-D-mannuronic acid (M) and α-L-guluronic acid (G) monomers. The polymers
can vary in both chain length and composition which, in conjunction with their ability to inter-
act with divalent metal cations, endows alginates with a wide range of physicochemical proper-
ties. Thus unsurprisingly alginates are widely used in the food industry, primarily due to their
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gelling capacity, and are also used in a range of medical applications, for example, in wound-
healing preparations[1], controlled drug release systems[2,3] and anti-reflux formulations.[4]
In addition, alginates are used for the construction of iron-oxide nanoparticles which have a
myriad of applications from drug delivery to magnetic resonance imaging.[5]
The use of alginate as a scaffold for nanoparticle formulation is a well-accepted synthetic
strategy, however, in these reactions the iron-oxide nanoparticles are fabricated using chemi-
cal-forcing conditions whereby highly basic conditions are used to form the iron hydroxide.[5–
8] These conditions are considered optimal for the formation of iron oxide nanoparticles, with
mean diameters ranging between 9 to 10 nm.[9,10] However, whether these iron oxide nano-
particles can form spontaneously in the gastrointestinal tract of man and in particular at low
pH conditions of the stomach, (the first reasonable site of interaction between iron and alginate
consumed in the diet) is unknown.
Supporting the concept of alginate binding iron, there is an increasing body of evidence
emerging that alginates impact on iron metabolism in man.[11,12] A recent human study iden-
tified that an alginate supplemented diet resulted in decreased serum iron levels, alluding to the
role of alginates chelating iron and thus limiting its absorption in the small bowel.[12] On the
contrary, cellular studies have previously shown alginate as having an enhancing effect on
intracellular iron concentration as assessed by ferritin expression; a surrogate biomarker for
cellular iron levels.[13] However, whether these observed changes in cellular iron metabolism
are related to the formation of alginate-iron nanoparticles is unknown. Interestingly, iron-
oxide nanoparticles have been studied with respect to their cellular uptake with a potential
application in iron fortification to treat anaemia.[14–16] No toxicity was associated with the
uptake of these nanoparticles and results indicated that these Fe(III) nanoparticles were
directly taken up by enterocytes in vitro and markedly increased cellular iron concentrations.
Thus, the existing published literature is inconsistent and it remains unclear how alginates
might interact with iron in the context of the gut and whether any resulting complexation may
be of use as a platform for iron fortification or chelation.
Therefore, the aims of this study are i) to determine how alginate and iron(III) interact at
gastric-comparable pH conditions; ii) to verify the speciation of iron with alginate upon com-




Sodium alginate LFR5/60 was a kind gift of FMC Biopolymer, Norway. The average molecular
weight is 34700 Da and a G/M composition of 65%/35%. Dispersion of alginates into water
was achieved through high vortex stirring and solutions left overnight to ensure full hydration.
Isothermal Titration Calorimetry
An adapted protocol was used whereby iron was titrated into LFR5/60 at 37°C.[17] Isothermal
Titration Calorimetry (ITC) measurements were performed on a VPITC MicroCalorimeter
and data was automatically analysed using MicoCal LLC ITC/Origin software package; the
binding isotherm was obtained by integrating injections and fitting them to an appropriate
binding model. All alginate solutions were excessively dialysed before use, to eliminate errors
caused by pH and ionic strength mismatches, and also degassed before use at 2°C below the
titration temperature. Typical experimental parameters included: 37°C cell temperature,
10 μcal s-1 reference power, stirring speed at 286 rpm with the initial injection being small
(2 μl) and discarded in the data analysis. Titration was performed by injection of 8 μl aliquots
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of aqueous iron (III) chloride (5mM) in DI H2O into a solution of aqueous LFR5/60 (0.07 mM,
pH = 5.8) in DI H2O. A delay of 350 sec between each injection was set to allow the energy dif-
ference to return back to baseline. To account for the high energy changes associated with iron
titration into water (the control titration), these heat integrations were subtracted from that of
the alginate-iron titration and the subsequent heats of interaction were fitted using a model of
two binding sites.
Equilibrium dialysis preparation of alginate-iron composites
Alginate solutions (0.1% w/v, 10 ml) were sealed into a dialysis membrane (Mr cut off = 12,400
Da) and incubated in aqueous FeCl36H2O (10 mM, 750 ml) for 120 min and washed in deio-
nised water for a subsequent 120 min. The pH changes of the alginate were tracked over the
period of the incubation. The pH of the alginate inside the dialysis bag pre-incubation was
5.8 and the pH of iron solution pre incubation was 1.7, equivalent to gastric acidity.[18] The
pH of the alginate after incubation was 1.9 and after the wash period this was 3.7.
UV-visible spectroscopy
Absorption spectra were recorded on a Varian Cary50 spectrometer using a quartz cuvette,
path length 1 cm. Increments of varying volumes of aqueous FeCl36H2O (10mM) in DI H2O
were titrated into a stirred solution of aqueous alginate (2 mL, 0.1% w/v) in DI H2O, allowed to
equilibrate for several seconds and then scanned. Measurements were taken up to a point of
saturation. To correct for the absorption of aqueous-iron species at the wavelengths of interest
difference absorbance spectra were obtained by correction of the alginate titration with the
equimolar iron-water control titration.
CD-spectroscopy
CDmeasurements were recorded on a Jasco J-810 CD spectropolarimeter (4 accumulations
with 1 s response) using a 1cm path length, blackened quartz cell. Samples for CD measure-
ments were prepared as described for the dialysis preparations above.
Cell culture
Human RKO colorectal carcinoma cells (obtained from the ACTT CRL-2577) were routinely
cultured in Dulbecco’s modified eagles medium including 10% v/v foetal calf serum, 100 units/
ml penicillin and 0.1 mg/ml streptomycin. Cells were seeded in six well plates at a concentra-
tion of 1x105 cells/ml and grown in medium alone for 24 hours. Once established, the growth
medium was removed and supplemented medium was added (Iron loaded medium: 100 μM
FeSO47H2O and 10 μM sodium ascorbate or alginate loaded medium: LFR5/60 (0.3% (w/v)),
100 μM FeSO47H2O and 10 μM sodium ascorbate)) and incubated for 24 hours. Preparation
of these media was performed as follows; aqueous FeSO47H2O (100 μL, 10 mM) containing
sodium ascorbate (500 mM) in DI H2O was added to a sample of aqueous sodium alginate
(1.5 mL, 2% w/v) in DI H2O and mixed. Growth medium was then added (8.4 mL) and all
constituents were thoroughly mixed. Where alginate was not supplemented, growth medium
(9.9 mL) was added to the iron only. After 24 hours the medium was removed and the cells
washed three times with phosphate buffered saline (PBS). Cells were lysed on ice in RIPA
buffer (nonyl phenoxypolyethoxylethanol 1% (v/v), sodium deoxycholate 0.5% (w/v) and
sodium dodecyl sulphate 0.1% (w/v)) containing protease inhibitors. All samples were then
sonicated for 10 sec whilst kept at 4°C. A protein assay kit (Peirce BCA protein assay) was used
to determine the protein concentration in each sample.
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Western blotting
Western blotting was performed as previously described, with monoclonal antibodies to ferri-
tin (1:5000, Abcam, Rabbit AB69090) and β-actin (1:5000, Abcam, Mouse AB8226).[19] All
blots were subject to densitometry analysis using ImageJ analysing software and data normal-
ised to respective β-actin loading controls.
Synthesis of FITC-alginate
Synthesis of FITC-alginate was performed according to the protocol of Strand et al. [20]
Sodium alginate LFR5/60 (0.32 g, 9.2X10-6 moles) was dissolved in a solution of phosphate
buffered saline at pH 7.4 (50 ml). 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (0.018 g,
9.2X10-5 moles) and n-Hydroxysulfosuccinimide sodium salt (0.02 g, 9.2X10-5 moles) was
added to the alginate solution and stirred for two hours. Once mixed, fluoresceinamine
(0.0319 g, 9.2X10-5 moles) was added and the reaction left to stir in darkness for 24 hours. Free,
unreacted fluorophore was removed by extensive dialysis; one wash in deionised H2O (3.5 L) at
4°C for 24 hours, three washes in NaCl (3.5 L, 1 M) for 24 hours each, then a subsequent six
washes in deionised H2O (3.5 L) for 24 hours each. Once purified, the pH of the solution was
adjusted to 7.4 and stored in the dark at 4°C until required.
Confocal microscopy
Slides for confocal microscopy were prepared by growing RKO cells on sterile 22 mm cover
slips placed in individual wells of a six well cell culture plate. Cells were seeded in six well plates
at a concentration of 1X105 cells/ml and grown in medium alone for 24 hours. Once estab-
lished, cell permeabilisation was performed using saponin (50 μg/ ml) as previously described.
[21] The growth medium was replaced with fluorescent-alginate loaded medium (0.04% fluo-
rescent alginate, 100 μM FeSO47H2O and 10 μM sodium ascorbate) and incubated for 24
hours. Cell nuclei and plasma membranes were subsequently stained with Hoechst 33450
(NucBlue Live Cell Stain, Life technologies) and CellMask Deep Red plasma stain, (Life tech-
nologies) respectively and cells fixed with a 4% paraformaldehyde solution (pH 7.4) at room
temperature. Once fixed images were captured using a Zeiss LSM510 META confocal system
with x63 1.4 oil immersion objective.
Intracellular iron assessment
Cells were seeded in six well plates at a concentration of 1X105 cells/ml and grown in medium
alone for 24 hours. Once established, the growth medium was removed and supplemented
medium was added (Iron loaded medium: 100 μM FeSO47H2O and 500 μM sodium ascorbate,
or alginate loaded medium: LFR5/60 (0.3% (w/v)), 100 μM FeSO47H2O and 500 μM sodium
ascorbate)) and incubated for 24 hours; in both instances iron stimulations were spiked with
59FeCl3 to reach ca. 10,000 counts per minute (CPM) per well. To prepare the radio-active iron
medium with alginate, aqueous FeSO47H2O (100 μL, 10 mM) in DI H2O containing sodium
ascorbate (500 mM) in DI H2O was mixed with
59FeCl3 in aqueous HCl (0.1M). This was then
added to aqueous sodium alginate (1.5 mL, 2% w/v) in DI H2O and thoroughly mixed. Growth
medium was then added (8.4 mL) and all constituents mixed. In iron-only supplemented
media, no sodium alginate was added, only the addition of growth medium (9.9 mL) to the
radio-active iron. After this incubation period the medium was removed and cells washed
three times with 2 ml Versene (0.2g/L EDTA in phosphate buffered saline), and lysed in 150 μl
HEPES-saline lysis buffer (10 mM, pH 7.4, NaCl 0.9% (w/v)). To determine cellular iron
content, the lysates were pipetted into scintillation tubes containing scintillation fluid (1 mL,
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PerkinElmer OPTIPHASE HISAFE3) and counted on a gamma-counter (Packard 2500 TR liq-
uid scintillation counter).
Scanning Transmission Electron Microscopy/ Energy-dispersive X-ray
spectroscopy
Alginate-iron samples used for STEM/EDX were made using the equilibrium dialysis tech-
nique as described earlier. Preparation of these samples was performed as follows; aqueous
sodium alginate (10 mL, 0.1% w/v, pH 5.8) in DI H2O was sealed within a dialysis membrane
and immersed in a pre-mixed solution of FeCl36H2O (10 mM, 750 ml, pH 1.7) for 120 min.
The dialysis bag was removed, and subsequently immersed in pure DI H2O (750 mL) and incu-
bated for another 120 min. Due to the viscous nature of the sample, copper TEM grids coated
with lacey carbon were loaded with 50 μl of sample and excess sample was drawn from under-
neath, effectively pulling the sample through the grid. This produced a thin sample coverage
over the grid with many sampling areas.
Electron microscopy images were taken using a 200kV FEG Jeol 2100F scanning transmis-
sion electron microscope fitted with a CEOS aberration corrector. Images were simultaneously
acquired in high angular annular dark field (HAADF) and bright field (BF) mode using the
Gatan DigitalMicrograph software package.
Results
Studies of iron-alginate complexation
Isothermal titration microcalorimetry (ITC) was performed to examine the strength of interac-
tion between iron and alginate (LFR5/60). Iron(III) chloride was titrated into a solution of
LFR5/60 and a drop in the integrated heats of each addition was observed (Fig 1A) Saturation
of iron binding by alginate occurred at a molar ratio of iron:alginate of 3:1, with a 5 times
excess of iron used to ensure saturation of all the binding sites on the alginate. Data analysis,
which was best fit using a two-site binding model, revealed two binding events between alginate
and iron with the estimated binding constants calculated as K1 = 1X10
6 and K2 = 3X10
4 M-1
respectively. The equation that models this binding can be found in S1 Fig. Entropy was posi-
tive in both binding events (18.4 and 23.2 cal mol-1 K-1). Enthalpy values were found to be exo-
thermic for both binding events (-704 x 104 and -1548 cal mol-1).
The binding of ferric ions to alginate was further verified using UV-Visible and Circular
Dichroism (CD) spectroscopy. (Fig 1B and 1C) Titration of an aqueous solution of Fe(III) to
an aqueous solution of sodium alginate LFR5/60 revealed the growth of a band at 280 nm
(Fig 1C); confirming iron binding to alginate. Profile changes were plotted against molar equiv-
alents of iron and a binding plot for alginate iron binding was obtained (Fig 1B). This data can
be fitted to a 1:1 binding equation and an alginate iron binding constant of K = 1X103 M-1 cal-
culated (S2 Fig).
To further support the spectroscopic results demonstrating alginate complexation, CD spec-
troscopy was also performed since its fundamental application is probing transitions within
chiral compounds; alginate is highly chiral due to its polymeric nature and the chiral carbon
centres on the individual monomers. Alginate-iron complexes were isolated using equilibrium
dialysis. The CD spectrum of the isolated iron-alginate complexes shows the appearance of a
peak at 280 nm (Fig 1C), which correlates with the peak identified in the UV-visible spectrum
(Fig 1B). This profile is indicative of iron hydroxide (Fe-OH) binding and confirms that the
changes observed in the UV-visible spectrum are attributed to the alginate binding to Fe-OH
species in solution (Fig 1C).
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Fig 1. Chemical analysis of iron alginate binding. (Ai) Isothermal titration microcalorimetry thermogram of 8 μl injectants of 5 mM Fe(III) into 0.04 mM
alginate at 37°C. (Aii) Corresponding isotherm. (Bi) UV-Visible difference spectra of iron (III) titrated into alginate with a clear absorbance change at ca. 280
nm (Bii) absorbance change at 274nm vs final Fe concentration (M) with binding curve) (C) CD spectra of alginate-iron composites isolated via equilibrium
dialysis. An induced CD signal is evident at ca. 280 nm. This correlates to the iron-hydroxide species bonded to the alginate as indicated from the UV-Visible
spectra.
doi:10.1371/journal.pone.0138240.g001
Alginate Modulation of Iron Metabolism
PLOSONE | DOI:10.1371/journal.pone.0138240 September 17, 2015 6 / 14
Alginates template iron oxide nanoparticle formation under simple
mixing conditions
As CD identified the presence of Fe-OH within the alginate-iron composites, these were fur-
ther characterised using aberration corrected STEM (Fig 2). This is capable of achieving ultra-
high resolution with atomic number contrast imaging in the material sciences, but is rarely
used to investigate ‘biological’ samples due to the low atomic number of most bio-materials.
[22] However, the iron component of the alginate-iron composites provided distinguishable
contrast, thus it was possible to image atomic structure at the highest resolution (Fig 2).
Low magnification HAADF-STEM imaging revealed a gel-like alginate network covered in
iron with dense nucleation-sites present (Fig 2A) while energy-dispersive X-ray spectroscopy
confirmed that these dense centres indeed contained iron (Fig 2C). Within this gel, small nano-
particles with a mean diameter of 1.78 ± 0.70 nm were detected and under higher magnifica-
tion lattice structures could be visualised within these nanoparticles (Fig 2B). Fast Fourier
transform analysis of the lattice arrangements gave diffraction spots (labelled) which were in
partial agreement with both Fe2O3 hematite, and ferrihydrite, but the small particles yielded
insufficient visible bright spots to determine the precise phase of these nanoparticles.[6,23]
Samples of aqueous iron chloride alone were imaged and there was no evidence of particulate
iron.
Fig 2. Physical characterisation of alginate iron composites. (Ai) Low magnification STEM images of alginate-iron composites revealed the alginate
network ‘decorated’ in iron (denoted by arrows) with a single highly dense iron nucleation site (denoted with an asterisk). (Aii) A higher magnification image of
the nucleation centre revealed nanoparticles of approximately 2–5 nm in diameter. (B) Fast Fourier transform analysis of HAADF-STEM images of two
individual nanoparticles. (C) EDXmapping of iron-alginate composites with oxygen, iron and sodium localisation shown in the sample area. The copper from
the copper TEM grid functions as a control.
doi:10.1371/journal.pone.0138240.g002
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The effect of alginate on cellular iron metabolism
To assess the influence of alginate-iron interaction in human intestinal cells, RKO cells were
challenged with an iron-enriched media either with, or without alginate LFR5/60. The iron-
enriched media was spiked with radio-active iron-59, and after an incubation period of 24
hours the iron-content of the cell was measured (Fig 3A). Results demonstrated a significant
decrease (37%, p< 0.05) in radioactivity in cells co-cultured in the presence of alginate com-
pared to control (no alginate). To support this result ferritin expression, a surrogate marker for
cellular iron levels was also determined. Ferritin expression was significantly decreased (17
fold; p< 0.05) when cells were cultured in the presence of iron and alginate compared to iron
alone (control) (Fig 3B).
Alginate iron composites are not cell-permeable
Since alginate depleted intracellular iron, confocal microscopy was performed to assess the
localisation of the alginate in these cell culture experiments and specifically to deduce if the
alginate is internalised. To assess the bioavailability of alginate LFR5/60 and the composites
Fig 3. Effects of alginate on cellular iron transport. (A) Intracellular iron concentration decreases when RKO cells were incubated with iron-59 and
alginate (0.3% w/v) compared to iron only control (B) Treatment of RKO cells with iron increases ferritin expression whilst co-incubation with alginate (0.3%
w/v) significantly suppressed the iron mediated ferritin induction. All experiments were performed in triplicate with error bars representing +/- SEM and
* denotes statistical significance at p < 0.05.
doi:10.1371/journal.pone.0138240.g003
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formed upon interaction with iron a fluorescent analogue was prepared by conjugation with
fluoresceinamine (FITC) as schematically illustrated in Fig 4Ai. Absorption and emission spec-
tra were recorded for the fluorescent alginate with absorption and emission maxima (λmax) at
ca. 490 and 550 nm respectively (Fig 4B).
RKO cells were then cultured in the presence of FITC-alginate with or without a cellular
permeabilisation step for 24 hours on microscope slips which were subsequently used for imag-
ing in confocal microscopy. Cells were stained with DeepRed and Hoechst to define the cellular
membrane and nucleus respectively (Fig 5).
Confocal image analysis revealed that whilst there was negligible amounts of FITC-alginate
bound on the cell periphery (Fig 5B) no FITC-alginate was observed within the cell (Fig 5). As
a further control cells were membrane-permeabilised and co-cultured with FITC-alginate, and
in this instance, FITC- alginate is able to penetrate the outer cell membrane supporting the lim-
ited bioavailability of alginate in non-permeabilised cells.
Discussion
Alginates and their use in nanoparticle formation is well established, however this is the first
study to examine the interaction of iron and alginate in gastric-comparable pH conditions.
This is particularly warranted since the existing literature is inconsistent in terms of the effect
of alginate on cellular iron absorption and ultimate effects on human iron metabolism.[12,13]
Our results unequivocally demonstrate that alginate chelates iron under gastric comparable
conditions as evidenced through UV Visible spectroscopy, ITC and CD. We have found by
ITC that alginate–iron complexation involves two distinct binding events; an initial iron bind-
ing which then facilitates alginate reorganisation to accommodate the final iron binding. This
Fig 4. Synthesis of FITC alginate. (Ai) Reaction coupling scheme of FITC onto alginate under peptide coupling conditions. (Aii) Image of fluorescent
alginate in normal light (left) and exposed to λ = 365 nm UV light (right). (B) Absorption and emission (red and blue lines respectively) spectra of the
fluorescent alginate (FlAlg) product. The native alginate reactant has no absorption or emission profile, however, upon conjugation with FITC a highly
absorption and emission peaks are observed.
doi:10.1371/journal.pone.0138240.g004
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is consistent with previous studies which indicate cooperativity of metal binding to alginate. In
addition structural reorganisation of alginate polymers during ion binding has been reported
previously in the case of calcium. [24,25]
With regards to the species of iron that is complexed to alginate, UV Visible spectroscopy,
upon iron titration, revealed a peak at 280 nm which has previously been attributed to the pres-
ence of an iron-oxide species. This electronic transition is characteristic to the charge transfer
originating from the OH- ligands to the Fe ion.[26] CD Spectroscopy demonstrated that the
Fe-OH species were complexed to alginate since an induced CD signal was observed at 280
nm.
To probe the physical structure of the alginate iron composites formed under these physio-
logical conditions HAADF-STEM was utilised. Interestingly, we demonstrate that alginate che-
lates iron to form a range of composites, from long range gel-like structured strands to smaller
nanoparticulate matter. This mix of composites is unsurprising since the way the alginate and
iron is brought together is uncontrolled. The combination of solution spectroscopy and high
resolution STEM identified the core of the alginate nanoparticles to be iron-oxide in composi-
tion. However, it is known that the electron beam energy can affect samples under investigation
during examination in an electron microscope and thus it is important to note that there is the
possibility of electron beam damage causing structural and/or chemical particle-phase
Fig 5. Cellular localisation of alginate with confocal microscopy. Cells were treated with iron alone (control) or iron and FITC alginate with or without cell-
membrane permeabilisation. (A) Cells treated with iron alone as expected showed no FITC signal. (B) Cells treated with iron and FITC alginate showed
negligible punctate FITC staining on the cell periphery (C) Cells permeabilised with Saponin and then cultured with iron and FITC alginate showed an
abundance of intracellular FITC signal which was mostly cytoplasmic in localisation.
doi:10.1371/journal.pone.0138240.g005
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conversion. This could indeed result in a phase conversion from, for example, a ferrihydrite-
particle to a haematite arrangement, which were both found here.[27]
A mechanism of nanoparticle formation can be proposed whereby iron initially binds to
alginate forming an iron-hydroxide. Subsequently, at a critical concentration of iron loading,
the alginate collapses and forms a nucleation site where iron hydroxide condensation can take
place to form iron-oxide centred nanoparticles; the whole process templated by alginate (Fig
6). This mechanism supports the two event binding observed by ITC. Such models have been
reported for other biopolymers binding metals including carrageenans. [28]
These findings confirmed the iron-binding ability of alginate, with iron binding constants
on par with other biological proteins (e.g. ferritin), [29] and interestingly, ferritin similarly
stores iron as its oxide form.[29,30] The formation of these composites may rationalise some of
the effects seen in biological systems by others [12]. However, whilst it is clear that the alginate
binds iron, what effect this has on cellular and human iron metabolism remains controversial
whilst some studies advocating the usefulness of alginate in iron fortification and others iron
chelation programmes. [13,31,32]. Our data suggest that alginate has the potential to bind ‘free’
reactive iron and this leads to the formation of iron-oxide centred nanoparticles. Although
whether such ‘free’ iron exists within the gastrointestinal tract and or what form the residual
unabsorbed iron takes still remains to be elucidated; indeed, there is evidence supporting the
presence of both the particulate and ‘free’ forms.[33] Whether alginate is able bind particulate
iron, if it exists within the gastrointestinal tract is not known and this clearly warrants further
study.
From our own studies it is clear that alginate inhibits cellular iron transport by binding the
iron in solution and the resulting complex remaining extracellular. This is evidenced by a sup-
pression in cellular iron transport in the presence of alginate and a lack of any notable alginate
present within the cells.[11,34–36] We may hypothesise from these observations that the algi-
nate-iron nanoparticles are unable to be internalised into cells which may be due to a number
of factors including nanoparticle size and surface coating.
Thus it can be considered that alginates act as iron chelators and are not bioavailable with
respect to cellular uptake. This confirms previous studies, most notably, a recent human study
has shown that alginate supplementation inhibits iron absorption in man, [11,36] and this may
be attributed to the formation of iron-alginate nanoparticles. Thus in vivo alginate could be
considered as an iron chelator and coupled with its inherent non-absorbability would make it
Fig 6. Schematic illustration of the binding arrangement of iron to alginate under simple mixing conditions.
doi:10.1371/journal.pone.0138240.g006
Alginate Modulation of Iron Metabolism
PLOSONE | DOI:10.1371/journal.pone.0138240 September 17, 2015 11 / 14
an ideal candidate for use in patients with inflammatory bowel disease and colorectal cancer
where excess reactive luminal iron is thought to be involved in the disease process.[37–39] One
might predict that alginate supplementation in these groups would enhance their health
through iron chelation.
Supporting Information
S1 Fig. ITC model of independent binding sites.Where Q = heat content of the solution,
n = number of binding sites, Mt = total concentration of macromolecule in Vo, Vo = active cell
volume, H = enthalpy, Xt = total ligand concentration and K = the binding constant.
(TIF)
S2 Fig. Equation of the 1:1 binding model.Where [H] = [alginate] and [G] = [Fe].
(TIF)
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